<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Market News &#38; Stocks to Watch from StraightStocks &#187; Europe</title>
	<atom:link href="http://www.straightstocks.com/tag/europe/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.straightstocks.com</link>
	<description>Leading Stock Market News, Opinions and Commentary</description>
	<lastBuildDate>Wed, 25 Nov 2009 09:50:28 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.5</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>GPRO, UCTT, VGPR, DrStockPick.com Watch List! for Wednesday Nov 25, 2009, Gen-Probe Inc., Ultra Clean Holdings Inc. and Vega Promotional Systems, Inc., VGPR.PK</title>
		<link>http://www.straightstocks.com/stock-watch/gpro-uctt-vgpr-drstockpick-com-watch-list-for-wednesday-nov-25-2009-gen-probe-inc-ultra-clean-holdings-inc-and-vega-promotional-systems-inc-vgpr-pk/</link>
		<comments>http://www.straightstocks.com/stock-watch/gpro-uctt-vgpr-drstockpick-com-watch-list-for-wednesday-nov-25-2009-gen-probe-inc-ultra-clean-holdings-inc-and-vega-promotional-systems-inc-vgpr-pk/#comments</comments>
		<pubDate>Wed, 25 Nov 2009 01:50:35 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Allegro Manufacturing Pte. Ltd]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[bio-diesel products]]></category>
		<category><![CDATA[biofuel products]]></category>
		<category><![CDATA[biomass facility]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[energy efficient pellet fuel]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Gen-Probe Inc.]]></category>
		<category><![CDATA[green energy products]]></category>
		<category><![CDATA[Infectious Disease]]></category>
		<category><![CDATA[infectious disease applications]]></category>
		<category><![CDATA[organic waste bi-products]]></category>
		<category><![CDATA[parainfluenza]]></category>
		<category><![CDATA[Prodesse Inc.]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[respiratory tract infections]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor capital equipment]]></category>
		<category><![CDATA[Singapore]]></category>
		<category><![CDATA[South America]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[UCTT]]></category>
		<category><![CDATA[Ultra Clean Holdings Inc.]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Vega Promotional Systems Inc.]]></category>
		<category><![CDATA[VGPR]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.gen-probe.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.uct.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4964</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

DrStockPick.com Watch List!
My Picks for Wednesday Nov 25, 2009 are:
**************************************************************
GPRO, Gen-Probe Inc.
GPRO is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/gpro-uctt-vgpr-drstockpick-com-watch-list-for-wednesday-nov-25-2009-gen-probe-inc-ultra-clean-holdings-inc-and-vega-promotional-systems-inc-vgpr-pk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Citi Expects Strong Economic Growth &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/citi-expects-strong-economic-growth-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/citi-expects-strong-economic-growth-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 22:37:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Argentina]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Citi]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Hungary]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Korea]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[Poland]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27607/Citi+Expects+Strong+Economic+Growth+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Citigroup Inc.</strong> (<a href="http://www.zacks.com/stock/quote/c">C</a>) forecasts strong economic growth in many countries in 2010. But although the company expects several countries to experience economic growth, it predicts that the growth will be somewhat uneven.<br />
<br />
According to the annual report of Citi&#8217;s Investment Research and Analysis group, though growth will be strong and even across major economies in the beginning of the year, it will be uneven later. Citi expects Asia, excluding Japan, to experience sustained economic growth. Though the U.S. is expected to see fairly strong economic growth, the recovery will be more gradual in Europe and Japan.<br />
<br />
Citi also upgraded its 2010 gross domestic product forecasts for the U.S., Japan, the U.K., Australia, New Zealand, Hong Kong, Korea, Argentina, Hungary, Poland, the Czech Republic and Turkey.<br />
<br />
The report also suggested that Central Banks are unlikely to hike key interest rates through the next year. However, credit availability is expected to remain restricted at least for a year or two as banks seek to raise additional capital under regulatory pressure. Also, inflation on a global basis appears to be controlled. Additionally, countries will need to achieve fiscal sustainability to post strong economic growth.<br />
<br />
The rankings of global economies are expected to change significantly in the next 5 to 15 years as Asia is predicted to experience rapid industrialization and increased domestic demand while resource-rich regions such as Africa, the Middle East, Latin America, Russia and Brazil see growth.<br />
<br />
Citi is a leading global financial services company and has approximately 200 million customer accounts, doing business in more than 140 countries. Hence, the company&#8217;s earnings will be benefited with the accuracy of the forecast.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=C">Read the full analyst report on "C"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/citi-expects-strong-economic-growth-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report! 11/24/09, CSRH, MHP, TEL, WU, PBTH, SVBI</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-csrh-mhp-tel-wu-pbth-svbi/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-csrh-mhp-tel-wu-pbth-svbi/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 16:47:09 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Committee for Medicinal Products for Human Use]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CTP]]></category>
		<category><![CDATA[CTP technology]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[Harold McGraw III;]]></category>
		<category><![CDATA[leader in the money transfer segment]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Merck Co]]></category>
		<category><![CDATA[New York City]]></category>
		<category><![CDATA[Office Of Thrift Supervision]]></category>
		<category><![CDATA[Otc Bulletin Board]]></category>
		<category><![CDATA[President and CEO]]></category>
		<category><![CDATA[PROLOR Biotech Inc.]]></category>
		<category><![CDATA[Severn Bancorp Inc.]]></category>
		<category><![CDATA[Severn Savings Bank]]></category>
		<category><![CDATA[Special General]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[The McGraw-Hill Companies]]></category>
		<category><![CDATA[Tyco Electronics Ltd.;]]></category>
		<category><![CDATA[UBS]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Washington University in St. Louis]]></category>
		<category><![CDATA[Western Union Company]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4947</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Tuesday Nov 24, 2009
DrStockPick.com Stock Report!
**************************************************************

Consorteum Holdings  Inc. (OTCBB: CSRH) launched its consumer stored value rebate card. The  consumer rebate card program will offer manufacturers and retailers a new way to  process mail-in rebates that ensures increased customer loyalty and decreased [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112409-csrh-mhp-tel-wu-pbth-svbi/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>H-P Revenue Down, EPS In-Line &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/h-p-revenue-down-eps-in-line-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/h-p-revenue-down-eps-in-line-analyst-blog/#comments</comments>
		<pubDate>Tue, 24 Nov 2009 13:39:13 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3Com Corporation;]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Americas]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[Business Critical Systems]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[consumer hardware]]></category>
		<category><![CDATA[data storage systems]]></category>
		<category><![CDATA[EDS]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[HP Software;]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27576/H-P+Revenue+Down%2C+EPS+In-Line+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Hewlett-Packard</strong> (<a href="http://www.zacks.com/stock/quote/hpq">HPQ</a>) reported fourth quarter EPS of $1.14, exceeding the Zacks Consensus Estimate by a penny.<br />
<em><strong><br />
Revenue</strong></em><br />
<br />
Revenue for the quarter came in at $30.8 billion, a decrease of 8.0% from the $33.6 billion reported in the year-ago period and down 5.0% on constant currency basis.<br />
<br />
Revenue fell across all businesses, including servers and data storage systems, software, PCs and printers. The Americas reported a 3.0% decline in revenue to $13.6 billion. Revenue declined 17.0% in Europe, the Middle East and Africa (EMEA) to $11.7 billion and 1.0% in the Asia Pacific to $5.4 billion. Revenue from China increased more than 20% from the year-ago quarter.<br />
<br />
International markets accounted for 64% of total revenue in the fourth quarter, with revenue in the BRIC countries (Brazil, Russia, India and China) declining 4.0% on a year-over-year basis and accounting for 10.0% of total HP revenue.<br />
<em><strong><br />
Results and Analysis by Segment<br />
</strong></em><br />
<ul>
    <li> <strong>The Technology Solutions Group (TSG)</strong> was $14.1 billion down 2.6% year over year. Within TSG, Enterprise Storage and Servers (ESS) revenue declined 17.0% year over year, driven by declines across all three business units -- Industry Standard Servers, Business Critical Systems and Storage. Services revenue increased 8.0% year over year, mainly due to the addition of EDS&#8217; revenue. EDS&#8217; integration was ahead of the company&#8217;s plans. HP Software revenue fell 16.0% year over year with declines in both the Business Technology Optimization (BTO) portfolio and other software.</li>
    <li><strong> Personal Systems Group (PSG)</strong> revenue was $9.8 billion, which fell 12.0% year over year despite an 8% year-over-year increase in unit shipments. The company maintained its leading market position in PCs in every region. However, notebook revenue declined 8.0%, while Desktop revenue declined 16.0%. Commercial client revenue was down 15% and Consumer client revenue down 8.0%.</li>
    <li><strong> Imaging and Printing Group (IPG)</strong> continued to struggle as revenue was $6.4 billion, down 15.0% year over year. Ink supplies, commercial hardware and consumer hardware also reported substantial declines. We believe this segment has come under pressure due to strong competition from cheaper brands. Printer unit shipments decreased 20.0% from which period, with consumer and commercial printer hardware units down 14.0% and 138.0%, respectively. Consumer and commercial hardware revenue declined 17.0% and 32.0%, respectively.</li>
    <li> <strong>HP Financial Services (HPFS) </strong>revenue was $0.7 billion, up 5.0% year over year. Financing volumes increased 6.0%, while in net portfolio assets increased 21.0%.</li>
</ul>
<em><strong><br />
Operating Results</strong></em><br />
<br />
Gross margins for the quarter were 23.7%, up 60 basis points year over year. This increase in gross margin can be attributed to efficiency gains in services and increased supplies mix in IPG. The company continues to reduce cost; lowering operating expenses by 16.0% from the year-ago quarter. The lower costs are driven by structural changes that drive sustainable improvements. GAAP operating margin for the quarter was 10.2%, up from 8.2% reported in the year-ago quarter.<br />
<br />
GAAP diluted net earnings per share (EPS) in the fourth quarter were $0.99, compared with $0.84 in the prior-year period. Non-GAAP financial information excludes after-tax costs related primarily to the amortization of purchased intangibles, restructuring charges and acquisition-related charges of approximately $0.15 per share and $0.19 per share in the fourth fiscal quarter of 2009 and 2008, respectively. Non-GAAP EPS were $1.14, compared with $1.03 in the prior-year period.<br />
<br />
HP generated $3.4 billion in cash flow from operations versus $3.9 billion in the previous quarter. Free cash flow was $2.6 billion. The company exited the quarter with long-term debt balance of $13.9 billion, after repaying $1.5 billion of debt.<br />
<br />
HP also returned $2.3 billion to shareholders in the form of share repurchases and dividends. The company ended the quarter with $13.3 billion in cash and short-term investments versus $13.7 billion in the previous quarter.<br />
<br />
<em><strong>Guidance</strong></em><br />
<br />
For the first quarter of fiscal 2010, HP estimates revenue of approximately $29.6 billion to $29.9 billion, GAAP diluted EPS of $0.90 to $0.92 and non-GAAP diluted EPS of $1.03 to $1.05. Non-GAAP diluted EPS estimates exclude after-tax costs of approximately $0.13 per share, related primarily to the amortization of purchased intangibles, restructuring charges and acquisition-related charges.<br />
<br />
For the full-year 2009, the company expects revenue of approximately $118.0 billion to $119.0 billion, up from its previous estimate of $117.0 billion to $118.0 billion. The GAAP diluted EPS is expected to be in the range of $3.65 to $3.75, up from its previous estimate of $3.60 to $3.70, and non-GAAP diluted EPS is expected to be in the range of $4.25 to $4.35, up from its previous estimate of $4.20 to $4.30.<br />
<br />
Non-GAAP diluted EPS estimates for fiscal year 2010 exclude after-tax costs of approximately $0.60 per share, related primarily to the amortization of purchased intangibles, restructuring charges and acquisition-related charges. These estimates exclude the potential impact of the acquisition of 3Com Corporation that the company announced in November 2009.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HPQ">Read the full analyst report on "HPQ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/h-p-revenue-down-eps-in-line-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Video: Radio Free Europe and the Velvet Revolution</title>
		<link>http://www.straightstocks.com/investing-lessons/video-radio-free-europe-and-the-velvet-revolution/</link>
		<comments>http://www.straightstocks.com/investing-lessons/video-radio-free-europe-and-the-velvet-revolution/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:52:29 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Europe]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22252</guid>
		<description><![CDATA[
         
        
    ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/video-radio-free-europe-and-the-velvet-revolution/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HZHI, CVAT, PWRM, HCEI, PSFT, TAXS, CSRH, AQNM, Stocks at a Glance. DrStockPick.com Report!</title>
		<link>http://www.straightstocks.com/stock-watch/hzhi-cvat-pwrm-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/hzhi-cvat-pwrm-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:26:57 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[3-D]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[BioMedReports.com]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemical sensors]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[emergency services;]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[environmental friendly technology]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Exmovere Holdings Inc.]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Homeland Security]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical diagnostics]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[mobility devices]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[Nano Cavitation Technologies]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[news portal;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online data centers]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[personal mobility device]]></category>
		<category><![CDATA[physical and chemical refining]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[platform semiconductor]]></category>
		<category><![CDATA[platform semiconductor technology]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[scientific instrumentation]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[wearable device]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.psftinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4937</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday November 23, 2009
DrStockPick.com Stock Report!
HZHI CVAT, PWRM, HCEI, PSFT, TAXS, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hzhi-cvat-pwrm-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TV to Launch Wireless Service &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/tv-to-launch-wireless-service-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/tv-to-launch-wireless-service-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 20:02:53 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[America Movil S.A.B. de C.V.]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[broadband Internet connection;]]></category>
		<category><![CDATA[cable operator]]></category>
		<category><![CDATA[Cable Tv]]></category>
		<category><![CDATA[Cablevision]]></category>
		<category><![CDATA[cellular telephone]]></category>
		<category><![CDATA[digital cable television services]]></category>
		<category><![CDATA[Dominant Player]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[fiber optic network;]]></category>
		<category><![CDATA[fixed telephony services]]></category>
		<category><![CDATA[high-definition television services]]></category>
		<category><![CDATA[I.R.I.S. s.a. TG3Z3510AFCS Headset]]></category>
		<category><![CDATA[long-distance services solutions]]></category>
		<category><![CDATA[media]]></category>
		<category><![CDATA[Megacable]]></category>
		<category><![CDATA[Mexican Ministry of Communication and Transportation]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[mobile phone services;]]></category>
		<category><![CDATA[telecommunications service providers]]></category>
		<category><![CDATA[Telefonica S.A.]]></category>
		<category><![CDATA[Televisa]]></category>
		<category><![CDATA[television network]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[video-on-demand products]]></category>
		<category><![CDATA[wireless communications]]></category>
		<category><![CDATA[wireless services market]]></category>
		<category><![CDATA[wireless services venture]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27544/TV+to+Launch+Wireless+Service+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Grupo Televisa S.A. </strong>(<a href="http://www.zacks.com/stock/quote/TV">TV</a>) has decided to explore the wireless communications market. Televisa is the largest media company in Mexico as well as in the Spanish-speaking world. Its cable TV subsidiary Cablevision will start providing mobile phone services in Mexico from the first quarter of 2010. Televisa has already started its own telecom business. On May 9, 2007, the Mexican Ministry of Communication and Transportation granted Cablevision permission to offer fixed telephony services through its network. As of now, Cablevision offers digital cable television services, broadband Internet connection, high-definition television services and video-on-demand products.<br />
 <br />
Televisa is a dominant force in the Mexican media business. The company is almost a monopoly with around 70% of the Mexican open television market. Televisa has a stable customer base in many different areas, including television broadcasting, pay television network, publishing, and radio. Cablevision will try to leverage this long-established customer base to explore its new wireless services venture. Furthermore, Televisa has been expanding to more stable and developed markets in the U.S. and in Europe. <br />
<br />
The Mexican wireless services market is highly competitive. <strong>America Movil S.A.B. de C.V.</strong> (<a href="http://www.zacks.com/stock/quote/AMX">AMX</a>) is the dominant player in this market commanding approximately 70% share. <strong>Telefonica S.A.</strong> (<a href="http://www.zacks.com/stock/quote/TEF">TEF</a>) is the other major competitor. Mexican cable operator Megacable also decided to enter this market in early 2010. Cablevision already provides data and long-distance services solutions to carriers and other telecommunications service providers through its fiber-optic network in Mexico and the U.S.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TV">Read the full analyst report on "TV"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMX">Read the full analyst report on "AMX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEF">Read the full analyst report on "TEF"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/tv-to-launch-wireless-service-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CytRx Technical Breakout on Pending News (NASDAQ:CYTR)</title>
		<link>http://www.straightstocks.com/stock-watch/cytrx-technical-breakout-on-pending-news-nasdaqcytr-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/cytrx-technical-breakout-on-pending-news-nasdaqcytr-2/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 18:58:25 +0000</pubDate>
		<dc:creator>Jay Garcilazo</dc:creator>
				<category><![CDATA[Biotech]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Am-80]]></category>
		<category><![CDATA[APL]]></category>
		<category><![CDATA[bone marrow transplant]]></category>
		<category><![CDATA[CytRx Corporation]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[FavStocks]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[MiV Investments Inc.]]></category>
		<category><![CDATA[STAR-1]]></category>
		<category><![CDATA[The star]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.favstocks.com/?p=2165</guid>
		<description><![CDATA[   Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.35 per share, up 20.18% from ...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cytrx-technical-breakout-on-pending-news-nasdaqcytr-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Novellus Raises Guidance &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/novellus-raises-guidance-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/novellus-raises-guidance-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 18:44:52 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Advanced Micro Devices]]></category>
		<category><![CDATA[analog]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[applied materials]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[ASML Holdings]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[computing]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Intel]]></category>
		<category><![CDATA[Intersil Corp;]]></category>
		<category><![CDATA[Linear Technology;]]></category>
		<category><![CDATA[Maxim Integrated Products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Novellus]]></category>
		<category><![CDATA[Novellus Systems]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27546/Novellus+Raises+Guidance+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Novellus Systems</strong> (<a href="http://www.zacks.com/stock/quote/NVLS">NVLS</a>) raised its fourth-quarter revenue and earnings outlook, as a result of the ongoing recovery in the semiconductor market.<br />
 <br />
The company now expects revenues of $225-245 million, compared to previous guidance of $215-245 million, which raises the mid-point from $230 to $235 million.<br />
 <br />
Management had previously guided to bookings increase of 25-50%, which were not subsequently revised. Therefore, we assume that bookings are expected to remain within this range.<br />
 <br />
GAAP gross margin expectations were also not revised and remain in the 44-47% range.<br />
 <br />
EPS expectations were raised to 25-40 cents from previous guidance of 20-40 cents. The Zacks Consensus Estimate for the fourth quarter is pegged at 31 cents, close to the middle of the revised range.<br />
 <br />
The company&#8217;s third-quarter earnings beat the Zacks Consensus Estimate by a penny. Order momentum, stronger DRAM and NAND prices, higher volumes, higher utilization rates and a lower cost structure contributed to the better-than-expected results.<br />
 <br />
The computing and smart phone markets drove strength in the third quarter and are expected to drive fourth quarter results as well.<br />
 <br />
The company generates the largest chunk of revenues from the Asia Pacific region, followed by North America and then Europe. We expect the Asia Pacific region to remain strong in the next quarter, as the strength in DRAM and NAND prices continue. Last quarter, revenues from the region increased double-digits both sequentially and year over year. We also expect improvement in both North America and Europe.<br />
 <br />
Not only Novellus, but other equipment makers such as <strong>ASML Holdings</strong> (<a href="http://www.zacks.com/stock/quote/ASML">ASML</a>), <strong>Applied Materials</strong> (<a href="http://www.zacks.com/stock/quote/AMAT">AMAT</a>) and <strong>KLA Tencor</strong> (<a href="http://www.zacks.com/stock/quote/KLAC">KLAC</a>), microprocessor makers such as <strong>Intel </strong>(<a href="http://www.zacks.com/stock/quote/INTC">INTC</a>) and <strong>Advanced Micro Devices </strong>(<a href="http://www.zacks.com/stock/quote/AMD">AMD</a>), and analog makers such as <strong>Linear Technology</strong> (<a href="http://www.zacks.com/stock/quote/LLTC">LLTC</a>), <strong>Maxim Integrated Products</strong> (<a href="http://www.zacks.com/stock/quote/MXIM">MXIM</a>), <strong>Intersil Corp</strong> (<a href="http://www.zacks.com/stock/quote/ISIL">ISIL</a>) and <strong>Semtech </strong>(<a href="http://www.zacks.com/stock/quote/SMTC">SMTC</a>) reported stronger results in the last quarter.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NVLS">Read the full analyst report on "NVLS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ASML">Read the full analyst report on "ASML"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMAT">Read the full analyst report on "AMAT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=KLAC">Read the full analyst report on "KLAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=INTC">Read the full analyst report on "INTC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMD">Read the full analyst report on "AMD"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLTC">Read the full analyst report on "LLTC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MXIM">Read the full analyst report on "MXIM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ISIL">Read the full analyst report on "ISIL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SMTC">Read the full analyst report on "SMTC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/novellus-raises-guidance-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TAXS, CSRH,  DrStockPick.com Stock Report! TaxMasters, Inc. and  Consorteum Holdings Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/taxs-csrh-drstockpick-com-stock-report-taxmasters-inc-and-consorteum-holdings-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/taxs-csrh-drstockpick-com-stock-report-taxmasters-inc-and-consorteum-holdings-inc/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 18:11:38 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4924</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________
Monday November 23, 2009
DrStockPick.com Stock Report!
**************************************************************
 CSRH, Consorteum Holdings Inc, CSRH.OB
CSRH will build on its extensive expertise within the Payments and Transaction Industry in North America, Europe and Internationally. By identifying new technologies and trends in the changing global marketplace, Consorteum Holdings Inc. aims [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taxs-csrh-drstockpick-com-stock-report-taxmasters-inc-and-consorteum-holdings-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cardio Vascular Medical Device Corp. (CVSL.OB) Applying for Patents in Europe, Canada, and Far East</title>
		<link>http://www.straightstocks.com/investing-lessons/cardio-vascular-medical-device-corp-cvsl-ob-applying-for-patents-in-europe-canada-and-far-east/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cardio-vascular-medical-device-corp-cvsl-ob-applying-for-patents-in-europe-canada-and-far-east/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 17:44:25 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[angioplasty]]></category>
		<category><![CDATA[bypass surgery]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cardio Vascular Medical Device Corp.]]></category>
		<category><![CDATA[cardiovascular surgery]]></category>
		<category><![CDATA[cardiovascular surgery technologies]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[developer]]></category>
		<category><![CDATA[Eli Gonen]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Far East]]></category>
		<category><![CDATA[heart attacks;]]></category>
		<category><![CDATA[Heart Disease]]></category>
		<category><![CDATA[neurosurgeon]]></category>
		<category><![CDATA[principal product]]></category>
		<category><![CDATA[steerable guidewire product]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19481</guid>
		<description><![CDATA[Cardio Vascular Medical Device Corp., an Israeli based developer of advanced cardiovascular surgery technologies, has announced that it will apply for additional patents for its proprietary steerable guidewire product for use in angioplasty procedures. The company already holds a U.S. patent for its innovative guidewire, but wants to obtain patents in Europe, Canada, and the [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cardio-vascular-medical-device-corp-cvsl-ob-applying-for-patents-in-europe-canada-and-far-east/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Campbell&#8217;s Beats, Raises Guidance &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/campbells-beats-raises-guidance-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/campbells-beats-raises-guidance-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 17:42:33 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Beverage Sales]]></category>
		<category><![CDATA[Campbell Soup Co.;]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food service sector]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Malaysia]]></category>
		<category><![CDATA[Pace Mexican]]></category>
		<category><![CDATA[Pepperidge Farm]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27552/Campbell%27s+Beats%2C+Raises+Guidance+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Campbell Soup Co.</strong> (<a href="http://www.zacks.com/stock/quote/cpb">CPB</a>) reported fiscal first-quarter earnings of 87 cents per share, which was above the Zacks Consensus Estimate of 81 cents. Quarterly earnings were up 14.5% compared to the prior-year quarter.<br />
<br />
Quarterly net sales declined 2.1% year over year due to a negative impact of 4% from volume and mix and 1% from increased promotional spending, partially offset by positive contributions of 2% from price and allowances and 1% from currency translation. Gross margin for the quarter expanded 170 basis points (bps) to 41.9% versus 40.2% in the year-ago quarter, reflecting productivity improvements and pricing benefits.<br />
<br />
Sales of the US Soup, Sauces and Beverages segment decreased 5% year over year. US soup sales fell 3%, driven by sales declines in condensed, RTS and broth. Prego pasta sauce and Pace Mexican sales dropped due to competitive pressures, while beverage sales declined due to weak sales of V-8 vegetable juice.<br />
<br />
Sales of the Baking and Snacking segment were up 4%, driven by growth in the Arnott's branded business, led by higher biscuits sales. Pepperidge Farm sales were similar to the year-ago level as increased sales in bakery business were offset by lower sales in the cookies and cracker business.<br />
<br />
In the International Soups and Sauces business, sales contracted 2% due to declines in Europe, primarily attributable to divestitures and lower sales in Germany. In Canada, sales increased due to gain in soups and favorable impact of currency. Sales in the Asia-Pacific region also increased, led by strength in Malaysia, Hong Kong and Australia along with the favorable currency impact.<br />
<br />
Sales in the North American Foodservice business declined 2% year over year due to continued weakness in the food service sector. Price and sales allowances benefits were more than offset by unfavorable volume and mix.<br />
<br />
Based on its performance in the first quarter, Campbell raised its guidance for fiscal 2010. The company now expects net sales growth of 4%-5%, as compared to its previous guidance of 3%-4% growth. Annual earnings growth is expected in the range of 9% and 11%. Earlier, the company provided earnings growth guidance of 5% to 7%. The guidance is consistent with the company&#8217;s long-term growth targets.<br />
<br />
We hold a Neutral recommendation on Campbell shares.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CPB">Read the full analyst report on "CPB"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/campbells-beats-raises-guidance-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Grigory Pasko: Yuri Luzhkov&#8217;s Water Grab</title>
		<link>http://www.straightstocks.com/investing-lessons/grigory-pasko-yuri-luzhkovs-water-grab/</link>
		<comments>http://www.straightstocks.com/investing-lessons/grigory-pasko-yuri-luzhkovs-water-grab/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 15:55:23 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[energy inputs]]></category>
		<category><![CDATA[engineer]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[FSB]]></category>
		<category><![CDATA[gas and oil]]></category>
		<category><![CDATA[gas pipelines]]></category>
		<category><![CDATA[Iraq]]></category>
		<category><![CDATA[Lake Baikal;]]></category>
		<category><![CDATA[Leo Tolstoy]]></category>
		<category><![CDATA[Mayor]]></category>
		<category><![CDATA[Moscow]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Roland Emmerich]]></category>
		<category><![CDATA[United Russia]]></category>
		<category><![CDATA[V.V.Putin]]></category>
		<category><![CDATA[Vladimir Lenin]]></category>
		<category><![CDATA[vladimir putin]]></category>
		<category><![CDATA[War and Peace]]></category>
		<category><![CDATA[Water and the World]]></category>
		<category><![CDATA[writer]]></category>
		<category><![CDATA[Yuri Luzhkov]]></category>
		<category><![CDATA[Yuri Mikhailovich]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22250</guid>
		<description><![CDATA[ Water - the oil and gas of the not-too-distant future What's news is this: «The world community is hoping that Russia will soon become a supplier to the countries of Europe not only of energy inputs, but of fresh...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/grigory-pasko-yuri-luzhkovs-water-grab/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Good News for Bristol-Myers &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/good-news-for-bristol-myers-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/good-news-for-bristol-myers-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 15:40:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Abilify]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca Plc]]></category>
		<category><![CDATA[atherosclerosis]]></category>
		<category><![CDATA[autistic disorder]]></category>
		<category><![CDATA[bipolar disorder]]></category>
		<category><![CDATA[Bristol]]></category>
		<category><![CDATA[Bristol Myers Squibb Co]]></category>
		<category><![CDATA[Cefzil]]></category>
		<category><![CDATA[Depression]]></category>
		<category><![CDATA[Eli Lilly & Co]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[fatigue]]></category>
		<category><![CDATA[Heart Attack]]></category>
		<category><![CDATA[irritation]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[Medarex;]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Otsuka Pharmaceutical Co.;]]></category>
		<category><![CDATA[Pfizer Inc]]></category>
		<category><![CDATA[schizophrenia]]></category>
		<category><![CDATA[treatment of irritability associated with autistic disorder]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vomiting]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27527/Good+News+for+Bristol-Myers+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, <strong>Bristol-Myers Squibb Co</strong>. (<a href="http://www.zacks.com/stock/quote/BMY">BMY</a>) received approval from the U.S. Food and Drug Administration (FDA) to market Abilify (aripiprazole) for the treatment of irritability in pediatric patients having autistic disorder. Abilify can be used to treat children aged 6 to 17 years for symptoms of aggression toward others, deliberate self injury, temper tantrums and quick mood swings. <br />
<br />
Bristol-Myers and Otsuka Pharmaceutical Co. jointly develop and distribute the drug in the U.S. and Europe. The FDA approval of Abilify for treating irritation in pediatric patients with autistic disorder is based on data from two eight-week late-stage studies in which Abilify significantly improved scores on the irritability subscale of the caregiver-rated Aberrant Behavior Checklist (ABC-I), compared to placebo. <br />
<br />
The most common adverse affects were sedation, fatigue, vomiting, somnolence, tremor and pyrexia. However, the efficacy of Abilify for the maintenance treatment of irritability associated with autistic disorder was not evaluated. Abilify, which is approved to treat depression, bipolar disorder, and schizophrenia, generated sales of $2,153 million in 2008, up 30% from 2007. Furthermore, sales in the third quarter of 2009 grew 16% to $653 million. <br />
<br />
Abilify has been growing at about five times the overall antipsychotic market. The company&#8217;s beefed-up sales force and new Direct to Consumer (DTC) campaigns are aiding sales growth. Abilify faces competition from other drugs in the market such as <strong>Merck&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/MRK">MRK</a>) Saphris, <strong>Pfizer Inc.'s</strong> (<a href="http://www.zacks.com/stock/quote/PFE">PFE</a>) Geodon, <strong>Johnson &#38; Johnson's</strong> (<a href="http://www.zacks.com/stock/quote/JNJ">JNJ</a>) Risperdal, <strong>AstraZeneca PLC's</strong> (<a href="http://www.zacks.com/stock/quote/AZN">AZN</a>) Seroquel and <strong>Eli Lilly &#38; Co.'s</strong> (<a href="http://www.zacks.com/stock/quote/LLY">LLY</a>) Zyprexa. <br />
<br />
Plavix, the antiplatelet blood thinner indicated to reduce the risk of heart attack in patients with atherosclerosis, is the top growth driver for Bristol. However, patent expirations loom large on the company starting 2011 when the Plavix patent expires. The company has lost patent protection on products worth about $4 billion in sales over the past four years. <br />
<br />
Drugs such as Cefzil, Paraplatin, Glucophage, Monopril and Taxol are also experiencing declining sales due to generic competition. However, the $1 billion addition in cost cuts in 2012-2013, the extension of the Abilify agreement with Otsuka, and the acquisition of Medarex indicate that management is taking meaningful steps to prepare for the loss of exclusivity of Plavix. Currently, we are Neutral on Bristol-Myers.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BMY">Read the full analyst report on "BMY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLY">Read the full analyst report on "LLY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MRK">Read the full analyst report on "MRK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/good-news-for-bristol-myers-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Solar Energy Initiatives, Inc. (SNRY.OB): Grass Roots Solar</title>
		<link>http://www.straightstocks.com/investing-lessons/solar-energy-initiatives-inc-snry-ob-grass-roots-solar/</link>
		<comments>http://www.straightstocks.com/investing-lessons/solar-energy-initiatives-inc-snry-ob-grass-roots-solar/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 15:13:27 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Akeena Solar Inc]]></category>
		<category><![CDATA[Ascent Solar;]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[collector]]></category>
		<category><![CDATA[DayStar Technologies Inc.]]></category>
		<category><![CDATA[dealer networks]]></category>
		<category><![CDATA[Electricity]]></category>
		<category><![CDATA[Electricity generation]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Conversion Devices Inc.]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Evergreen Solar Inc.]]></category>
		<category><![CDATA[fossil fuel systems]]></category>
		<category><![CDATA[gas-powered generators]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[home size power generation systems]]></category>
		<category><![CDATA[Hot water systems]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[photovoltaic systems]]></category>
		<category><![CDATA[Solar Energy Initiatives Inc.;]]></category>
		<category><![CDATA[Solar EnerTech Corp.]]></category>
		<category><![CDATA[solar heat collector]]></category>
		<category><![CDATA[Solar Inc.;]]></category>
		<category><![CDATA[Surplus Electricity]]></category>
		<category><![CDATA[thermal systems]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[XsunX;]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19472</guid>
		<description><![CDATA[
These days, solar is one of the most popular words in the green lexicon. You hear it everywhere, with most of the talk focusing on the increasingly large solar power plants that are now being built. New designs have dropped the price of large scale solar electricity generation by over 80% in the last 25 [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/solar-energy-initiatives-inc-snry-ob-grass-roots-solar/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Semtech Beats, Acquires SMI &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/semtech-beats-acquires-smi-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/semtech-beats-acquires-smi-analyst-blog/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 14:40:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[communications infrastructure;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Intersil Corporation]]></category>
		<category><![CDATA[Linear Technology;]]></category>
		<category><![CDATA[Maxim Integrated Products]]></category>
		<category><![CDATA[military and aerospace segments]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Peer Group]]></category>
		<category><![CDATA[power discrete products]]></category>
		<category><![CDATA[power management;]]></category>
		<category><![CDATA[protection products]]></category>
		<category><![CDATA[Semtech Corp]]></category>
		<category><![CDATA[SGD]]></category>
		<category><![CDATA[Sierra Monolithic Inc.]]></category>
		<category><![CDATA[SMI]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27523/Semtech+Beats%2C+Acquires+SMI+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Semtech Corp&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/SMTC">SMTC</a>) third quarter earnings beat consensus estimates by 6 cents. This follows better-than-expected results reported by the entire peer group, including <strong>Maxim Integrated Products</strong> (<a href="http://www.zacks.com/stock/quote/MXIM">MXIM</a>), <strong>Intersil Corporation</strong> (<a href="http://www.zacks.com/stock/quote/ISIL">ISIL</a>) and <strong>Linear Technology</strong> (<a href="http://www.zacks.com/stock/quote/LLTC">LLTC</a>). <br />
<br />
Revenue <br />
<br />
Revenue of $75.1 million was up 13.3% sequentially and down 5.7% year over year. The sequential strength was broad-based across all end-markets except industrial and was derived from sequential increases across all product lines except power discrete. The decline from the year-ago period was recession-related. <br />
<br />
Asia remained the largest region, with a 61% revenue share. North America was next, representing 23% of total revenue and Europe third, generating the remaining 16%. All three regions witnessed higher demand, with Asia growing 15.2% sequentially, North America growing 4.2% and Europe 20.9%. Both distribution and OEM sales grew in the last quarter, and distributor inventories declined. <br />
<br />
Revenue by End Market <br />
<br />
All except the industrial end-market saw double-digit sequential growth. The 21.8% and 20.9% increases in the high-end consumer and computing markets, respectively were on account of positive seasonality. The 19.0% sequential increase in communications was driven by strength in infrastructure spending. <br />
<br />
The 9.3% sequential decline in industrial was due to weak demand for power discrete products within the military and aerospace segments of the North America region. The advanced communication and sensing product line witnessed the strongest growth, with revenue increasing 27.0% due to momentum at communications infrastructure OEMs. <br />
<br />
The power management business grew 20.0%, helped by a more diverse product line and particular strength in high-end consumer and computing applications. Revenue from protection products was up 16.0%, again driven by consumer, communications infrastructure and computing markets. The 31.0% decline in the power discrete business was below management&#8217;s expectations, although order rates showed some improvement. <br />
<br />
The protection, power management, advanced communication and sensing, and power discrete product lines generated 53%, 24%, 14% and 9% of third quarter revenue, respectively. <br />
<br />
Orders <br />
<br />
Orders were up strongly in the last quarter and we estimate the book to bill at 1.03. Turns sales increased both sequentially and year over year. We estimate that the backlog increased mid single-digits. Lead times remained short, in the 2-6 week range. Historically, management has always met guided revenue numbers, and in the last quarter revenue exceeded the high end of the guided range. Given the order momentum and backlog growth, we expect the company to meet or exceed guidance in the Jan quarter as well. <br />
<br />
Operating Results <br />
<br />
The pro forma gross margin for the quarter was 55.4%, up 40 basis points (bps) from the previous quarter&#8217;s 55.0%. The gross margin benefited from higher volumes and better product mix. Operating expenses of $24.0 million were higher than the previous quarter&#8217;s $2.2 million. The operating margin was 23.4%, up 192 bps from 21.5% recorded in the previous quarter. <br />
<br />
The improvement was because of lower SG&#38;A expenses as a percentage of sales, as well as flattish COGS and offset by higher R&#38;D as a percentage of sales. New product development expenses had a significant impact on R&#38;D in the last quarter. <br />
<br />
Excluding the impact of restructuring charges, acquisition-related costs, stock compensation expenses and option and restatement related legal expenses on a tax-adjusted basis as well as one-time tax items, the pro forma net income was $16.4 million or 21.9% net margin, compared to $11.8 million or 17.8% in the previous quarter and $16.3 million or 20.5% in the year-ago quarter. Including the special items (-$0.61 per share), the GAAP EPS was -$0.34 compared to $0.12 in the Jul 2009 quarter and $0.19 in the Oct quarter of last year. <br />
<br />
Balance Sheet <br />
<br />
Inventories were down 4.6%, raising inventory turns from 4.5x to 5.3x. Days sales outstanding (DSOs) decreased from 35 to around 31. The company ended with cash and short term investments of $4.40 per share. Capital additions were $3.8 million in the quarter, netting a free cash flow of $19.5 million. <br />
<br />
Guidance <br />
<br />
The fourth quarter guidance is for sequential revenue increase of 0-4%, with the GAAP gross margin increasing by up to 40 bps, GAAP R&#38;D of $11.2 million, GAAP SG&#38;A of $ 20 million, interest and other income of $300K, a GAAP tax rate of 14% and a weighted average diluted share count of around 62.2 million. Capital additions are expected to be $10-15 million and depreciation of around $4 million. <br />
<br />
Sierra Monolithic Inc. Acquisition <br />
<br />
Management announced that the company would be acquiring SMI for $180 million in cash, pick up $8 million of existing unvested stock options standing to the credit of SMI employees and pay out another $12 million in incentives to SMI employees. Transaction costs are currently estimated at around $2.5 million. SMI is expected to generate $15 million in revenue in 2009, which is expected to grow 20-30% in 2010. <br />
<br />
The gross margin is expected to be 55-60% (slightly higher than Semtech&#8217;s current gross margin). Management also expects the business to require an additional $6-7 million in operating expenses and attract a non-GAAP tax rate of 22-25%. Management expects the business to be accretive to GAAP earnings within the next twelve months.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SMTC">Read the full analyst report on "SMTC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MXIM">Read the full analyst report on "MXIM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ISIL">Read the full analyst report on "ISIL"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLTC">Read the full analyst report on "LLTC"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/semtech-beats-acquires-smi-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MWW Automotive Group (MWWC.OB) Subsidiary Signs Major Distribution Agreement</title>
		<link>http://www.straightstocks.com/investing-lessons/mww-automotive-group-mwwc-ob-subsidiary-signs-major-distribution-agreement/</link>
		<comments>http://www.straightstocks.com/investing-lessons/mww-automotive-group-mwwc-ob-subsidiary-signs-major-distribution-agreement/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 14:31:36 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Cobra]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gerald Haas]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Isomotive BV]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[MWW Automotive Group]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[protective car accessories]]></category>
		<category><![CDATA[reduced auto insurance rates]]></category>
		<category><![CDATA[The Netherlands]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19470</guid>
		<description><![CDATA[MWW Automotive Group is a young corporation that has gained notoriety across the globe for producing and delivering their products, design and Class A painting services to automobile manufacturers and assembly lines across the world.  Today, MWW announced that Modelworxx, its wholly owned subsidiary located in Germany, signed an executive agreement with Isomotive BV, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/mww-automotive-group-mwwc-ob-subsidiary-signs-major-distribution-agreement/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR)</title>
		<link>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/</link>
		<comments>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 13:35:02 +0000</pubDate>
		<dc:creator>Michael Vlaicu</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2 protocol]]></category>
		<category><![CDATA[Acute Myeloid Leukemia]]></category>
		<category><![CDATA[Alexion Pharmaceuticals Inc;]]></category>
		<category><![CDATA[Am-80]]></category>
		<category><![CDATA[Amgen Inc.]]></category>
		<category><![CDATA[APL]]></category>
		<category><![CDATA[bone marrow transplant]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[breast cancers]]></category>
		<category><![CDATA[Celsion Corporation]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[chairman and CEO]]></category>
		<category><![CDATA[Chief Medical Officer]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[chronic myeloid leukemia]]></category>
		<category><![CDATA[CytRx Corporation]]></category>
		<category><![CDATA[Daniel Levitt]]></category>
		<category><![CDATA[director]]></category>
		<category><![CDATA[director of clinical oncology]]></category>
		<category><![CDATA[Discovery Laboratories Inc;]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Medicines Agency]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Head of Oncology]]></category>
		<category><![CDATA[Hepatocellular carcinoma;]]></category>
		<category><![CDATA[INNO-406]]></category>
		<category><![CDATA[Jack R. Barber]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Joseph Rubinfeld]]></category>
		<category><![CDATA[leukemia]]></category>
		<category><![CDATA[leukemias]]></category>
		<category><![CDATA[lung cancers]]></category>
		<category><![CDATA[Max Link]]></category>
		<category><![CDATA[Michael Vlaicu;]]></category>
		<category><![CDATA[MiV Investments Inc.]]></category>
		<category><![CDATA[multiple myeloma]]></category>
		<category><![CDATA[myelodysplastic syndrome;]]></category>
		<category><![CDATA[myelodysplastic syndromes]]></category>
		<category><![CDATA[one of the four initial founders]]></category>
		<category><![CDATA[ovarian cancer]]></category>
		<category><![CDATA[Pancreatic Cancer]]></category>
		<category><![CDATA[Philadelphia]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Protein Design Labs]]></category>
		<category><![CDATA[Sandoz Pharma]]></category>
		<category><![CDATA[Sandoz Pharmaceuticals]]></category>
		<category><![CDATA[sarcoma]]></category>
		<category><![CDATA[STAR-1]]></category>
		<category><![CDATA[The star]]></category>
		<category><![CDATA[treatment for patients with Chronic Myeloid Leukemia]]></category>
		<category><![CDATA[tumor]]></category>
		<category><![CDATA[tumors]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[who served as president]]></category>

		<guid isPermaLink="false">http://www.stockshaven.com/?p=827</guid>
		<description><![CDATA[Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.14 per share, up 20.18% from the opening bell on heavy buying pressure. As of 11/18/09, the biopharmaceutical company announced plans to initiate an open-label, multinational Phase 2 clinical [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/technical-breakout-alert-issued-for-cytrx-nasdaqcytr/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Energy Blast &#8211; Nov 23, 2009</title>
		<link>http://www.straightstocks.com/investing-lessons/energy-blast-nov-23-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/energy-blast-nov-23-2009/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 11:41:42 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[electric car  manufacture]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[Islamic Republic of Iran]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[nuclear energy]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil fields]]></category>
		<category><![CDATA[Renault]]></category>
		<category><![CDATA[Uganda]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22246</guid>
		<description><![CDATA[Iran began five-day, large-scale air defense war games yesterday aimed at protecting its nuclear facilities from attack. &#160;Changes in the permafrost in western Siberia are costing Russian oil companies a reported $1.9 billion every year in damage repair for infrastructure...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/energy-blast-nov-23-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prieur’s readings (November 23, 2009)</title>
		<link>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-23-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-23-2009/#comments</comments>
		<pubDate>Mon, 23 Nov 2009 08:38:15 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Bonds]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Aline van Duyn]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[American Chamber of Commerce]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[CBS]]></category>
		<category><![CDATA[Chairman]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[Daria Taglioni (Vox)]]></category>
		<category><![CDATA[Dean Baker]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Executive]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Hussman Funds]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[James Kwak;]]></category>
		<category><![CDATA[John Hussman]]></category>
		<category><![CDATA[Mark Thoma]]></category>
		<category><![CDATA[Michael Panzner]]></category>
		<category><![CDATA[MoneyWatch]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[Morgan Stanley Asia]]></category>
		<category><![CDATA[Paul Krugman]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Richard Baldwin]]></category>
		<category><![CDATA[Robert Shiller]]></category>
		<category><![CDATA[Robert Skidelsky]]></category>
		<category><![CDATA[Singapore]]></category>
		<category><![CDATA[Stephen Roach]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[times Online]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[William Rees-Mogg;]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=14120</guid>
		<description><![CDATA[This post provides links to a number of interesting articles I have read over the past few days that you may also enjoy. Please also add the links to any other worthwhile articles you would like to share to the comments section. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-23-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SEED, CVAT, HZHI, DrStockPick.com Watch List! for Monday Nov 23, 2009, Origin Agritech Limited, Cavitation Technologies Inc. and Horizon Health International Corp.</title>
		<link>http://www.straightstocks.com/stock-watch/seed-cvat-hzhi-drstockpick-com-watch-list-for-monday-nov-23-2009-origin-agritech-limited-cavitation-technologies-inc-and-horizon-health-international-corp/</link>
		<comments>http://www.straightstocks.com/stock-watch/seed-cvat-hzhi-drstockpick-com-watch-list-for-monday-nov-23-2009-origin-agritech-limited-cavitation-technologies-inc-and-horizon-health-international-corp/#comments</comments>
		<pubDate>Sun, 22 Nov 2009 23:30:46 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agricultural Biotechnology]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Calgary]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[corn product]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[eBay US]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[king]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[Ministry of Agriculture]]></category>
		<category><![CDATA[Nano Cavitation Technologies]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[On-line sales]]></category>
		<category><![CDATA[online shopping network]]></category>
		<category><![CDATA[Origin Agritech Limited]]></category>
		<category><![CDATA[owned subsidiary]]></category>
		<category><![CDATA[physical and chemical refining]]></category>
		<category><![CDATA[player]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Samson Industries]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[seed products]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[Southeast Asia]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US Subsidiary SunCity Ventures]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.medichair-calgary.com]]></category>
		<category><![CDATA[www.originagritech.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4910</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

DrStockPick.com Watch List!
My Picks for Monday Nov 23, 2009 are:
**************************************************************
 SEED, Origin Agritech Limited
SEED, a leading agricultural biotechnology company and a top player in seed industry, specializes in research and development, production, sale and distribution of agricultural crop seeds. The Company&#8217;s major seed products [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/seed-cvat-hzhi-drstockpick-com-watch-list-for-monday-nov-23-2009-origin-agritech-limited-cavitation-technologies-inc-and-horizon-health-international-corp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CVAT, PWRM, HZHI, HCEI, PSFT, TAXS, CSRH, AQNM, Stocks at a Glance. DrStockPick.com Report!</title>
		<link>http://www.straightstocks.com/stock-watch/cvat-pwrm-hzhi-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/cvat-pwrm-hzhi-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/#comments</comments>
		<pubDate>Sun, 22 Nov 2009 19:16:21 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[BioMedReports.com]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemical sensors]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil refining;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[CVAT]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[environmental friendly technology]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Homeland Security]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical diagnostics]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[news portal;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[platform semiconductor]]></category>
		<category><![CDATA[platform semiconductor technology]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[scientific instrumentation]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.psftinc.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4909</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Sunday November 22, 2009
DrStockPick.com Stock Report!
CVAT, PWRM, HZHI, HCEI, PSFT, TAXS, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cvat-pwrm-hzhi-hcei-psft-taxs-csrh-aqnm-stocks-at-a-glance-drstockpick-com-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The week ahead</title>
		<link>http://www.straightstocks.com/investing-lessons/the-week-ahead-4/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-week-ahead-4/#comments</comments>
		<pubDate>Sat, 21 Nov 2009 07:15:37 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[DSG International]]></category>
		<category><![CDATA[electronics retailer]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Gdp]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Hewlett-Packard]]></category>
		<category><![CDATA[Honda]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Philippines]]></category>
		<category><![CDATA[Remy Cointreau]]></category>
		<category><![CDATA[Taiwan]]></category>
		<category><![CDATA[Thailand]]></category>
		<category><![CDATA[The London Stock Exchange]]></category>
		<category><![CDATA[Toyota]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13993</guid>
		<description><![CDATA[The video clips in this post provide a handy summary of the reports expected on the economic, financial and corporate front around the globe during the week ahead.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-week-ahead-4/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Exponential Growth, Finite World &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/exponential-growth-finite-world-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/exponential-growth-finite-world-analyst-blog/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 21:27:04 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[actual oil discovery]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Alaska]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Bangladesh]]></category>
		<category><![CDATA[Burma]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[computer chips]]></category>
		<category><![CDATA[EnCana]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[energy consumption]]></category>
		<category><![CDATA[energy needs]]></category>
		<category><![CDATA[Energy Use]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[gas producers]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[I-shares  MSCI Emerging Market Fund]]></category>
		<category><![CDATA[international energy agency]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[natural annual global crude oil depletion rate]]></category>
		<category><![CDATA[Natural Gas]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[North Sea]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Petrobras]]></category>
		<category><![CDATA[potato chips]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[south korea]]></category>
		<category><![CDATA[Thomas Malthus]]></category>
		<category><![CDATA[United Nations]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wisdom Tree India]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27512/Exponential+Growth%2C+Finite+World+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
I want to talk about the challenge of exponential growth in a finite world. This is a concept that while on its surface seems easy to get, most people don&#8217;t fully grasp it.<br />
<br />
Any growth rate that is positive will lead to a doubling in size eventually -- the higher the growth rate, the quicker the doubling. A quick "back of the envelope" method of figuring it out is known as the rule of 70. If you divide a growth rate into 70, it will roughly give you the time for something to double. Thus if something is growing at 2% a year, then it will double in about 35 years, at 5% only 14 years, etc. If you want to be more precise, you can always use your Y^x button on your calculator, but the rule of 70 will do for this discussion.<br />
<br />
Clearly, exponential growth is what we are looking for when we invest -- better known as compound interest -- and it is vital to anyone&#8217;s financial health that they stay on the right side of it. People who get on the wrong side -- for example, by carrying a credit card balance -- are eventually headed towards financial oblivion. If that is you, then your best investment is probably not one of the stocks or ETFs that I recommend, it is paying down you damm Visa bill.<br />
<br />
It is also why I try to watch the downside when I make investment decisions. It is far more important to avoid 50% losses than it is to have a 50% gain. After all, if you had a 50% gain in one year, but in the next year you suffered a 50% loss, at the end of two years  that dollar would have turned into just $0.75 -- a 25% loss.<br />
<br />
However, far more important to the world is the dark side of exponential growth. Let's start with the obvious one: population growth. The table below comes from Wikipedia, but is based on UN data. Note that from 1750 to 1800, the world population grew from 791 million to 978 million -- an increase of 187 million, or 0.4% per year. From 1850 to 1900, it grew from 1.262 billion to 1.650 billion -- an increase of 388 million or at 0.53% per year.<br />
<br />
Thus, even very small growth rates can result in some very large increases extended long enough, and as the base grows, the absolute increase gets larger each year even if the rate of increase stays the same. Now look at what has happened more recently. From 1950 to 1999, world population increased by 3.457 billion, more than doubling from 2.521 billion, an increase of 1.78% per year. Lately we have seen a slowdown in the growth rate; from 1999 to 2008 it was just 1.29% per year, but that has meant an increase of 729 million in just nine years, or 92% of the entire world population in 1750.<br />
<br />
Looking forward, the U.N does see a further reduction in the rate of growth, to just 0.68% per year, or almost back down to the growth rate in the very earliest days of the Industrial Revolution. But the base is so much larger, the absolute increase is 2.2 billion, or almost the world population of 1950. The effect is that a long-term graph of world population looks like a picture of a rocket launch. And unless you believe in the Mayan calendar or the equally silly "end times" nonsense, this is going to cause some very big problems (not that the end of the world in 2012 wouldn't be a very big problem on its own).<br />
<br />
Now look at where the growth is coming from. The combined populations of North America (Mexico is included in the Latin American numbers, so basically the US and Canada) and Europe are actually expected to fall from the current 1.069 billion to 1.020 billion. All of the growth is coming from Asia, Africa and Latin America.<br />
<br />
The only thing that can keep up with exponential growth is something that itself grows exponentially. Fortunately, the one thing that grows exponentially at a very fast rate is computing power, which in turn allows for technological advances. So far, technology has managed to hold off the worst of the problems that one might expect. After all, this analysis is not exactly original. It was first made by Thomas Malthus back before world population hit the 1 billion mark.<br />
<br />
However, you can eat potato chips, not computer chips. One of the things that technology has done is level the playing field, so that people in Asia and eventually Africa will have the same shot at success as people in the U.S. and Europe. They can see how we live, and surprise, surprise -- they would prefer to live the way we do, and are increasingly able to do so. As they do, the economic growth opportunities will be huge.<br />
<br />
That is why I like the emerging markets story so much. However, given the challenges of trying to research foreign firms who might be best positioned to take advantage of these trends, it probably makes sense to use ETFs such as the I-shares <strong>MSCI Emerging Market Fund</strong> (<a href="http://www.zacks.com/stock/quote/eem">EEM</a>) or more country-specific variants like the <strong>Claymore China Small Cap ETF</strong> (<a href="http://www.zacks.com/stock/quote/hao">HAO</a>) or the <strong>Wisdom Tree India Earnings ETF </strong>(<a href="http://www.zacks.com/stock/quote/epi">EPI</a>).<br />
<br />
<img alt="" src="http://www.zacks.com/images/upload_dir/1258752669.jpg" /><br />
<img alt="" src="http://www.zacks.com/images/upload_dir/1258752681.jpg" /><br />
<br />
One of the things that has been absolutely key to our ability to have so much higher living standards today than back in, say, 1850 is that we use a lot more energy.<br />
<br />
So let&#8217;s take a look at energy consumption per capita (the data I&#8217;m using comes from <a href="http://earthtrends.wri.org/searchable_db/index.php?step=countries&#38;ccID%5B%5D=0&#38;ccID%5B%5D=1&#38;ccID%5B%5D=6&#38;ccID%5B%5D=2&#38;ccID%5B%5D=3&#38;ccID%5B%5D=5&#38;ccID%5B%5D=7&#38;allcountries=checkbox&#38;theme=6&#38;variable_ID=351&#38;action=select_years">here</a> if you want to investigate further). In 2005, people in North America used the equivalent of 8157.9 kilograms of oil per year (kgoe/y) per person, up from 7942.9 kgoe/y in 2000. Thus while our rate of increase in energy consumption was just 0.54% per year, it was on a high base so the absolute increase was 215 kgoe/y over that time.<br />
<br />
Now look at Asia (excluding the Middle East). In 2000, they were using 865.2 kgoe/y, and by 2005 it was up to 1051.5 per year. That is an increase of 3.98% per year, or to go back to the rule of 70, it means that if it keeps up Asia&#8217;s energy consumption per capita will double by 2022. Combine that with a population that is expected to grow at 0.6% per year, and Houston, we have a problem. <br />
<br />
However, note that the absolute increase in energy use per capita in Asia was just 186 kgoe/y, or just 86.5% of the increase in North America, despite the far higher growth rate. However, if the relative growth rates continue, that will not last. If we extrapolate out the growth rates of 2000 to 2005 then by 2015, Asia&#8217;s per capita consumption will grow to 1,553.0 kgoe/y, an increase of 501.5, while the absolute increase in North America will be "only" 451.4 kgoe/y.<br />
<br />
Put another way, right now we use 7.76x as much energy per person as in Asia (keep in mind these figures include relatively rich countries like Japan and South Korea, as well as basket-cases like Burma and Bangladesh), and by 2015 that ratio will fall all the way down to 5.54x as much.<br />
<br />
Now, the peak year for actual oil discovery in the world was in 1964, and as you pump oil out of the ground it is gone. Once you reach the point where you have pumped half the original oil in a field, it is basically impossible to increase the annual output from that field without causing serious damage that eventually results in that oil being trapped forever. Most of the currently producing fields are past their peak. As the International Energy Agency (IEA) found last year:<br />
<br />
<em>"Output from the world's oilfields is declining faster than previously thought, the IEA said in its annual report. Without extra investment to raise production, the natural annual global crude oil depletion rate is 9.1%. The findings suggest the world will struggle to produce enough oil to make up for steep declines in existing fields, such as in the North Sea, Russia and Alaska. The effort will become even more acute as prices fall and investment decisions are delayed. Even with investment, the annual rate of output decline is 6.4."</em> (See <a href="http://www.post1.net/lowem/entry/peak_oil_iea_reports_global_depletion_rate_could_go_up_to_9_1_struggle_to_produce_crude_oil">here</a> for full story.) <br />
<br />
Now the situation is better for natural gas (NG) than it is for oil, but eventually that will run out as well. However, we have much more time thanks to the new shale plays here in the U.S. We need to shift to more usage of NG as a bridge towards the eventual goal of producing most of our energy from renewable sources like wind and solar. But given the tiny fraction of the world&#8217;s energy they now represent, we will need many years of very fast growth in them to make a substantial dent in world energy needs.  <br />
<br />
Natural gas also has the benefit of being located here in North America, rather than in rather unstable and hostile areas of the world, the way oil is.<br />
<br />
The U.S. cannot continue to run massive trade deficits with the rest of the world. The trade deficit is the source of our external debt, not the fiscal deficit. Our external debt is now (<a href="http://www.ustreas.gov/tic/external-debt.shtml">as of 6/30/09</a>)  at $13.454 trillion -- up from just $7.744 trillion five years ago. That is a growth rate of 11.7% per year, and is clearly not sustainable (that might be overstating it since it is a gross number; we do hold some debts of other countries that offsets it in part). Still, even if the net growth rate is half that amount, it is clearly unsustainable, and is one of the reasons the dollar is going to be under long-term pressure.<br />
<br />
Putting this all together it seems clear to me that the price of energy must continue to rise over the long term. Companies that are going to be able to increase their production of oil, such as <strong>Petrobras </strong>(<a href="http://www.zacks.com/stock/quote/pbr">PBR</a>) are going to be exceptionally well positioned.<br />
<br />
While natural gas should see a big growth in demand, it is not a perfect substitute for oil. Still, big gas producers like<strong> EnCana </strong>(<a href="http://www.zacks.com/stock/quote/eca">ECA</a>) have a very bright long-term future. I would also note that what I am saying about oil also holds true for other commodities. Energy and commodities are going to be the real stores of value and of wealth over the next few decades.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EEM">Read the full analyst report on "EEM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HAO">Read the full analyst report on "HAO"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EPI">Read the full analyst report on "EPI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PBR">Read the full analyst report on "PBR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ECA">Read the full analyst report on "ECA"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/exponential-growth-finite-world-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Cowen’s Stone Maintains Suntech (NYSE:STP) at NEUTRAL on Q3 Earnings Report</title>
		<link>http://www.straightstocks.com/investing-lessons/cowen%e2%80%99s-stone-maintains-suntech-nysestp-at-neutral-on-q3-earnings-report/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cowen%e2%80%99s-stone-maintains-suntech-nysestp-at-neutral-on-q3-earnings-report/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 21:06:00 +0000</pubDate>
		<dc:creator>Small Cap Pulse</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cowen’s Stone Maintains Suntech]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Korea]]></category>
		<category><![CDATA[R]]></category>
		<category><![CDATA[Results Suntech]]></category>
		<category><![CDATA[Rob Stone]]></category>
		<category><![CDATA[small cap pulse]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.smallcappulse.com/index.php/site/cowens_stone_maintains_suntech_nysestp_at_neutral_on_q3_earnings_report/#When:13:06:00Z</guid>
		<description><![CDATA[November 20, 2009 ndash; Analyst Comments ndash; Cowenrsquo;s Rob Stone weighed in on Suntechrsquo;s (NYSE:STP) Q3 financial results this morning noting that given the delayed ramp of Pluto and thin-film production, and outstanding GSF A/R exposure, he thinks shares are fairly valued. He maintains a NEUTRAL rating on the stock. 


Q3 Results


Suntech (NYSE:STP) reported Q3 revenues of $473.1 million, compared with revenues of $594.4 million for the same period last year, and $320.9 million in Q209. Gross margins in Q3 were 17.7%, down from 18.5% in Q2, and 21.5% in Q308. Net income was $30,1, or $0.16 per diluted ADS, compared with $42.5 million for the same period last year and $9.6 million in Q208. Highlights for the quarter included hitting 16.53% conversion efficiency. Management increased its FY09 shipment target from 600MW to a range of 640MW to 660MW, and an increase in total cell and module production capacity to 1.4GW by mid-2010, of which 450MW will be Pluto-enabled. 


Stonersquo;s Key Takeaways


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Shipments to Germany should continue to grow, but account for a smaller percentage, with stronger growth in the rest of Europe (Italy, France, Czech Republic) 


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; U.S. distribution and utility scale projects, China and other Asian markets (Australia, Korea and Japan) should also drive growth


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Raising 2009-12E shipments to 640MW, 1.1GW, 1.6GW and 2.2GW including system integration of 37MW, 100MW, 160MW and 230MW


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Mix of systems reduces GM by about 60 basis points in 2009, 80-100 basis points in 2011/12 but GM in 2010 reflect better H1 module ASPs


middot;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp;nbsp; Raised EPS to $0.35, $0.65, $0.99 and $1.35 on revenue of $1.6B, $2.1B, $2.7B and $3.5B]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cowen%e2%80%99s-stone-maintains-suntech-nysestp-at-neutral-on-q3-earnings-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSRH, TAXS,  DrStockPick.com Stock Report! Consorteum Holdings Inc.and TaxMasters, Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/csrh-taxs-drstockpick-com-stock-report-consorteum-holdings-inc-and-taxmasters-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/csrh-taxs-drstockpick-com-stock-report-consorteum-holdings-inc-and-taxmasters-inc/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 20:45:07 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4906</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________
Friday November 20, 2009
DrStockPick.com Stock Report!
**************************************************************
 CSRH, Consorteum Holdings Inc, CSRH.OB
CSRH will build on its extensive expertise within the Payments and Transaction Industry in North America, Europe and Internationally. By identifying new technologies and trends in the changing global marketplace, Consorteum Holdings Inc. aims [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/csrh-taxs-drstockpick-com-stock-report-consorteum-holdings-inc-and-taxmasters-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DrStockPick.com Stock Report!  11/20/09, WAKE, CSRH, NTRI, ERTS, SOTK, WATG</title>
		<link>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112009-wake-csrh-ntri-erts-sotk-watg/</link>
		<comments>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112009-wake-csrh-ntri-erts-sotk-watg/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 15:43:48 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[American Diabetes Association;]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Chief Financial Officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Electronic Arts Inc.]]></category>
		<category><![CDATA[energy applications]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fuel Cells]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Loan Association]]></category>
		<category><![CDATA[Meirong Yuan]]></category>
		<category><![CDATA[Nomura’s Office]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[NutriSystem Inc]]></category>
		<category><![CDATA[online  racing]]></category>
		<category><![CDATA[Qingjie Zhao]]></category>
		<category><![CDATA[Sono-Tek Corporation]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stop DiabetesSM]]></category>
		<category><![CDATA[suspension products]]></category>
		<category><![CDATA[ultrasonic coating systems]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wake Forest Bancshares Inc.]]></category>
		<category><![CDATA[weight loss products]]></category>
		<category><![CDATA[Wonder Auto Technology Inc.;]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4897</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Friday Nov 20, 2009
DrStockPick.com Stock Report!
**************************************************************

Consorteum Holdings Inc.  (OTCBB: CSRH) launched its consumer stored value rebate card. The  consumer rebate card program will offer manufacturers and retailers a new way to  process mail-in rebates that ensures increased customer loyalty and decreased [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/drstockpick-com-stock-report-112009-wake-csrh-ntri-erts-sotk-watg/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Top European Equity Funds &#8211; Mutual Fund Commentary</title>
		<link>http://www.straightstocks.com/stock-watch/top-european-equity-funds-mutual-fund-commentary-6/</link>
		<comments>http://www.straightstocks.com/stock-watch/top-european-equity-funds-mutual-fund-commentary-6/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 06:10:59 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[DFA Continental Small Company]]></category>
		<category><![CDATA[Eastern Europe]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[former Soviet Union]]></category>
		<category><![CDATA[Ing]]></category>
		<category><![CDATA[Karen E. Umland]]></category>
		<category><![CDATA[lead manager]]></category>
		<category><![CDATA[manager of the fund]]></category>
		<category><![CDATA[Managing Director]]></category>
		<category><![CDATA[Mediterranean]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[North Africa]]></category>
		<category><![CDATA[Rank European Equity Funds;]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[S. Leigh Robertson]]></category>
		<category><![CDATA[Soviet Union]]></category>
		<category><![CDATA[Steven D. Burton]]></category>
		<category><![CDATA[T. Rowe Price]]></category>
		<category><![CDATA[T. Rowe Price Group;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vice President]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27476/Top+European+Equity+Funds+-+Mutual+Fund+Commentary</guid>
		<description><![CDATA[<p>Today we are featuring top-performing "European" equity mutual funds, which primarily invest in equity securities of companies based in Europe.</p>
<p>Investors can find such funds by checking out the entire list of <a href="http://www.zacks.com/funds/mutualfund/allmfs.php?rank_in=ALL&#38;TableType=1Y&#38;fundtype=Equity - Country European">Zacks #1 Rank European Equity Funds</a>.</p>
<p><strong>3 Solid Samples</strong></p>
<p><strong>ING European Real Estate Fund</strong> A (<a href="http://www.zacks.com/funds/mfrank/quotes.php?t=IAERX&#38;type=main">IAERX</a>) seeks to provide investors with high total return, consisting of capital appreciation and current income. It was incepted in November 2007.</p>
<p>The fund normally invests at least 80% of net assets in a portfolio of equity securities of real estate companies located in Europe. The fund may invest in convertible securities, initial public offering and depositary receipts.</p>
<p>The fund has an expense ratio of 1.75%. As of July 2009, it has a portfolio turnover of 166%.</p>
<p>Steven D. Burton has been lead manager of the fund since November 2007. Burton is a managing director at ING and has 24 years investment experience.</p>
<p><strong>T. Rowe Price European Stock</strong> (<a href="http://www.zacks.com/funds/mfrank/quotes.php?t=PRESX&#38;type=main">PRESX</a>) seeks long-term growth of capital through investments primarily in the common stocks of companies in the emerging market countries of Europe and the Mediterranean region. It was incepted in August 2000.</p>
<p>The fund invests in stocks of companies in emerging European and Mediterranean economies, including Eastern Europe, the Middle East, North Africa and the former Soviet Union. It may purchase the stocks of companies of any size, but focuses primarily on large and medium-sized companies in these regions.</p>
<p>The fund has an expense ratio of 1.94%. As of April 2009, it has a portfolio turnover of 51.8%.</p>
<p>S. Leigh Robertson has been lead manager of the fund since September 2007. Robertson is a vice president of T. Rowe Price Group and has been with the firm since 2002.</p>
<p><strong>DFA Continental Small Company</strong> (<a href="http://www.zacks.com/funds/mfrank/quotes.php?t=DFCSX&#38;type=main">DFCSX</a>) seeks long-term capital appreciation. It was incepted in April 1988.</p>
<p>The fund pursues its objective by investing in a broad range of readily marketable stocks of small companies that are traded principally in the securities markets of certain European countries. As a non-fundamental policy the fund invests most of its net assets in securities companies located in continental Europe</p>
<p>Shareholders have to make a minimum initial investment of $100,000 to enter this Zacks #1 Rank ("Strong Buy") fund. It has an expense ratio of 0.15%.</p>
<p>Karen E. Umland has been Lead Manager of the fund since 31-Dec-98. Umland has been with Dimensional since 1993 and is a vice president with the firm.</p>
<p><strong>Discover Many More Funds</strong></p>
<p>Learn more about the new Zacks Mutual Fund Rank and discover some of the best market-beating mutual funds by browsing our <a href="http://www.zacks.com/funds/mutualfund/">mutual funds section</a>. This part of Zacks.com offers a variety of tools, including mutual fund research, a new mutual fund screener, helpful answers to frequently asked questions and quick access to prospectuses and other information.</p>
<p>By applying the Zacks Rank to mutual funds, investors can find funds that not only outpaced the market in the past but are also expected to outperform going forward.</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/top-european-equity-funds-mutual-fund-commentary-6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cooper Tire &amp; Rubber Company &#8211; Value &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/cooper-tire-rubber-company-value-zacks-rank-buy-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/cooper-tire-rubber-company-value-zacks-rank-buy-2/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Tracey Ryniec</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Cooper Tire & Rubber]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12809/Cooper+Tire+%26+Rubber+Company+-+Value+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Cooper Tire &#38; Rubber Company</b> (<a href="http://www.zacks.com/stock/quote/CTB">CTB</a>) has surprised on estimates 4 consecutive quarters by an average of 330.99%. The company trades is attractively valued with a forward P/E of 10.6.<p ALIGN="left">

<b>Company Description</b></p><p ALIGN="left">

Cooper Tire &#38; Rubber manufactures tires for passenger cars, light and medium trucks. It also has subsidiaries that make motorcycle and racing tires. The company has facilities in 10 countries.</p><p ALIGN="left">

<b>Cooper Tire Surprised Again in the Third Quarter</b></p><p ALIGN="left">

On Nov 2, Cooper Tire reported third quarter results and continued its hot streak by beating the Zacks Consensus Estimate by 20.31%. Earnings per share were 77 cents compared to the Zacks Consensus of 64 cents.</p><p ALIGN="left">

Sales rose 1% to $803 million from $794 million in the year ago period. Lower raw material costs, manufacturing improvements and improved utilization of capacity boosted the results. </p><p ALIGN="left">

Quarterly sales volumes, which showed improvement, also helped propel results. However, the company is still seeing unfavorable price and mix and also saw restructuring charges in the quarter.</p><p ALIGN="left">

International tire sales rose 4% to $297 million from a year ago. It was a tale of two markets as Asian sales were strong, increasing 28%, while Europe saw a decline of 13%. North American tire sales fell 2%.</p><p ALIGN="left">

Raw material costs have jumped in recent months but the company doesn't expect levels to return to the 2008 highs which significantly impacted operating results.</p><p ALIGN="left">

<b>Zacks Consensus Estimates Jump</b></p><p ALIGN="left">

Covering analysts are optimistic about the rest of 2009 and 2010. The fourth quarter Zacks Consensus Estimate is up 1 cent to 38 cents in the last 30 days but is up 55% from 90 days ago.</p><p ALIGN="left">

All 4 covering analysts are bullish on 2009. The full year consensus climbed 19.6% to $1.77 from $1.48 per share in the last month. For 2010, estimates rose to $1.87 from $1.75 per share in the last 30 days.</p><p ALIGN="left">

<b>Value Fundamentals</b></p><p ALIGN="left">

Cooper Tire &#38; Rubber is a Zacks #1 Rank (strong buy) stock. It has a price-to-book ratio of 2.55. The company has a solid 1-year return on equity (ROE) of 11.7%. It also rewards shareholders with a dividend of 2.24%. </p><p ALIGN="left">

<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cooper-tire-rubber-company-value-zacks-rank-buy-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Crane Co. &#8211; Growth And Income &#8211; Zacks Rank Buy</title>
		<link>http://www.straightstocks.com/stock-watch/crane-co-growth-and-income-zacks-rank-buy/</link>
		<comments>http://www.straightstocks.com/stock-watch/crane-co-growth-and-income-zacks-rank-buy/#comments</comments>
		<pubDate>Fri, 20 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Alex Kolb</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[aerospace]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[bank credit agreement]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Crane Co.;]]></category>
		<category><![CDATA[electronics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[hydrocarbon processing]]></category>
		<category><![CDATA[industrial products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[South America]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12818/Crane+Co.+-+Growth+And+Income+-+Zacks+Rank+Buy</guid>
		<description><![CDATA[<b>Crane Co.</b> (<a href="http://www.zacks.com/stock/quote/cr">CR</a>), which boasts an industry-leading yield of 2.7%, recently declared a quarterly dividend of 20 cents per share. The company also posted solid results for the third quarter, raising the lower end of its earnings outlook.
<p>
<b>Company Description</b>
</p><p>
Crane Co. manufactures highly engineered industrial products. Founded in 1855, the company provides products and solutions to customers in the aerospace, electronics, hydrocarbon processing, petrochemical, chemical, power generation, automated merchandising, transportation and other markets. Crane's five business segments are: Aerospace &#38; Electronics, Engineered Materials, Merchandising Systems, Fluid Handling and Controls. Crane has approximately 11,000 employees in North America, South America, Europe, Asia and Australia. 
</p><p>
<b>Solid Income</b>
</p><p>
The company recently declared a quarterly dividend of 20 cents per share, noting that it is payable on December 10 to shareholders of record as of the close of business on November 30. 
</p><p>
Crane's dividend yield of 2.7% tops the industry average of 1.6%
</p><p>
<b>A Strong Quarter</b>
 </p><p>
The company also posted solid results for the third quarter, raising the lower end of its earnings outlook.
</p><p>
Third-quarter earnings per share of 60 cents surpassed the Zacks Consensus Estimate by 25% and matched the year-prior earnings. Sales of $551 million slipped 14% year-over-year. 
</p><p>
Management noted that despite a 14% decline in sales from the third quarter of 2008, operating profit and earnings per share were flat compared to 2008, primarily reflecting the company's success in re-aligning its cost base, adding that operating margin improved by 160 basis points, to 10.1%, compared to 8.5% a year ago. 
</p><p>
The company said its $305 million in cash, $300 million revolving bank credit agreement and no near-term debt maturities provide it with a solid financial foundation to continue to manage through the current environment, positioning Crane for growth as end markets recover.
</p><p> 
<b>Bullish Estimates and a Surging Share Price</b>
</p><p>
The company upped the lower end of its full-year earnings guidance to a range of $1.90 - $2.05 from $1.75 - $2.05.
</p><p>
Analysts boosted the 2009 Zacks Consensus Estimate to $2.05 per share from last month's $1.90. For the following year, analysts polled by Zacks are projecting earnings of $2.21 per share, versus the previous month's $2.08.
</p><p>
Shares of Crane soared past the market by more than 100% over the past year. 

 <a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/crane-co-growth-and-income-zacks-rank-buy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, HZHI, HCEI, CVAT, PSFT, TAXS, CSRH, AQNM, DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-taxs-csrh-aqnm-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-taxs-csrh-aqnm-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 21:45:12 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[BioMedReports.com]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[chemical sensors]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil refining;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[CVAT]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Distribution Inc]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[environmental friendly technology]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[General Counsel for TAXS]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Homeland Security]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Indiana]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical diagnostics]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[Michael Wallace]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[New York]]></category>
		<category><![CDATA[New Zealand]]></category>
		<category><![CDATA[news portal;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[Pilipinas]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[platform semiconductor]]></category>
		<category><![CDATA[platform semiconductor technology]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[scientific instrumentation]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Sweden]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety-canada]]></category>
		<category><![CDATA[www.horizonhealthandsafety-us]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4883</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Thursday November 18, 2009
DrStockPick.com Stock Report!
PWRM, HZHI, HCEI, CVAT, PSFT, TAXS, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-taxs-csrh-aqnm-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DVAX Completes Hep-B Enrollment &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/dvax-completes-hep-b-enrollment-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/dvax-completes-hep-b-enrollment-analyst-blog/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 20:40:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cancer Therapy]]></category>
		<category><![CDATA[cirrhosis;]]></category>
		<category><![CDATA[DV]]></category>
		<category><![CDATA[Dynavax Technologies Corp.;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[HBV therapeutics]]></category>
		<category><![CDATA[Hepatitis B;]]></category>
		<category><![CDATA[hepatitis C]]></category>
		<category><![CDATA[Hepatocellular carcinoma;]]></category>
		<category><![CDATA[liver carcinoma]]></category>
		<category><![CDATA[Symphony Dynamo Inc]]></category>
		<category><![CDATA[treating cancer]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27474/DVAX+Completes+Hep-B+Enrollment+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Recently, <strong>Dynavax Technologies Corp.</strong> (<a href="http://www.zacks.com/stock/quote/dvax">DVAX</a>) announced the completion of enrollment for the first of three cohorts of patients receiving DV-601 hepatitis B (HBV) therapy in an open-label, dose-escalating early-stage study. The second cohort has been opened for enrollment. All commercial rights to this product are with Dynavax.<br />
<br />
In the study conducted in Europe, up to 30 patients are to be administered with 6 injections of DV-601 over a period of three months. The study will evaluate the safety and tolerability of DV-601. The company expects to report top-line data from this study in the second half of 2010.<br />
<br />
HBV affects more than 350 million individuals globally. It is a chronic disease which can lead to cirrhosis of the liver and hepatocellular carcinoma. Currently the global market for HBV therapeutics is estimated at over $1 billion annually and available therapies have limited efficacy.<br />
<em><strong><br />
Dynavax to Buy Symphony Dynamo</strong></em><br />
<br />
With the objective of regaining all rights to its hepatitis C and cancer therapy programs Dynavax Technologies has decided to purchase all the equity of Symphony Dynamo, Inc, or SDI. The transaction, which will give Dynavax access to the $20.446 million cash held by SDI to fund its HBV vaccine Heplisav in late-stage trials, is expected to close in the first quarter of 2010. In the event of Dynavax partnering the programs for hepatitis C and cancer therapy, SDI stands to receive half of the first $50 million received from any potential upfront and development milestones.<br />
<br />
Furthermore, Dynavax will issue SDI 13 million shares of its common stock at $1.57 per share and delay a $15 million payment due to SDI by 20 months. SDI and its co-investors are expected to own approximately 24% of the total outstanding common stock of Dynavax on closure of the deal. As a reminder, Symphony Dynamo was created three years ago with the purpose of advancing some of Dynavax's programs.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DVAX">Read the full analyst report on "DVAX"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/dvax-completes-hep-b-enrollment-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hitting Rock Bottom</title>
		<link>http://www.straightstocks.com/investing-lessons/hitting-rock-bottom/</link>
		<comments>http://www.straightstocks.com/investing-lessons/hitting-rock-bottom/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 16:22:34 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Stalin;]]></category>
		<category><![CDATA[U.S.S.R.]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22215</guid>
		<description><![CDATA[The writer Victor Erofeyev has published an opinion article in the New York Times commenting about what motivations Russians to embrace a familiar if ugly past instead of imagining a reformed future.&#160; His expression of support here echoes what he...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/hitting-rock-bottom/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Goodrich to Acquire AIS Global  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/goodrich-to-acquire-ais-global-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/goodrich-to-acquire-ais-global-analyst-blog/#comments</comments>
		<pubDate>Thu, 19 Nov 2009 14:20:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Actuation Systems]]></category>
		<category><![CDATA[AIS Global]]></category>
		<category><![CDATA[AIS Global Holdings LLC]]></category>
		<category><![CDATA[AIS;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Atlantic Inertial Systems]]></category>
		<category><![CDATA[cargo systems]]></category>
		<category><![CDATA[Charlotte]]></category>
		<category><![CDATA[components and systems]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Goodrich Corporation]]></category>
		<category><![CDATA[inertial sensors products]]></category>
		<category><![CDATA[Integrated Systems]]></category>
		<category><![CDATA[Interior Systems]]></category>
		<category><![CDATA[land systems]]></category>
		<category><![CDATA[Landing Systems]]></category>
		<category><![CDATA[missile telemetry systems]]></category>
		<category><![CDATA[Nacelles]]></category>
		<category><![CDATA[navigation products;]]></category>
		<category><![CDATA[navigation systems products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[North Carolina]]></category>
		<category><![CDATA[stability systems]]></category>
		<category><![CDATA[terrain avoidance systems]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27439/Goodrich+to+Acquire+AIS+Global++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Goodrich Corporation</strong> (<a href="http://www.zacks.com/stock/quote/GR">GR</a>) has signed an agreement to acquire AIS Global Holdings LLC for approximately $375 million. AIS Global also known as Atlantic Inertial Systems is a leading provider of mission-critical guidance, stabilization and navigation products and systems for the military and defense market. The transaction is expected to close by the end of 2009, subject to customary government approvals. <br />
<br />
Goodrich expects the company to be accretive to earnings in fiscal 2010. The acquired company mainly caters to defense prime contractors as well as U.S. and allied military forces around the world. Primary products include inertial sensors, inertial measurement units (IMUs), integrated systems, stability systems and terrain avoidance systems for missiles, military aircraft and land systems. <br />
<br />
AIS will become part of Goodrich's Sensors and Integrated Systems business within its Electronic Systems segment. The acquisition will boost the Electronic Systems segment, where operating income fell 11% due to lower sales volume and unfavorable product mix in the recently reported third quarter of fiscal 2009. <br />
<br />
Fortunes were down due to lower sales of engine controls, aviation airplane spares, and aviation airplane aftermarket sales. The company expects AIS's portfolio of inertial sensors products to complement its guidance, control and navigation systems products. Based in Charlotte, North Carolina, Goodrich is a supplier of components, systems and services to the commercial and general aviation airplane markets. <br />
<br />
The company also supplies systems and products to the global defense and space markets. Its businesses including manufacturing, service and sales are carried out in locations throughout the world. The company&#8217;s products and services are sold to customers in North America, Europe and Asia . <br />
<br />
Goodrich operates through three business segments &#8211; Actuation and Landing Systems, Nacelles and Interior Systems, and Electronic Systems. <br />
<br />
Actuation and Landing Systems provide components and systems in aircraft used in take-off and landing, wheels and brakes, as well as actuation systems. Nacelles and Interior Systems produce aero-structures, aircraft interiors including lighting and cargo systems, and other services. The third operating segment, Electronic Systems, produces inputs for in-flight monitoring and control and safety data, as well as ice detection, ISR, and launch and missile telemetry systems.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GR">Read the full analyst report on "GR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/goodrich-to-acquire-ais-global-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSRH, Consorteum Holdings Inc. Its Consumer Stored Value Rebate Card will Offer Manufacturers and Retailers a New Way to Process Mail-in Rebates</title>
		<link>http://www.straightstocks.com/stock-watch/csrh-consorteum-holdings-inc-its-consumer-stored-value-rebate-card-will-offer-manufacturers-and-retailers-a-new-way-to-process-mail-in-rebates-6/</link>
		<comments>http://www.straightstocks.com/stock-watch/csrh-consorteum-holdings-inc-its-consumer-stored-value-rebate-card-will-offer-manufacturers-and-retailers-a-new-way-to-process-mail-in-rebates-6/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 21:53:52 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.BestOTC.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.crwenewswire.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.PennyOmega.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.stock-pr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4859</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Wednesday November 18, 2009
DrStockPick.com Stock Report!
CSRH, Consorteum Holdings Inc, CSRH.OB
**********************************************************
Consorteum Holdings Inc. Launched Alternative Mail-In Rebate Program for Manufacturers and Retailers
Consorteum Holdings Inc. (OTCBB: CSRH) will build on its extensive expertise within the Payments and Transaction Industry in North America, Europe and Internationally. By [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/csrh-consorteum-holdings-inc-its-consumer-stored-value-rebate-card-will-offer-manufacturers-and-retailers-a-new-way-to-process-mail-in-rebates-6/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Salesforce.com Up on EPS, Revs &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/salesforce-com-up-on-eps-revs-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/salesforce-com-up-on-eps-revs-analyst-blog/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 20:09:46 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Americas]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Guidance Management]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27433/Salesforce.com+Up+on+EPS%2C+Revs+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Salesforce.com</strong> (<a href="http://www.zacks.com/stock/quote/crm">CRM</a>) reported third quarter EPS of 34 cents, which exceeded the Zacks Consensus Estimate of 16 cents per share.<br />
<br />
<em><strong>Revenue</strong></em><br />
<br />
Revenue for the third quarter was $330.5 million, an increase of 20.0% from $276.5 million reported in the year-ago quarter and an increase of 4.5% from $316.1 million reported in the second quarter of fiscal 2010. This exceeded the company&#8217;s guidance range of $323.0 million to $324.0 million. The increase in revenue can be attributed to improvement in new business demand and lower attrition rate experienced by the company.<br />
<br />
Subscription &#38; Support revenue of $306.9 million increased 21.0% from the year-ago quarter. Professional Services &#38; Other revenue of $23.7 million increased 3.0% from the year-ago quarter. Geographically, the Americas contributed 70.0% of total third quarter 2010 revenue, growing 26.4% year-over-year. Europe contributed 18.0%, growing 13.0% year-over-year. Asia-Pacific contributed 12.0%, growing 33.2% year-over-year.<br />
 <br />
<em><strong>Customers</strong></em><br />
 <br />
Net paying customers increased by 4,700 during the quarter, bringing the total to 67,900. This was an increase of 16,100 customers from the year-ago quarter. New business in the third quarter grew compared to the last year and the company claims that it is the best growth quarter of the year.<br />
 <br />
<em><strong>Operating Results</strong></em><br />
 <br />
Gross margin was 80.2% in the third quarter as compared to 79.6% reported in the year-ago quarter. This minimal increase in gross margin is attributable to a mix shift between revenue lines, with the high-margin subscription revenue comprising more of the company&#8217;s total revenue than the low-margin professional services business. Average selling price per subscriber for each service addition continued to be stable.  Operating margin was 9.0% in the quarter, versus 6.0% in the year-ago quarter.<br />
 <br />
On a GAAP basis, fully diluted EPS for the third quarter was $0.16 compared to $0.08 in the year-ago quarter. Earnings per share have exceeded the company&#8217;s guidance of $0.15 to $0.16. Earnings per share on a GAAP basis include approximately $20.4 million in stock-based compensation expense and approximately $2.6 million in amortization of purchased intangibles related to previously announced acquisitions. On an adjusted basis, the EPS was $0.34.<br />
 <br />
<em><strong>Balance Sheet &#38; Cash Flow</strong></em><br />
 <br />
Salesforce.com generated $36.0 million in cash from operating activities in the third quarter of 2010 versus $45.9 million in the previous quarter. The company ended the quarter with $1070.0 million in cash and cash equivalents and marketable securities (both current and non-current) versus $1030.4 million in the previous quarter. Salesforce.com has no long-term debt. Deferred revenue for the quarter was $533.5 million, down from $549.0 million in the previous quarter.<br />
 <br />
<em><strong>Guidance</strong></em><br />
 <br />
Management has provided guidance for the fourth quarter. Revenue for the fourth quarter is projected in the range of $340.0 million to $342.0 million, with the GAAP based EPS in the range of $0.14 to $0.15. The company has provided its full-year 2010 guidance and expects revenue to increase from its previous outlook. Revenue is now expected to be approximately $1.292 billion to $1.294 billion compared to its previous outlook of $1.27 billion to $1.28 billion. The company now expects GAAP based EPS to be in the range of approximately $0.62 to $0.63, compared to its previous outlook of $0.60 to $0.61. The company also expects fiscal year 2011 revenue to increase 15% to 16% from 2010 levels.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CRM">Read the full analyst report on "CRM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/salesforce-com-up-on-eps-revs-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Another Acquisition by Danaher &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/another-acquisition-by-danaher-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/another-acquisition-by-danaher-analyst-blog/#comments</comments>
		<pubDate>Wed, 18 Nov 2009 15:42:45 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[automation systems solutions]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[consumer products]]></category>
		<category><![CDATA[Danaher Corporation]]></category>
		<category><![CDATA[Emerson Electric Company]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gilbarco Veeder-Root]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Johnson Controls Inc.]]></category>
		<category><![CDATA[petroleum marketers]]></category>
		<category><![CDATA[site management]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27410/Another+Acquisition+by+Danaher+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Gilbarco Veeder-Root, a wholly owned unit of <strong>Danaher Corporation </strong>(<a href="http://www.zacks.com/stock/quote/DHR">DHR</a>), agreed to buy a petroleum dispensing pump (PDP) unit from Larsen &#38; Toubro (L&#38;T) in India. The PDP business unit manufactures, sells, integrates and services petroleum dispensers, LPG equipment, and automation systems solutions. The financial terms of the acquisition were not disclosed.<br />
 <br />
This acquisition will further strengthen Gilbarco&#8217;s position in the fast growing Indian market. Danaher&#8217;s management stated that the acquisition reaffirms the company&#8217;s interest in India and is in tandem with its long-term growth strategy. The acquired unit will be joining 14 other Danaher companies in India.<br />
 <br />
The PDP unit will be a part of Gilbarco Veeder-Root&#8217;s organization in a new division called Gilbarco Veeder-Root India. Gilbarco supplies integrated fuel control, site management and support services for petroleum marketers and commercial fuelling enterprises.<br />
 <br />
During its third quarter conference call, Danaher pointed that it was seeing strongly positive growth in China and India, the two high growth countries in Asia. The company said that though the rest of the emerging markets were soft, it witnessed mid-single digit growth in China and India during the quarter. The company is quite bullish on growth opportunities in these two countries.<br />
 <br />
Danaher is focused on strengthening its competitive position and accelerating its sales and earnings growth potential through acquisitions. During the third quarter, the company completed six acquisitions and announced another two acquisitions to be completed in the fourth quarter.<br />
 <br />
Danaher Corporation, together with its subsidiaries, designs, manufactures, and markets professional, medical, industrial, commercial, and consumer products, primarily in the United States, Europe, and Asia. Major competitors are <strong>Emerson Electric Company </strong>(<a href="http://www.zacks.com/stock/quote/EMR">EMR</a>) and <strong>Johnson Controls Inc</strong> (<a href="http://www.zacks.com/stock/quote/JCI">JCI</a>).<br />
 <br />
We currently have a Neutral recommendation on DHR.<br /><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DHR">Read the full analyst report on "DHR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=EMR">Read the full analyst report on "EMR"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JCI">Read the full analyst report on "JCI"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/another-acquisition-by-danaher-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, HZHI, HCEI, CVAT, PSFT, CSRH, AQNM, DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-csrh-aqnm-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-csrh-aqnm-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 22:44:50 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[beverage processor]]></category>
		<category><![CDATA[beverage processors]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil refining;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[e-coli]]></category>
		<category><![CDATA[e-commerce sites]]></category>
		<category><![CDATA[eBay US]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[food products]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[non-chemical process;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online shopping network]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[ozone equipment;]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US Subsidiary SunCity Ventures]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[water treatment equipment]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4830</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Tuesday November 17, 2009
DrStockPick.com Stock Report!
PWRM, HZHI, HCEI, CVAT, PSFT, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-hzhi-hcei-cvat-psft-csrh-aqnm-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Gas Comics: EU Sells Out Human Rights to Turkmenistan</title>
		<link>http://www.straightstocks.com/investing-lessons/the-gas-comics-eu-sells-out-human-rights-to-turkmenistan/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-gas-comics-eu-sells-out-human-rights-to-turkmenistan/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 19:10:51 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[Caspian Sea]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[diplomat]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[energy diplomacy]]></category>
		<category><![CDATA[energy grid]]></category>
		<category><![CDATA[energy reliance]]></category>
		<category><![CDATA[Energy Security]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Steve Mann]]></category>
		<category><![CDATA[Turkmenistan]]></category>
		<category><![CDATA[Ukraine]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[unreliable supplier]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22186</guid>
		<description><![CDATA[ You've got to respect Global Witness ... for a watchdog NGO, they bring a lot of creativity and innovation to their cause (see this past campaign for another example).&#160; GW has also done a tremendous job in the past...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-gas-comics-eu-sells-out-human-rights-to-turkmenistan/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Intel Raises Dividend &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/intel-raises-dividend-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/intel-raises-dividend-analyst-blog/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 19:05:25 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Advanced Micro Devices]]></category>
		<category><![CDATA[Analog Devices]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Intel Corp]]></category>
		<category><![CDATA[Linear Technology;]]></category>
		<category><![CDATA[Maxim Integrated Products]]></category>
		<category><![CDATA[National Semiconductor;]]></category>
		<category><![CDATA[technology turnaround]]></category>
		<category><![CDATA[Texas Instruments]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27385/Intel+Raises+Dividend+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Intel Corp</strong> (<a href="http://www.zacks.com/stock/quote/intc">INTC</a>) raised the quarterly cash dividend by 12.5%, totaling 63 cents a share in 2010. The dividend yield comes to 3.1%.<br />
<br />
The company has been paying a cash dividend for the last 17 years and has raised the dividend 14 times since it started.<br />
<br />
Intel has over $8 billion of net cash on its balance sheet, or around $1.58 a share. The $1.25 billion payment to <strong>Advanced Micro Devices </strong>(<a href="http://www.zacks.com/stock/quote/amd">AMD</a>) will take another 23 cents a share off the cash balance.<br />
<br />
The remaining cash ($1.35 a share) is sufficient to fund its growth plans, even after paying the higher rate of dividend. We also expect Intel to continue generating strong cash flows, based on its leading market position and product development strategies.<br />
<br />
Intel&#8217;s announcement comes as an indication of the technology turnaround. However, the company is not the first to recognize the gain, or pass it to investors. <strong>Texas Instruments</strong> (<a href="http://www.zacks.com/stock/quote/txn">TXN</a>) announced a nice raise in September, as the company started seeing broad-based strength in its business.<br />
<br />
Chip companies have rallied strongly from the downturn, both due to changes in market dynamics and a more cautious approach by most players. Companies like <strong>Linear Technology</strong> (<a href="http://www.zacks.com/stock/quote/lltc">LLTC</a>), <strong>Maxim Integrated Products</strong> (<a href="http://www.zacks.com/stock/quote/mxim">MXIM</a>), <strong>Analog Devices</strong> (<a href="http://www.zacks.com/stock/quote/adi">ADI</a>), <strong>National Semiconductor</strong> (<a href="http://www.zacks.com/stock/quote/nsm">NSM</a>) and TI were all quick to cut inventories at the first signs of the recession.<br />
<br />
The companies also benefited from the growing demand in Asia, as a lot of the manufacturing and particularly, assembling has shifted to the region. Another positive for these companies has been the growing consumption of electronic goods in Asia. Therefore, despite the recession, demand has held up relatively better than other sectors in the recession-dampened U.S. and Europe.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=INTC">Read the full analyst report on "INTC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMD">Read the full analyst report on "AMD"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TXN">Read the full analyst report on "TXN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LLTC">Read the full analyst report on "LLTC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MXIM">Read the full analyst report on "MXIM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ADI">Read the full analyst report on "ADI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NSM">Read the full analyst report on "NSM"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/intel-raises-dividend-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Small Cap Voice Featured Company: Wind Works Power Corp. (WWPW.OB)</title>
		<link>http://www.straightstocks.com/investing-lessons/small-cap-voice-featured-company-wind-works-power-corp-wwpw-ob/</link>
		<comments>http://www.straightstocks.com/investing-lessons/small-cap-voice-featured-company-wind-works-power-corp-wwpw-ob/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 16:26:23 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Baker Wind Park]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Chief Executive Officer]]></category>
		<category><![CDATA[Clean Breeze Wind Park]]></category>
		<category><![CDATA[Energy Projects]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Grand Prairie Wind Park]]></category>
		<category><![CDATA[Grey Highlands Wind Park]]></category>
		<category><![CDATA[Illinois]]></category>
		<category><![CDATA[Ingo Stuckmann]]></category>
		<category><![CDATA[Montana]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Pleasant Bay Wind Park]]></category>
		<category><![CDATA[Polar Bear Wind Park]]></category>
		<category><![CDATA[Seeba Energy Farming Gmbh]]></category>
		<category><![CDATA[Settlers Landing Wind Park]]></category>
		<category><![CDATA[Snowy Ridge Wind Park]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Whispering Woods Wind Park]]></category>
		<category><![CDATA[Wind Park]]></category>
		<category><![CDATA[Wind Works Power Corp.]]></category>
		<category><![CDATA[WWPW]]></category>
		<category><![CDATA[Zero Emission People LLC]]></category>
		<category><![CDATA[Zorra Wind Park]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19340</guid>
		<description><![CDATA[Wind Works Power Corp. is on a mission to become a leading developer of wind energy projects in North America. To facilitate this business plan, WWPW has entered into a joint venture agreement and option agreement with Zero Emission People LLC, (“Zero Emission”) an entity controlled by Dr. Ingo Stuckmann, WWPW&#8217;s chief executive officer. 
Zero [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/small-cap-voice-featured-company-wind-works-power-corp-wwpw-ob/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ITT Corporation Beats Estimates &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/itt-corporation-beats-estimates-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/itt-corporation-beats-estimates-analyst-blog/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 16:23:31 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[defense electronics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[flow control]]></category>
		<category><![CDATA[fluids management]]></category>
		<category><![CDATA[ITT Corporation;]]></category>
		<category><![CDATA[Lockheed Martin Corporation]]></category>
		<category><![CDATA[Raytheon Company;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27368/ITT+Corporation+Beats+Estimates+-+Analyst+Blog</guid>
		<description><![CDATA[<p><br />
<strong>ITT Corporation </strong>(<a href="http://www.zacks.com/stock/quote/ITT">ITT</a>) reported third quarter 2009 net income from continuing operations of $190 million or $1.03 per share, exceeding the Zacks Consensus Estimate of 89 cents.<br />
 <br />
The results included the effects of improved operating performance primarily driven by productivity initiatives. Revenue for the quarter was $2.7 billion, down 6% year-over-year and down 4% excluding the impact of foreign exchange and acquisitions on a comparable basis.<br />
 <br />
In the Defense Electronics &#38; Services segment, revenue of $1.57 billion was up 2% over the comparable period in 2008. The segment recorded growth in revenues at every value center, except for the Communications Systems division, where the expected reduction in domestic SINCGARS radio deliveries resulted in a negative comparison.</p>
<p>In Fluid Technology, third quarter 2009 revenue was $826 million, down 13% year-over-year and 10% organically. Results outperformed expectations, despite challenged industrial, municipal and residential market conditions.</p>
<p>In Motion &#38; Flow Control, revenue for the quarter was $307 million, down 22% in total and 16% organically compared to the prior year. Revenue in the automotive market exceeded expectations, primarily due to the recent stimulus activity in Europe, while performance in general industrial markets met expectations, despite some contraction. Rail markets in Europe also showed gains.</p>
<p>Free cash flow generation of $916 million for the first nine months of the year represents a 174% conversion of income from continuing operations, excluding special items primarily related to the charge for asbestos liability.</p>
<p>ITT forecasts its full-year earnings excluding special items to be $3.70 to $3.74 per share. The current Zacks Consensus Estimate is $3.75. Full-year 2009 revenue is expected to be in the range of $10.9 billion to $11.0 billion.</p>
<p>ITT Corporation is a high-technology engineering and manufacturing company operating on all seven continents in three vital markets: water and fluids management, global defense and security, and motion and flow control. With a heritage of innovation, ITT partners with its customers to deliver solutions that create more livable environments, provide protection and safety and connect the world. Major competitors include <strong>Lockheed Martin Corporation </strong>(<a href="http://www.zacks.com/stock/quote/LMT">LMT</a>) and <strong>Raytheon Company </strong>(<a href="http://www.zacks.com/stock/quote/RTN">RTN</a>).</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ITT">Read the full analyst report on "ITT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LMT">Read the full analyst report on "LMT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=RTN">Read the full analyst report on "RTN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/itt-corporation-beats-estimates-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Citigroup Inc., Liberty Global Inc., Comcast Corp., Deutsche Telekom AG and Vodafone Plc &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-citigroup-inc-liberty-global-inc-comcast-corp-deutsche-telekom-ag-and-vodafone-plc-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-citigroup-inc-liberty-global-inc-comcast-corp-deutsche-telekom-ag-and-vodafone-plc-press-releases/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 12:00:07 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[analog]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bain Capital Partners]]></category>
		<category><![CDATA[Bellsystem24]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[Cable Tv]]></category>
		<category><![CDATA[call center operator]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Citi]]></category>
		<category><![CDATA[Citi Holdings;]]></category>
		<category><![CDATA[Citigroup Capital Partners Japan Ltd.]]></category>
		<category><![CDATA[Citigroup Inc]]></category>
		<category><![CDATA[Comcast Corp.;]]></category>
		<category><![CDATA[Deutsche Telekom Ag]]></category>
		<category><![CDATA[Digital Tv]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[formidable cable TV player]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Jpy]]></category>
		<category><![CDATA[Kabel Deutschland]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Liberty Global Inc.]]></category>
		<category><![CDATA[retail broadband internet]]></category>
		<category><![CDATA[telephony]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Unitymedia GmbH]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vodafone plc;]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27355/Zacks+Analyst+Blog+Highlights%3A+Citigroup+Inc.%2C+Liberty+Global+Inc.%2C+Comcast+Corp.%2C+Deutsche+Telekom+AG+and+Vodafone+Plc+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 17, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Citigroup Inc.</strong> (<a href="void(0)">C</a>), <strong>Liberty Global Inc.</strong> (<a href="void(0)">LBTYA</a>), <strong>Comcast Corp.</strong> (<a href="void(0)">CMCSA</a>), <strong>Deutsche Telekom AG </strong>(<a href="void(0)">DT</a>) and <strong>Vodafone Plc </strong>(<a href="void(0)">VOD</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Monday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Citi to Sell Stake in Bellsystem24</strong></p>
<p align="left"><strong>Citigroup Inc.</strong> (<a href="void(0)">C</a>) announced that it will sell stake in Bellsystem24 to U.S. private equity firm, Bain Capital Partners, in a deal that values the Japanese call center operator at $1.1 billion.</p>
<p align="left">The company announced on Sunday that it will sell its 93.5% controlling stake in Bellsystem24 &#8722; which it held through its Citigroup Capital Partners Japan Ltd. &#8722; to Bain Capital Partners through a tender offer. The tender offer is expected to start on or before Nov 20 and be completed on Dec 30, 2009. Under the terms of the deal, Citi will receive 93.5 billion of yen ($1 billion) in cash.</p>
<p align="left">Following the completion of the deal, Citi Holdings&#8217; assets will be reduced by $1.2 billion. However, Citi&#8217;s net income and capital ratios will not be significantly impacted by this stake sale, the company said.</p>
<p align="left"><strong>Liberty to Acquire Unitymedia</strong></p>
<p align="left"><strong>Liberty Global Inc.</strong> (<a href="void(0)">LBTYA</a>) announced it will acquire all of the issued and outstanding capital stock of Unitymedia GmbH, the second largest cable TV operator in Germany. The total consideration will be approximately $5.2 billion. Liberty Global will acquire 100% of the shares of Unitymedia for an equity purchase price of around $3 billion and will also assume around $2.2 billion of net outstanding debt of Unitymedia. The deal is expected to be completed by the first half of 2010 subject to regulatory clearance.</p>
<p align="left">Liberty Global is the second largest cable TV operator in the world. However, it is the largest international cable TV operator since <strong>Comcast Corp.</strong> (<a href="void(0)">CMCSA</a>), the largest cable MSO in the world does not have any operation outside the U.S. As of now, the company has approximately 16.6 million customers in 14 nations, most of which are in Europe. On the other hand, Unitymedia has approximately 6.4 million RGUs (revenue generating units); including 4.5 million analog and digital basic cable subscribers and 1.9 million new service RGUs (digital TV Pay, retail broadband internet, wholesale MMA internet, and telephony).</p>
<p align="left">Germany is one of the lucrative markets in Europe. In 2002, Liberty Global has failed in its attempt to acquire the cable TV business of <strong>Deutsche Telekom AG </strong>(<a href="void(0)">DT</a>). Unitymedia has the highest uptake of digital TV and highest RGU per household in Germany. Integration of Unitymedia&#8217;s operations with Liberty Global will create a formidable cable TV player in Germany to compete with Kabel Deutschland (the largest cable TV operator in Germany), Deutsche Telekom and <strong>Vodafone Plc </strong>(<a href="void(0)">VOD</a>).</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-citigroup-inc-liberty-global-inc-comcast-corp-deutsche-telekom-ag-and-vodafone-plc-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prieur’s readings (November 17, 2009)</title>
		<link>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-17-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-17-2009/#comments</comments>
		<pubDate>Tue, 17 Nov 2009 08:50:30 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[China]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Alec MacGillis;]]></category>
		<category><![CDATA[Ambrose Evans-Pritchard]]></category>
		<category><![CDATA[Atlanta]]></category>
		<category><![CDATA[bank of china]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[Carlo Cottarelli]]></category>
		<category><![CDATA[Central Intelligence Agency]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[CRE]]></category>
		<category><![CDATA[Daniel  Gross;]]></category>
		<category><![CDATA[Dennis Lockhart;]]></category>
		<category><![CDATA[Deutsche Bank]]></category>
		<category><![CDATA[Dow 10]]></category>
		<category><![CDATA[Dow 30]]></category>
		<category><![CDATA[Ethan Hill]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Federal Reserve Bank of Atlanta;]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[Hussman Funds]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Jeremy Shapiro]]></category>
		<category><![CDATA[John Carney (Clusterstock)]]></category>
		<category><![CDATA[John Hussman]]></category>
		<category><![CDATA[Michael Lerner]]></category>
		<category><![CDATA[Nick Witney]]></category>
		<category><![CDATA[not-so-small small bank]]></category>
		<category><![CDATA[Obama administration]]></category>
		<category><![CDATA[Paul Lim]]></category>
		<category><![CDATA[Peter Garnham]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Real Estate]]></category>
		<category><![CDATA[real estate catastrophe]]></category>
		<category><![CDATA[Register-Guard]]></category>
		<category><![CDATA[Simon Schama;]]></category>
		<category><![CDATA[special adviser]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[The Register-Guard]]></category>
		<category><![CDATA[Tracy Alloway]]></category>
		<category><![CDATA[U.S. Department of Defense]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Washington]]></category>
		<category><![CDATA[White House]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13779</guid>
		<description><![CDATA[This post provides links to a number of interesting articles I have read over the past few days that you may also enjoy. Please also add the links to any other worthwhile articles you would like to share to the comments section. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-17-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HCEI, HZHI, CVAT, PWRM, PSFT, CSRH, AQNM, DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/hcei-hzhi-cvat-pwrm-psft-csrh-aqnm-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/hcei-hzhi-cvat-pwrm-psft-csrh-aqnm-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 21:37:17 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(718) 951-8021]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[(951) 657-8832]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[Amplification Technologies Inc.]]></category>
		<category><![CDATA[Aquentium Inc.;]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[beverage processor]]></category>
		<category><![CDATA[beverage processors]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[crude oil refining;]]></category>
		<category><![CDATA[CSRH]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[e-coli]]></category>
		<category><![CDATA[e-commerce sites]]></category>
		<category><![CDATA[eBay US]]></category>
		<category><![CDATA[end-product]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[food products]]></category>
		<category><![CDATA[Food Safety]]></category>
		<category><![CDATA[green technologies;]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[high-energy physics]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[InGaAs/InP technologies]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[Jack Mayer]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Krishna Linga]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[light level imaging]]></category>
		<category><![CDATA[Mark Taggatz;]]></category>
		<category><![CDATA[medical imaging]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[mining]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[non-chemical process;]]></category>
		<category><![CDATA[non-chemical sanitation equipment]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[online shopping network]]></category>
		<category><![CDATA[online transactions]]></category>
		<category><![CDATA[ozone equipment;]]></category>
		<category><![CDATA[Palm Springs]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[PowerSafe Technology Corp.]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[PSFT]]></category>
		<category><![CDATA[PWRM]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[semiconductor]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[spectroscopy]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US Subsidiary SunCity Ventures]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[Waste To Energy]]></category>
		<category><![CDATA[water treatment equipment]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.amplificationtechnologies.com]]></category>
		<category><![CDATA[www.aquentium.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.HCEI.biz]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[www.horizonhealthandsafety.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4800</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Monday November 16, 2009
DrStockPick.com Stock Report!
HCEI, HZHI, CVAT, PWRM, PSFT, CSRH, AQNM
**************************************************************
 HCEI, Healthy Coffee International Inc., HCEI.PK
HCEI is well positioned in the market place at the intersection of three mega-billion dollar industries: coffee, wellness and energy drinks, and has quickly established offices in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hcei-hzhi-cvat-pwrm-psft-csrh-aqnm-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Liberty to Acquire Unitymedia &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/liberty-to-acquire-unitymedia-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/liberty-to-acquire-unitymedia-analyst-blog/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 19:39:12 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[analog]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[Cable Tv]]></category>
		<category><![CDATA[Comcast Corp.;]]></category>
		<category><![CDATA[Deutsche Telekom Ag]]></category>
		<category><![CDATA[Digital Tv]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[formidable cable TV player]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Kabel Deutschland]]></category>
		<category><![CDATA[Liberty Global Inc.]]></category>
		<category><![CDATA[retail broadband internet]]></category>
		<category><![CDATA[telephony]]></category>
		<category><![CDATA[Unitymedia GmbH]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vodafone plc;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27341/Liberty+to+Acquire+Unitymedia+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
Liberty Global Inc.</strong> (<a href="http://www.zacks.com/stock/quote/LBTYA">LBTYA</a>) announced it will acquire all of the issued and outstanding capital stock of Unitymedia GmbH, the second largest cable TV operator in Germany. The total consideration will be approximately $5.2 billion. Liberty Global will acquire 100% of the shares of Unitymedia for an equity purchase price of around $3 billion and will also assume around $2.2 billion of net outstanding debt of Unitymedia. The deal is expected to be completed by the first half of 2010 subject to regulatory clearance.<br />
 <br />
Liberty Global is the second largest cable TV operator in the world. However, it is the largest international cable TV operator since <strong>Comcast Corp.</strong> (<a href="http://www.zacks.com/stock/quote/CMCSA">CMCSA</a>), the largest cable MSO in the world does not have any operation outside the U.S. As of now, the company has approximately 16.6 million customers in 14 nations, most of which are in Europe. On the other hand, Unitymedia has approximately 6.4 million RGUs (revenue generating units); including 4.5 million analog and digital basic cable subscribers and 1.9 million new service RGUs (digital TV Pay, retail broadband internet, wholesale MMA internet, and telephony).<br />
 <br />
Germany is one of the lucrative markets in Europe. In 2002, Liberty Global has failed in its attempt to acquire the cable TV business of <strong>Deutsche Telekom AG</strong> (<a href="http://www.zacks.com/stock/quote/DT">DT</a>). Unitymedia has the highest uptake of digital TV and highest RGU per household in Germany. Integration of Unitymedia&#8217;s operations with Liberty Global will create a formidable cable TV player in Germany to compete with Kabel Deutschland (the largest cable TV operator in Germany), Deutsche Telekom and <strong>Vodafone Plc</strong> (<a href="http://www.zacks.com/stock/quote/VOD">VOD</a>).<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LBTYA">Read the full analyst report on "LBTYA"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CMCSA">Read the full analyst report on "CMCSA"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DT">Read the full analyst report on "DT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VOD">Read the full analyst report on "VOD"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/liberty-to-acquire-unitymedia-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Consorteum Holdings, Inc. (CSRH.OB) Sees Itself as Best Solutions Financial Provider</title>
		<link>http://www.straightstocks.com/investing-lessons/consorteum-holdings-inc-csrh-ob-sees-itself-as-best-solutions-financial-provider/</link>
		<comments>http://www.straightstocks.com/investing-lessons/consorteum-holdings-inc-csrh-ob-sees-itself-as-best-solutions-financial-provider/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 16:16:31 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Dominant Player]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[financial transaction processing]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[possible solutions]]></category>
		<category><![CDATA[products/services]]></category>
		<category><![CDATA[supporting technologies]]></category>
		<category><![CDATA[transaction processing]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19309</guid>
		<description><![CDATA[
Consorteum Holdings Inc., a financial transaction solution provider, clearly believes it has the right people, with the right skills, along with more flexible access to the best technologies. In addition, it has extensive relationships within the payments and transaction industry. For all these reasons, the company sees itself as offering customers the best possible solutions [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/consorteum-holdings-inc-csrh-ob-sees-itself-as-best-solutions-financial-provider/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TAXS, CVAT, CSRH,  DrStockPick.com Stock Report! TaxMasters Inc., Cavitation Technologies Inc. and Consorteum Holdings Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/taxs-cvat-csrh-drstockpick-com-stock-report-taxmasters-inc-cavitation-technologies-inc-and-consorteum-holdings-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/taxs-cvat-csrh-drstockpick-com-stock-report-taxmasters-inc-cavitation-technologies-inc-and-consorteum-holdings-inc/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 15:46:53 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[281.497.4226 x700]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CTI Nano-Cavitation Process Systems]]></category>
		<category><![CDATA[customer service management]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[Internal Revenue Service]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[TaxMasters Inc.]]></category>
		<category><![CDATA[TAXS]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[workflow management software application]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.txmstr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4779</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Monday November 16, 2009
DrStockPick.com Stock Report!
CVAT, Cavitation Technologies Inc, CVAT.OB
CSRH, Consorteum Holdings Inc, CSRH.OB
TAXS, TaxMasters Inc., TAXS.OB
**************************************************************
TaxMasters, Inc. Managing Growth, Improving Efficiency, Increasing Speed of Service
TAXS,the IRS tax relief company, began operational implementation this week of a proprietary system to increase productivity and improve [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/taxs-cvat-csrh-drstockpick-com-stock-report-taxmasters-inc-cavitation-technologies-inc-and-consorteum-holdings-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: GlaxoSmithKline plc, Sanofi-Aventis, Novartis, Baxter International and AstraZeneca &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-glaxosmithkline-plc-sanofi-aventis-novartis-baxter-international-and-astrazeneca-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-glaxosmithkline-plc-sanofi-aventis-novartis-baxter-international-and-astrazeneca-press-releases/#comments</comments>
		<pubDate>Mon, 16 Nov 2009 13:15:46 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Baxter International]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[CSL Limited of Australia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Glaxosmithkline Plc]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[MedImmune LLC]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Novartis Vaccines and Diagnostics Limited]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United  States Department of Health and Human Services]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Government]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27314/Zacks+Analyst+Blog+Highlights%3A+GlaxoSmithKline+plc%2C+Sanofi-Aventis%2C+Novartis%2C+Baxter+International+and+AstraZeneca+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 16, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>GlaxoSmithKline plc </strong>(<a href="void(0)">GSK</a>), <strong>Sanofi-Aventis </strong>(<a href="void(0)">SNY</a>), <strong>Novartis </strong>(<a href="void(0)">NVS</a>), <strong>Baxter International </strong>(<a href="void(0)">BAX</a>) and <strong>AstraZeneca </strong>(<a href="void(0)">AZN</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Friday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Glaxo H1N1 Vaccine Approved</strong></p>
<p align="left"><strong>GlaxoSmithKline plc </strong>(<a href="void(0)">GSK</a>) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine. The FDA approved the supplemental biologics license application (sBLA), which was filed as a strain change supplement to Glaxo&#8217;s FluLaval seasonal flu vaccine. This means that Glaxo can now market its swine flu vaccine for use in adults to prevent influenza.</p>
<p align="left">The company has already received an order for 7.6 million doses of its swine flu vaccine from the United States Department of Health and Human Services. This order is a part of the US Government&#8217;s intention to secure about 250 million doses to help fight the swine flu pandemic.</p>
<p align="left">The current outbreak of swine flu pandemic can prove to be a big opportunity for vaccine manufacturers. In addition to Glaxo, other major players in this field include <strong>Sanofi-Aventis </strong>(<a href="void(0)">SNY</a>), <strong>Novartis </strong>(<a href="void(0)">NVS</a>), <strong>Baxter International </strong>(<a href="void(0)">BAX</a>) and <strong>AstraZeneca </strong>(<a href="void(0)">AZN</a>).</p>
<p align="left">In fact, several companies including Sanofi Pasteur, the vaccine division of Sanofi-Aventis, Novartis Vaccines and Diagnostics Limited, the vaccine and diagnostics arm of Novartis, MedImmune LLC, a subsidiary of AstraZeneca and CSL Limited of Australia, have already received approval from the FDA for their swine flu vaccines.</p>
<p align="left">Glaxo intends to start shipping its vaccine in December and expects to provide all the doses by year-end. We expect the company&#8217;s vaccine segment to post strong revenues in the fourth quarter of 2009. In addition to strong influenza product sales, the company has made significant progress in expanding its vaccine product portfolio. The approval of cervical cancer vaccine Cervarix in the US and Japan, H1N1 vaccine Pandemrix in Europe, and the H1N1 vaccine in the US should all help drive vaccine segment revenue.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-glaxosmithkline-plc-sanofi-aventis-novartis-baxter-international-and-astrazeneca-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Commodity inflation</title>
		<link>http://www.straightstocks.com/investing-lessons/commodity-inflation/</link>
		<comments>http://www.straightstocks.com/investing-lessons/commodity-inflation/#comments</comments>
		<pubDate>Sun, 15 Nov 2009 14:36:39 +0000</pubDate>
		<dc:creator>James Hamilton</dc:creator>
				<category><![CDATA[Economics]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[bloomberg]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Central Television;]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[crude oil stocks]]></category>
		<category><![CDATA[Dow Jones Commodity]]></category>
		<category><![CDATA[easy bank credit]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[Finance Minister]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Ke Tang]]></category>
		<category><![CDATA[Liu Na]]></category>
		<category><![CDATA[lower oil]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil going]]></category>
		<category><![CDATA[Oil Markets]]></category>
		<category><![CDATA[Oil Prices]]></category>
		<category><![CDATA[precious metal]]></category>
		<category><![CDATA[Scotia Capital Inc;]]></category>
		<category><![CDATA[Steve Gordon]]></category>
		<category><![CDATA[Stock Brokers]]></category>
		<category><![CDATA[The Financial Times]]></category>
		<category><![CDATA[The Wall Street Journal]]></category>
		<category><![CDATA[Treasury Inflation Protected Securities]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wall Street Journal]]></category>
		<category><![CDATA[Wei Xiong]]></category>
		<category><![CDATA[year oil prices]]></category>
		<category><![CDATA[Yves Smith]]></category>

		<guid isPermaLink="false">http://www.econbrowser.com/archives/2009/11/commodity_infla.html</guid>
		<description><![CDATA[<p>Why are the prices of so many commodities rising in an economy that seems to remain quite weak?</p>

<table align="right" border="1" rules="all" bgcolor="#00FFFF">
<tr> <th> </th><th colspan="2"> % change
<tr><td>butter</td><td align="center">35
<tr><td>coffee</td><td align="center">21.8
<tr><td>cocoa</td><td align="center">20.2
<tr><td>copper</td><td align="center">89.1
<tr><td>corn</td><td align="center">-8.3
<tr><td>cotton</td><td align="center">38.6
<tr><td>gold</td><td align="center">32.1
<tr><td>hogs</td><td align="center">2.7
<tr><td>oats</td><td align="center">13.4
<tr><td>oil</td><td align="center">63.2
<tr><td>lead</td><td align="center">81.9
<tr><td>palladium</td><td align="center">75.9
<tr><td>platinum</td><td align="center">61.7
<tr><td>silver</td><td align="center">59.1
<tr><td>steel</td><td align="center">-0.9
<tr><td>sugar</td><td align="center">73.6
<tr><td>tin</td><td align="center">22.5
<tr><td>wheat</td><td align="center">-26.6
<tr><td>zinc</td><td align="center">55.4
<tr><td><b>average</b></td><td align="center"><b>37.4</b>
<tr><td>euro</td><td align="center">12
</td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></td></tr></th></tr></table>

<p>The table at the right summarizes the percent change between January 6 and November 11 in the cash prices of 19 commodities reported in the Wall Street Journal (downloaded via Webstract).  The average commodity in this list has appreciated 37% since the start of the year.</p>

<p>A recent <a href="http://www.princeton.edu/~wxiong/papers/commodity.pdf">
paper by Ke Tang and Wei Xiong</a> documents an increasing tendency for commodity prices to move together over the last few years.  A decade ago, what happened to oil prices was largely unrelated to movements in most other commodity prices.  The graphs below show how the correlations between oil prices and the prices of four representative commodities have increased significantly over time.

<br />

<table>
<caption align="bottom"> <h6>
Correlation (using a rolling sample beginning one year before indicated date) between returns on oil and specified commodity.  Source:
<a href="http://www.princeton.edu/~wxiong/papers/commodity.pdf">Tang and Xiong (2009)</a>.
</h6></caption>
<tr><td><img alt="wei1.gif" src="http://www.econbrowser.com/archives/2009/11/wei1.gif"/>
</td></tr></table>

<br />

</p><p>One explanation I often see in the popular press is that movements in commodity prices are driven by changes in the value of the dollar relative to other currencies.  However, the magnitude of movements in commodity prices greatly exceeds the size of changes in the exchange rate.  For example, the table above shows that since the start of this year oil prices have increased five times as much as the dollar price of a euro; see also <a href="http://worthwhile.typepad.com/worthwhile_canadian_initi/2009/10/oil-prices-in-currencies-other-than-the-usd.html">Steve Gordon's graphs</a>.  While the depreciation of the dollar is part of the story, most of the explanation must be found elsewhere.</p>

<p>Another important factor is resurging real economic growth outside the United States, which produces pressures for both the dollar to depreciate and the real price of commodities to appreciate.  According to this theory, the increasing correlations between commodity prices results from the fact that countries like China are so much more important for the world economy today than they were a decade ago.</p>

<p>A third explanation is that investors are making increasing use of commodities as an investment class.  Although Treasury Inflation Protected Securities offer a hedge against an increase in the U.S. consumer price index, they don't offer protection for foreign investors against depreciation of the dollar.  Insofar as increases in the prices of commodities like oil may depress real economic activity, holding commodities as an investment also offers useful diversification against risks to equities.  Particularly when <a href="http://www.hks.harvard.edu/fs/jfrankel/CP.htm">interest rates are low</a>, there is an incentive to hoard physical commodities as an investment vehicle.</p>

<p>The paper by <a href="http://www.princeton.edu/~wxiong/papers/commodity.pdf">Tang and Xiong</a> proposes that the increased use of commodities as a financial investment accounts for the increasing correlation among commodity price changes over time.  In support of that claim, they note the growing popularity of investment strategies based on the <a href="http://www2.goldmansachs.com/services/securities/products/sp-gsci-commodity-index/tables.html">Goldman Sachs Commodity Index</a> or the <a href="http://www.djindexes.com/ubs/index.cfm?go=home">Dow Jones Commodity Index</a>.  Tang and Xiong document that correlations among commodities included in the indexes have increased faster than those not included.  For example, one of the regressions they estimate relates the return on commodity <em>i</em> to equity returns, bond yields, the value of the dollar, and oil prices, where the coefficients are allowed to grow with time at different rates before and after 2004, and with different trends on these coefficients estimated for commodities included in indexes as for those excluded.  The figure below shows their estimated time path for the coefficient on oil prices comparing the indexed and non-indexed groups.</p>

<br />

<table>
<caption align="bottom"> <h6>
Coefficient relating return on average commodity to return on oil as a function of time for commodities included in the GS or DJ indexes (top curve) and those excluded (bottom curve). Source:
<a href="http://www.princeton.edu/~wxiong/papers/commodity.pdf">Tang and Xiong (2009)</a>.
</h6></caption>
<tr><td><img alt="wei2.gif" src="http://www.econbrowser.com/archives/2009/11/wei2.gif"/>
</td></tr></table>

<br />

<p>For any of the explanations in this third class, one of the important challenges is to reconcile the story of commodity speculation with <a href="http://krugman.blogs.nytimes.com/2008/05/13/more-on-oil-and-speculation/">supply and demand</a> for the underlying physical commodity.  If we propose that speculators have driven the price of the commodity up, the physical quantity demanded should decline as a result.  In order to be sustained, a coherent speculation-based theory of commodity price appreciation requires increased physical storage of the commodity.</p>

<p>The solid black curve in the figure below plots the typical U.S. crude oil stocks (excluding those held in the Strategic Petroleum Reserve) for each week of the year, based on the average over 1990-2007.  The red line gives the actual values for 2008, which were significantly below the historical average, particularly in the spring of 2008 when oil prices were rising so dramatically.  Those below-normal inventories were one reason I focused on what was going on to the fundamentals of supply and demand in trying to understand the behavior of oil markets in the first half of 2008.</p>

<br />

<table>
<caption align="bottom"> <h6>
Weekly U.S. crude oil ending stocks, excluding SPR, in thousands of barrels, from <a href="http://tonto.eia.doe.gov/dnav/pet/hist/LeafHandler.ashx?n=PET&#38;s=WCESTUS1&#38;f=W">EIA</a>.  Black line: average over 1990-2007.  Red: 2008.  Green: 2009.
</h6></caption>
<tr><td><img alt="oil_inv_nov_09.gif" src="http://www.econbrowser.com/archives/2009/11/oil_inv_nov_09.gif"/>
</td></tr></table>

<br />

<p>On the other hand, inventories of crude oil this year, shown in green above, have been substantially above normal, meaning that in the absence of that oil going into storage, we would have expected to see lower oil prices than we currently have.</p>

<p>Moreover, much of the current stockpiling may be taking place outside the United States.  For example, <a href="http://www.nakedcapitalism.com/2009/08/copper-stockpiled-by-chinese-pig.html">Yves Smith</a> noted this <a href="http://www.bloomberg.com/apps/news?pid=newsarchive&#38;sid=ae8qY8FcYJa4">story from Bloomberg</a> last August:</p>

<blockquote><p>
Copper, nickel and other base metals stockpiled by speculative Chinese investors including pig farmers may be sold when "market sentiment turns," said Scotia Capital Inc.</p>
<p>
A price surge and easy bank credit this year encouraged pig farmers, stock brokers and businessmen to buy copper and nickel for speculation, Liu Na, an analyst with Scotia Capital, wrote in a note dated Aug. 17, citing reports from the state-owned China Central Television....</p>

<p>
"These stockpiles are in 'weak hands' as speculators have no real use for base metals," Liu wrote. "When the market sentiment turns, they are very likely to turn into quick sellers, especially when the bank's money is involved."</p></blockquote>

<p>I also found this November 3 story from the <a href="http://www.ft.com/cms/s/0/0eaa4a80-c856-11de-a69e-00144feabdc0.html">Financial Times</a> of interest:</p>

<blockquote><p>
Gold prices continued to rise on Wednesday extending the all-time highs which followed India's central bank bought 200 tonnes of the precious metal, swapping dollars for bullion as the country's finance minister warned the economies of the US and Europe had "collapsed".
</p><p>
India's decision to exchange $6.7bn for gold equivalent to 8 per cent of world annual mine production sent the strongest signal yet that Asian countries were moving away from the US currency.</p>
</blockquote>

<p>Policy-makers in the Federal Reserve have traditionally thought of inflation as a broad movement in all wages and prices, which to some extent is under their control, and viewed changes in relative commodity prices as outside their control.  I believe that this is not the correct understanding of the current situation.  Concerns about inflation, particularly on the part of foreign dollar-holders, are likely to show up first in the relative prices of internationally traded commodities.  Insofar as these relative price changes can be destabilizing in themselves, it cannot be wise for U.S. policy-makers to ignore them.  
</p>

]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/commodity-inflation/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The week ahead</title>
		<link>http://www.straightstocks.com/investing-lessons/the-week-ahead-3/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-week-ahead-3/#comments</comments>
		<pubDate>Sat, 14 Nov 2009 05:16:00 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Airline]]></category>
		<category><![CDATA[Bank Of Japan]]></category>
		<category><![CDATA[Barack Obama]]></category>
		<category><![CDATA[Burberry]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Home-Depot]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[luxury-goods group]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[report  Airbus owner]]></category>
		<category><![CDATA[Retail Sales]]></category>
		<category><![CDATA[target]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13645</guid>
		<description><![CDATA[The video clips in this post provide a handy summary of the reports expected on the economic, financial and corporate front around the globe during the week ahead.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-week-ahead-3/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Glaxo H1N1 Vaccine Approved &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/glaxo-h1n1-vaccine-approved-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/glaxo-h1n1-vaccine-approved-analyst-blog/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 21:51:07 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[Aventis]]></category>
		<category><![CDATA[Baxter International]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CSL Limited of Australia]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Glaxo H1N1 Vaccine]]></category>
		<category><![CDATA[Glaxosmithkline Plc]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[MedImmune LLC]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Novartis Vaccines and Diagnostics Limited]]></category>
		<category><![CDATA[Swine Flu;]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[United  States Department of Health and Human Services]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Us Government]]></category>
		<category><![CDATA[Vaccines]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27303/Glaxo+H1N1+Vaccine+Approved+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
GlaxoSmithKline plc</strong> (<a href="http://www.zacks.com/stock/quote/GSK">GSK</a>) recently received approval from the U.S. Food and Drug Administration (FDA) for its unadjuvanted influenza A (H1N1) pandemic vaccine.  The FDA approved the supplemental biologics license application (sBLA), which was filed as a strain change supplement to Glaxo&#8217;s FluLaval seasonal flu vaccine. This means that Glaxo can now market its swine flu vaccine for use in adults to prevent influenza.   <br />
 <br />
The company has already received an order for 7.6 million doses of its swine flu vaccine from the United States Department of Health and Human Services. This order is a part of the US Government&#8217;s intention to secure about 250 million doses to help fight the swine flu pandemic. <br />
 <br />
The current outbreak of swine flu pandemic can prove to be a big opportunity for vaccine manufacturers. In addition to Glaxo, other major players in this field include <strong>Sanofi-Aventis</strong> (<a href="http://www.zacks.com/stock/quote/SNY">SNY</a>), <strong>Novartis</strong> (<a href="http://www.zacks.com/stock/quote/NVS">NVS</a>), <strong>Baxter International</strong> (<a href="http://www.zacks.com/stock/quote/BAX">BAX</a>) and <strong>AstraZeneca</strong> (<a href="http://www.zacks.com/stock/quote/AZN">AZN</a>). <br />
 <br />
In fact, several companies including Sanofi Pasteur, the vaccine division of Sanofi-Aventis, Novartis Vaccines and Diagnostics Limited, the vaccine and diagnostics arm of Novartis, MedImmune LLC, a subsidiary of AstraZeneca and CSL Limited of Australia, have already received approval from the FDA for their swine flu vaccines.<br />
 <br />
Glaxo intends to start shipping its vaccine in December and expects to provide all the doses by year-end. We expect the company&#8217;s vaccine segment to post strong revenues in the fourth quarter of 2009. In addition to strong influenza product sales, the company has made significant progress in expanding its vaccine product portfolio. The approval of cervical cancer vaccine Cervarix in the US and Japan, H1N1 vaccine Pandemrix in Europe, and the H1N1 vaccine in the US should all help drive vaccine segment revenue.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GSK">Read the full analyst report on "GSK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNY">Read the full analyst report on "SNY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NVS">Read the full analyst report on "NVS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BAX">Read the full analyst report on "BAX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/glaxo-h1n1-vaccine-approved-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>HCEI, CVAT, CSRH,  DrStockPick.com Stock Report!</title>
		<link>http://www.straightstocks.com/stock-watch/hcei-cvat-csrh-drstockpick-com-stock-report/</link>
		<comments>http://www.straightstocks.com/stock-watch/hcei-cvat-csrh-drstockpick-com-stock-report/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 20:53:13 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CTI Nano-Cavitation Process Systems]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Energy Drinks]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Florida]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[Healthy Coffee International Inc.]]></category>
		<category><![CDATA[Healthy Coffee INTL]]></category>
		<category><![CDATA[Healthy Coffee USA Inc.]]></category>
		<category><![CDATA[Internet-driven international business model]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[Michael Sharp]]></category>
		<category><![CDATA[motivational speaker]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[PK Healthy Coffee INTL]]></category>
		<category><![CDATA[Savi Ranch Parkway business complex]]></category>
		<category><![CDATA[speaker]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[This new facility]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.HealthyCoffee.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>
		<category><![CDATA[Yorba Linda]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4758</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Friday November 13, 2009
DrStockPick.com Stock Report!
**************************************************************
HCEI, Healthy Coffee International Inc., HCEI.PK
** Healthy Coffee INTL is well Positioned in the Market Place at the Intersection of Three Mega-billion Dollar Industries: Coffee, Wellness and Energy Drinks
HCEI is focused on bringing health to the world’s largest and [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hcei-cvat-csrh-drstockpick-com-stock-report/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Tyco Exceeds Zacks Estimate &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/tyco-exceeds-zacks-estimate-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/tyco-exceeds-zacks-estimate-analyst-blog/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 18:45:15 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[ADT Worldwide]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[detection products]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[flow control]]></category>
		<category><![CDATA[general electric co]]></category>
		<category><![CDATA[Honeywell International Inc.]]></category>
		<category><![CDATA[industrial products]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[security products]]></category>
		<category><![CDATA[Tyco International Ltd]]></category>
		<category><![CDATA[United Technologies Corp]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27283/Tyco+Exceeds+Zacks+Estimate+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Tyco International Ltd.</strong> (<a href="http://www.zacks.com/stock/quote/TYC">TYC</a>) reported fourth-quarter earnings per share from continuing operations of 61 cents. This was higher than the Zacks Consensus Estimate of 54 cents per share.<br />
 <br />
Quarterly Revenues of $4.4 billion declined 16% versus the prior year with an organic revenue decline of 12%. For the largest operating segment, ADT Worldwide, revenues of $1.8 billion declined 9% in the quarter with an organic revenue decline of 5% and a 4% decline due to changes in foreign currency. ADT's recurring revenues grew 4% organically on a global basis. Systems installation and service revenue declined 14% organically, mostly due to weakness in North America and Europe, as a result of continuing lower sales to commercial customers, including the retailer end market.</p>
<p>For Flow Control, revenues of $1 billion declined 15% in the quarter with an organic revenue decline of 10%. Organic revenues declined 7% in the Valves business, 17% in Water and 12% in Thermal Controls. In Fire Protection Services, revenues of $904 million declined 11% in the quarter with an organic revenue decline of 7%. Service revenues declined 5% organically and installation revenues declined 8% driven by continued softness in the North American and EMEA regions. Revenues declined 45% in the Electrical and Metal Products segment and 25% in Safety Products on a year-over-year basis.<br />
 <br />
Operating income was $226 million in the quarter and the operating margin was 12.6%. Special items of $31 million resulted primarily from restructuring activities. The operating margin before special items improved 160 basis points to 14.3%, as cost-containment initiatives, restructuring activities and growth in ADT's higher-margin recurring revenue business more than offset volume declines.<br />
 <br />
Cash from operating activities was $985 million in the quarter. The company had free cash flow of $614 million, which included cash payments of $84 million for restructuring and legacy legal matters.<br />
 <br />
Cash and equivalents were $2.3 billion with long-term debt at $4 billion and shareowners&#8217; equity at $12.9 billion.<br />
 <br />
The company&#8217;s large and growing service revenue base has provided stability and consistency to its performance in 2009 and now represents about 40% of its total revenues. A significant portion of service revenues is contractual recurring revenue in ADT, which grew 4% organically for the year with growth across all geographic regions.<br />
 <br />
Throughout the year the company was very active in executing cost containment programs, which resulted in charges of about $250 million. These actions, which are expected to provide incremental savings of $175 million in 2010, included staffing reductions as well as the consolidation of both back office operations and manufacturing facilities.</p>
<p>The company anticipates an organic revenue decline of 11% to 13% for the first quarter of 2010. Partially offsetting this decline will be the currency tailwind which is estimated at about 5% of revenue. This brings the total revenue for the quarter to approximately $4.1 billion Tyco expects earnings per share from continuing operations before special items in the first quarter to be between 48 and 50 cents. The Zacks Consensus Estimate is currently 52 cents.<br />
 <br />
Tyco is a diversified, global company that provides vital products and services to customers around the world. Tyco is a leading provider of security products and services, fire protection and detection products and services, valves and controls, and other industrial products. Major competitors include <strong>General Electric Co.</strong> (<a href="http://www.zacks.com/stock/quote/GE">GE</a>), <strong>Honeywell International Inc.</strong> (<a href="http://www.zacks.com/stock/quote/HON">HON</a>) and <strong>United Technologies Corp. </strong>(<a href="http://www.zacks.com/stock/quote/UTX">UTX</a>).<br />
 <br />
We currently have an Outperform recommendation on TYCO.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TYC">Read the full analyst report on "TYC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GE">Read the full analyst report on "GE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HON">Read the full analyst report on "HON"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=UTX">Read the full analyst report on "UTX"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/tyco-exceeds-zacks-estimate-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dow Divests Business  &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/dow-divests-business-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/dow-divests-business-analyst-blog/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 15:32:17 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Advanced Materials]]></category>
		<category><![CDATA[Akzo Nobel N.V.]]></category>
		<category><![CDATA[Amsterdam]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[chemical]]></category>
		<category><![CDATA[chemical businesses]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[Dow Chemical Company]]></category>
		<category><![CDATA[Eastern Europe]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[leading producer]]></category>
		<category><![CDATA[Rohm Haas]]></category>
		<category><![CDATA[The Netherlands]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27276/Dow+Divests+Business++-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Diversified chemical company <strong>Dow Chemical Company </strong>(<a href="http://www.zacks.com/stock/quote/dow">DOW</a>) has signed an agreement to sell its non-core Powder Coatings Business to <strong>Akzo Nobel N.V.</strong> (<a href="http://www.zacks.com/stock/quote/AKZOY">AKZOY</a>), a leading producer of paints and coatings, based in Amsterdam, The Netherlands. Financial terms of the transaction were not disclosed. The transaction is expected to close by the second quarter of 2010, subject to customary closing conditions, including regulatory approvals. <br />
<br />
Dow plans to use the proceeds from the transaction to repay debt, consistent with the company's de-leveraging plan. Dow plans to raise about $3.5 billion by divesting its non-core assets. For the Chemicals group Akzo Nobel, the deal will bring upgraded technological expertise and significant synergy potential for the Powder Coatings business, as well as enhance the company's position in the U.S. <br />
<br />
The powder coatings activities were purchased by Dow earlier this year as part of its acquisition of Rohm &#38; Haas. Dow Chemical has become the world&#8217;s leading specialty chemicals and advanced materials company after acquiring Rohm and Haas for $16.3 billion. The acquisition appears positive for Dow, which is expected to consolidate higher margin and higher growth specialty businesses and reduce volatility in earnings and cash flow, going forward. <br />
<br />
Joint ventures and acquisitions are an integral part of Dow&#8217;s growth strategy. These provide access to potential markets, new technologies and feedstock, at the same time lowering capital investment and risk. Management intends to place Rohm &#38; Haas, along with some specialty chemical businesses, in a new Advanced Materials division. The acquisition has increased Dow&#8217;s position in the Specialty Chemicals market by broadening its product range in paints, coatings and electronic materials. This new division expects to achieve annual sales of $14 billion and cost synergies of $1.3 billion. Dow's current business profile has an anticipated growth rate of about 4% for the period 2009&#8722;2012. <br />
<br />
The Rohm &#38; Haas portfolio, on the other hand, is rooted in faster growing segments with an expected growth rate ranging between 5% and 9%. On a consolidated basis, the growth rate of the combined portfolio over this period is expected to be within 5% to 7%. The merger would be neutral to earnings in the second half of 2009. However, it is likely to boost Dow&#8217;s earnings by 5% in 2010 and 13% in 2011. <br />
<br />
Dow is targeting faster-growing regions. The company earns two-thirds of its income from outside the U.S. Growth in emerging economies have been especially rapid, generating almost 28% of Dow&#8217;s revenues. Growth is 17% in Europe, where sales are $19.6 billion; 15% in the Asia-Pacific, where sales are $6.2 billion; and 14% in Latin America, where sales are $5.8 billion. Meanwhile, sales growth in Greater China and Eastern Europe were 24% and 30%, respectively. <br />
<br />
We maintain our Outperform recommendation on the stock.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DOW">Read the full analyst report on "DOW"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AKZOY">Read the full analyst report on "AKZOY"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/dow-divests-business-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AstraZeneca Beats, Raises &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/astrazeneca-beats-raises-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/astrazeneca-beats-raises-analyst-blog/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 14:17:16 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Astrazeneca]]></category>
		<category><![CDATA[bacterial pneumonia]]></category>
		<category><![CDATA[Brilinta;]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Chemotherapy]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[constipation]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[european commission]]></category>
		<category><![CDATA[Forest Laboratories;]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[inflammation]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[late stage investigational product]]></category>
		<category><![CDATA[Nektar Therapeutics]]></category>
		<category><![CDATA[neuroscience]]></category>
		<category><![CDATA[Neuroscience and Infection]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[NSCLC;]]></category>
		<category><![CDATA[pain]]></category>
		<category><![CDATA[small cell lung cancer]]></category>
		<category><![CDATA[structure infections;]]></category>
		<category><![CDATA[Toprol-XL;]]></category>
		<category><![CDATA[type 2 diabetes mellitus]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[US]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[use of Zactima]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27263/AstraZeneca+Beats%2C+Raises+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><br />
AstraZeneca&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/azn">AZN</a>) third quarter earnings came in at $1.68 per American Depositary Shares (ADS), well above the Zacks Consensus Estimate of $1.36 and $1.32 reported in the year-ago period. Revenues increased 10% at constant exchange rates (CER) to $8.2 billion compared to the same period last year.<br />
<br />
The primary reasons for the increase in revenues were strong US sales of Toprol-XL benefiting from generic withdrawal, US sales of its H1N1 vaccine and robust growth in emerging markets.<br />
<br />
AstraZeneca recorded strong sales across all geographies. Sales in North America, Emerging Markets and Established Markets increased (at CER) by 13%, 15% and 4%, respectively. The company expects double-digit revenue growth in Emerging Markets for the full year.<br />
<br />
Among the product categories, apart from gastrointestinal and oncology, which recorded sales decline of 1% and 10% respectively, all other segments increased their revenues. AstraZeneca recorded more than 26% of its revenues during the quarter from cardiovascular drug sales.<br />
<br />
This segment recorded the highest growth at 29%. Revenues for Respiratory and Inflammation, Neuroscience and Infection and others increased by 13%, 11% and 22%, respectively.<br />
<br />
AstraZeneca&#8217;s gross margin improved to 84.9% from 81.3% in the year-ago period due to a reduction in cost of sales. Operating profit increased 29% to $3.6 billion due to improved gross margin and lower R&#38;D expenditure, partially offset by higher SG&#38;A expenses and less other income.<br />
<br />
During the quarter, AstraZeneca received significant regulatory approval and entered into new licensing collaborations. These include:<br />
<br />
·         Approval from the US Food and Drug Administration (FDA) for Onglyza (saxagliptin) to be used for the treatment of type 2 diabetes mellitus in adults. In addition, the drug received marketing authorization from the European Commission.<br />
 <br />
·         Approval from the US FDA for the H1N1 vaccine.<br />
 <br />
·         Collaboration agreement with <strong>Forest Laboratories </strong>(<a href="http://www.zacks.com/stock/quote/frx">FRX</a>) for the development and commercialization of ceftaroline in all major markets other than the U.S., Canada and Japan. The drug is in a late stage of development for the treatment of complicated skin and skin structure infections (cSSSI) and community-acquired bacterial pneumonia (CABP). While Forest expects to file a New Drug Application (NDA) in the US by the end of 2009, AstraZeneca expects to file a Marketing Authorization Application (MAA) in Europe by the end of 2010.<br />
 <br />
·         An exclusive worldwide license agreement with <strong>Nektar Therapeutics</strong> (<a href="http://www.zacks.com/stock/quote/nktr">NKTR</a>) for two drug candidates; NKTR-118, a late stage investigational product for the treatment of opioid-induced constipation and NKTR-119, an early stage compound intended to deliver products for the treatment of pain without constipation as its side effect.<br />
 <br />
·         AstraZeneca submitted a MAA for Brilinta and expects to submit the NDA by the year end.<br />
 <br />
While all these were positive developments, AstraZeneca has had its share of failures too. The company had to withdraw the regulatory submissions for the use of Zactima (vandetanib) 100mg in combination with chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) from both the US and the EU. The submission was withdrawn due to lack of positive data.<br />
<br />
Based on strong quarterly results, AstraZeneca provided guidance for the full year of 2009. The company expects its earnings per ADS in the range of $6.20-$6.40.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AZN">Read the full analyst report on "AZN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FRX">Read the full analyst report on "FRX"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NKTR">Read the full analyst report on "NKTR"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/astrazeneca-beats-raises-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Hewlett Packard Company, 3Com Corporation, Cisco Systems Inc., Wal-Mart Stores Inc. and GlaxoSmithKline, plc &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-hewlett-packard-company-3com-corporation-cisco-systems-inc-wal-mart-stores-inc-and-glaxosmithkline-plc-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-hewlett-packard-company-3com-corporation-cisco-systems-inc-wal-mart-stores-inc-and-glaxosmithkline-plc-press-releases/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 12:30:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3Com Corporation;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cisco Systems Inc]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[gear maker]]></category>
		<category><![CDATA[Glaxosmithkline Plc]]></category>
		<category><![CDATA[Hewlett-Packard]]></category>
		<category><![CDATA[Hewlett-Packard Company]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[ProCurve]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wal Mart Stores Inc]]></category>
		<category><![CDATA[Wellbutrin Xl]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27257/Zacks+Analyst+Blog+Highlights%3A+Hewlett+Packard+Company%2C+3Com+Corporation%2C+Cisco+Systems+Inc.%2C+Wal-Mart+Stores+Inc.+and+GlaxoSmithKline%2C+plc+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 13, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Hewlett Packard Company </strong>(<a href="void(0)">HPQ</a>), <strong>3Com Corporation </strong>(<a href="void(0)">COMS</a>), <strong>Cisco Systems Inc.</strong> (<a href="void(0)">CSCO</a>), <strong>Wal-Mart Stores Inc.</strong> (<a href="void(0)">WMT</a>) and <strong>GlaxoSmithKline, plc </strong>(<a href="void(0)">GSK</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Thursday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Hewlett-Packard to Acquire 3Com</strong></p>
<p align="left"><strong>Hewlett Packard Company </strong>(<a href="void(0)">HPQ</a>) is planning to take over networking gear maker <strong>3Com Corporation </strong>(<a href="void(0)">COMS</a>). The acquisition, valued at $2.7 billion, enables HP to challenge networking leader <strong>Cisco Systems Inc.</strong> (<a href="void(0)">CSCO</a>) on its own turf.</p>
<p align="left">HP&#8217;s current networking products, sold under the ProCurve brand, generate around $1 billion in annual sales (less than 1% of the company&#8217;s total revenue). The product line lacks competitive data center switches, which makes it hard to take market share from well-entrenched Cisco.</p>
<p align="left">3Com's expertise is in networking products for data centers, which supports HP's ProCurve networking equipment. Although the company has seen better times, it has been beefing up its portfolio by utilizing its design capabilities in low-cost China. The company is, therefore, in a position to compete aggressively on price. 3Com&#8217;s challenges include its poor brand value in American and European markets and its weak position in these geographies.</p>
<p align="left">The HP-3Com combination is therefore an ideal fit, in our opinion. If the deal closes, HP will acquire a new capability overnight, strengthen its position in China and grow at its competitor&#8217;s expense. 3Com will benefit from HP&#8217;s superior brand value and find a broader market for its new products.</p>
<p align="left"><strong>Wal-Mart Sales Up in U.S., Europe</strong></p>
<p align="left"><strong>Wal-Mart Stores Inc.</strong> (<a href="void(0)">WMT</a>) reported strong fiscal third-quarter earnings of 84 cents per share, which surpassed the Zacks Consensus Estimate of 81 cents. Earnings grew 9.1% year over year from 77 cents recorded in the year-ago quarter, and exceeded management&#8217;s guidance of 78 cents to 82 cents per share.</p>
<p align="left">Wal-Mart&#8217;s net sales recorded a growth of 1.1% year over year to $98.7 billion, as a 1.2% expansion in Wal-Mart's U.S. segment coupled with a 1.6% increase in the International segment was partially offset by 0.7% decline in the Sam&#8217;s Club segment. The growth in International sales was driven by robust performance in the U.K., Mexico and Brazil, but was limited by unfavorable currency fluctuations.</p>
<p align="left">The retailing behemoth, widely considered as a barometer of the country&#8217;s economy, said U.S. same-store sales dipped 0.5% year-over-year, while that for Sam&#8217;s Club rose by 0.1%.</p>
<p align="left"><strong>Glaxo Reports Higher Revenues</strong></p>
<p align="left"><strong>GlaxoSmithKline, plc </strong>(<a href="void(0)">GSK</a>) reported third quarter income of 92 cents per American Depository Share (ADS), 3 cents below the Zacks Consensus Estimate. The company reported earnings of 94 cents in the year-ago period.</p>
<p align="left">Third quarter 2009 revenue increased 3%, with growth being driven by strong performances in emerging markets (up 25%), Japan (up 19%) and Consumer Healthcare (up 8%). We were pleased to see growth in Consumer Healthcare revenue despite the global slowdown.</p>
<p align="left">Meanwhile, US sales continued to be impacted by generic competition with revenue declining 12%. Sales of products like Imigran (down 74%), Lamictal (down 21%) and Requip (down 30%) and Wellbutrin XL (down 81%) kept declining.</p>
<p align="left">Pharmaceutical product revenue increased 2% with sales being driven by Advair/Seretide (up 5%) and Relenza. Relenza benefited from continued orders from several governments for stockpiling.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-hewlett-packard-company-3com-corporation-cisco-systems-inc-wal-mart-stores-inc-and-glaxosmithkline-plc-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Euro Is Overvalued</title>
		<link>http://www.straightstocks.com/investing-lessons/the-euro-is-overvalued/</link>
		<comments>http://www.straightstocks.com/investing-lessons/the-euro-is-overvalued/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 10:17:37 +0000</pubDate>
		<dc:creator>David Taggart</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Commission of European Communities;]]></category>
		<category><![CDATA[Disclaimer-The  Macro  Trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[JP-Morgan]]></category>
		<category><![CDATA[Morgan G-7]]></category>
		<category><![CDATA[Spain]]></category>
		<category><![CDATA[The Macro Trader]]></category>
		<category><![CDATA[TRADER]]></category>
		<category><![CDATA[Us Dollar]]></category>

		<guid isPermaLink="false">http://www.themacrotrader.com/?p=627</guid>
		<description><![CDATA[One of our major themes here at The Macro Trader over the past two years has been to short Europe.  We mean that in a general sense as we have been short Spain and Italy off and on for over a year and are bearish on most things EU relative to most of the world.  [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/the-euro-is-overvalued/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Economic prospects for 2010 and beyond</title>
		<link>http://www.straightstocks.com/investing-lessons/economic-prospects-for-2010-and-beyond/</link>
		<comments>http://www.straightstocks.com/investing-lessons/economic-prospects-for-2010-and-beyond/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 07:30:18 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Aussie]]></category>
		<category><![CDATA[Britain]]></category>
		<category><![CDATA[central bank balance sheets]]></category>
		<category><![CDATA[central-bank support]]></category>
		<category><![CDATA[Chancellor]]></category>
		<category><![CDATA[chief economist]]></category>
		<category><![CDATA[Electricity Shortages]]></category>
		<category><![CDATA[electricity supply]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[finance]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[George Bush]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[israel]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Merkel]]></category>
		<category><![CDATA[Minister of Finance]]></category>
		<category><![CDATA[Non-gold mining output]]></category>
		<category><![CDATA[Norway]]></category>
		<category><![CDATA[Oecd]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[passenger-car sales]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Reagan;]]></category>
		<category><![CDATA[retail conditions]]></category>
		<category><![CDATA[substantial higher electricity tariffs]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[World Cup;]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13555</guid>
		<description><![CDATA[By Cees Bruggemans, Chief Economist FNB.
After a great fall (2008), success in arresting the fall and stabilizing the economy on a low level of capacity utilization (2009), growth prospects tend to be very promising as slack resources as well as new inputs will be available to be put to work. Demand needs to grow in [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/economic-prospects-for-2010-and-beyond/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gilead Awaits Committee Outcome &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/gilead-awaits-committee-outcome-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/gilead-awaits-committee-outcome-analyst-blog/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 06:30:09 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Anti-Infective Drugs Advisory Committee;]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Cayston]]></category>
		<category><![CDATA[chronic pulmonary]]></category>
		<category><![CDATA[Cystic Fibrosis]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[genetic disease]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Gilead]]></category>
		<category><![CDATA[Inhalation Solution]]></category>
		<category><![CDATA[investigational product]]></category>
		<category><![CDATA[nebuliser solution]]></category>
		<category><![CDATA[Novartis]]></category>
		<category><![CDATA[Pseudomonas]]></category>
		<category><![CDATA[respiratory and digestive systems]]></category>
		<category><![CDATA[Switzerland]]></category>
		<category><![CDATA[TOBI]]></category>
		<category><![CDATA[tobramycin inhalation solution]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27281/Gilead+Awaits+Committee+Outcome+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Gilead Sciences, Inc</strong> (<a href="http://www.zacks.com/stock/quote/GILD">GILD</a>) is awaiting the outcome of the Anti-Infective Drugs Advisory Committee of the US Food and Drug Administration (FDA) scheduled on December 10, 2009. The committee will review Gilead &#8217;s aztreonam for inhalation solution, an investigational product for the treatment of chronic pulmonary infections due to Pseudomonas aeruginosa (P. aeruginosa) in patients with cystic fibrosis (CF). Earlier, in September 2008, the drug was denied approval by the FDA, which then asked Gilead to resubmit the application with more data. <br />
<br />
In September 2009, the drug received conditional marketing approval in Canada and Europe under the trade name Cayston (aztreonam lysine 75 mg powder and solvent for nebuliser solution). Gilead plans to make the product available in Germany and the UK in early 2010. Aztreonam formulated with lysine is a proprietary formulation of aztreonam developed specifically for inhalation, which has orphan drug status in the US and Europe . Applications for marketing approval of Cayston are pending in Australia , Switzerland and Turkey .<br />
 <br />
CF is a chronic, debilitating genetic disease that affects the respiratory and digestive systems of approximately 70,000 people worldwide, including 35,000 people in the European Union. Cayston was granted conditional marketing authorization to address the unmet medical need of the CF patients. A decision regarding full marketing authorization will be based on the completion of the ongoing phase III study examining the efficacy and safety of Cayston compared to <strong>Novartis</strong>&#8217; (<a href="http://www.zacks.com/stock/quote/NVS">NVS</a>) tobramycin inhalation solution (TOBI) in CF patients with pulmonary P. aeruginosa. <br />
<br />
During the third quarter conference call, Gilead stated that it expects to complete enrollment by the year end and make the data available towards the middle of next year. We believe positive data from this study will help it to receive approval from the regulatory authorities in both US and Europe . We have a Neutral recommendation on the stock.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GILD">Read the full analyst report on "GILD"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NVS">Read the full analyst report on "NVS"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/gilead-awaits-committee-outcome-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Steel Industry &#8211; Industry Outlook</title>
		<link>http://www.straightstocks.com/stock-watch/steel-industry-industry-outlook-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/steel-industry-industry-outlook-2/#comments</comments>
		<pubDate>Fri, 13 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Ak Steel]]></category>
		<category><![CDATA[AK Steel Holding Corporation]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[auto]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Central Europe]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Commercial Metals Company;]]></category>
		<category><![CDATA[Construction;]]></category>
		<category><![CDATA[electrical equipment]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Flat Roll Division]]></category>
		<category><![CDATA[Ford Motor Company]]></category>
		<category><![CDATA[General Motors]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Hamilton]]></category>
		<category><![CDATA[Honda Motor Company;]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[industrial machinery]]></category>
		<category><![CDATA[integrated flat-rolled producers]]></category>
		<category><![CDATA[integrated steel producer]]></category>
		<category><![CDATA[International Trade Administration]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Large automakers]]></category>
		<category><![CDATA[metal ore exploration]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Nanticoke]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Nucor Corporation]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Ontario plant]]></category>
		<category><![CDATA[Posco]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[shipbuilding]]></category>
		<category><![CDATA[steel]]></category>
		<category><![CDATA[Steel Dynamics Inc.]]></category>
		<category><![CDATA[Steel Producer]]></category>
		<category><![CDATA[Toyota Motor Corporation;]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[U.S. Steel Corp.]]></category>
		<category><![CDATA[Ukraine]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[United States Steel]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[World Steel]]></category>
		<category><![CDATA[World Steel Association;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12738/Steel+Industry+-+Industry+Outlook</guid>
		<description><![CDATA[<u><strong><br />
Steel Output Mounting</strong></u><br />
<br />
The Steel industry, which consists of companies engaged in the extraction of iron ore and coke coal for the processing of iron and steel, has the major chunk of sales concentrated with a few producers. The industry includes metal ore exploration and mining services, iron and steel foundries for smelting, rolling, forging, spinning, recycling, stamping, polishing and plating of iron and steel products such as pipes, tubes, wire, spring, rolls and bars.<br />
<br />
The largest drivers of steel consumption have historically been the automotive and construction markets, which make up more than 50% of total steel consumption. Other steel consuming industries include appliances, converters, containers, tin, energy, electrical equipment, agricultural, domestic and commercial equipment and industrial machinery. Large automakers such as General Motors, <strong>Ford Motor Company</strong> ([url=http://www.zacks.com/stock/quote/f]F[/url]), <strong>Toyota Motor Corporation </strong>([url=http://www.zacks.com/stock/quote/tm]TM[/url]) and<strong> Honda Motor Company </strong>([url=http://www.zacks.com/stock/quote/hmc]HMC[/url]) depend upon the steel industry.<br />
<br />
<strong>ArcelorMittal</strong> ([url=http://www.zacks.com/stock/quote/mt]MT[/url]) is the world&#8217;s largest steel company with steel production of 103.3 million tons in 2008. Other major players in the industry are <strong>POSCO </strong>([url=http://www.zacks.com/stock/quote/pkx]PKX[/url]), <strong>Steel Dynamics Inc.</strong> ([url=http://www.zacks.com/stock/quote/stld]STLD[/url]), <strong>AK Steel Holding Corporation</strong> ([url=http://www.zacks.com/stock/quote/aks]AKS[/url]), <strong>United States Steel Corporation</strong> ([url=http://www.zacks.com/stock/quote/x]X[/url]) and <strong>Nucor Corporation</strong> ([url=http://www.zacks.com/stock/quote/nue]NUE[/url]).<br />
<br />
The Asia-Pacific region, especially China and India, is witnessing higher production and consumption of steel. This is due to the per capita consumption reaching up to U.S./European levels, which could, theoretically at least, double steel demand in the longer-term. China has set up the largest steel industries in the world, driven by increasing demand for rapid urbanization and large infrastructure projects. The country accounted for nearly 50% of monthly total world production in August 2009.<br />
<br />
China&#8217;s share is larger than the combined production of the U.S., the European Union (EU), Russia and Japan, which have historically been the largest producers of steel. In 2001, China's annual share of world production stood at 17%, while the EU accounted for the largest share at 18%. In eight years, China's share of world production has almost tripled, while other producers have seen their shares decrease. Ranked behind China are Japan and the U.S.<br />
<br />
According to the World Steel Association, global steel output had increased to 107 million tons in the month of September 2009, down marginally (0.6%) from the same month of the previous year. Month-on-month, steel output improved slightly from 106.5 million tons. World crude steel production has continued to show a steady increase since April 2009. Steel production had reached its highest level in July this year on the back of a moderate rise in demand and the resumption of idled facilities by producers. The total output of 103.9 million tons was an improvement of 4% from 99.8 million tons produced in October, but down 11.1% year over year.<br />
<br />
All major steel producing countries -- China, Japan, Germany, the U.S., Brazil, Turkey, Russia and the Ukraine -- have shown peak monthly figures so far this year. Production in the Middle East, where demand was buoyant last year due to booming infrastructure spending, edged up by 2.0% in September, while monthly steel output in Asia increased 15% to over 60 million tons. Of this, production in China climbed 28.7% to 39.4 million tons. However, global steel production was down 32.3% in North America while production in Europe saw a drop of 23.7%.<br />
<br />
According to the data released by the International Trade Administration, steel prices increased across almost all product groups in September 2009 from August 2009. Hot-rolled sheet prices increased 12.6% to $535 per ton from $475 per ton. Cold-rolled sheet increased 10.04% to $625 per from $568 per ton. Stainless sheet prices increased 2.7% to $2,334 per ton.<br />
<br />
Steel prices across all product groups have fallen significantly from the previous year despite recent price increases, with the price of hot-rolled sheet showing a 54.6% decrease and cold-rolled sheet a 41.3% decrease from September 2008.<br />
<br />
In 2007, China&#8217;s steel industry revealed signs of consolidation in a market that was previously rather fragmented and in need of mergers and acquisitions (M&#38;A). Despite the current slowdown in consolidation within the global steel industry, M&#38;A activity remains a critically important business strategy for companies. While the economic downturn is a significant factor in short-term decisions regarding M&#38;A activity, steel companies expect to make acquisitions over the next three years.<br />
<br />
<strong>OPPORTUNITIES</strong><br />
<br />
We expect global steel demand to improve in the long term with the recovery of the user industries. China is expected to remain the largest consumer of steel going forward. World Steel is forecasting an 8.6% year over year decline in steel production, better than the previous forecast of a 14.1% decline, driven by a strong growth in Chinese steel demand. With signs of a recovery across the world since the beginning of the second half of 2009, the association is anticipating global steel demand in 2010 to grow by 9.2% to 1,206 million tons, which is similar to the level in 2008. <br />
<br />
With steel demand picking up in the last couple of months, steel producers are restarting facilities. U.S. Steel Corp. is restarting its blast furnace at its Hamilton, Ontario plant after a nine-month shutdown. The company had closed its Hamilton blast furnace in November 2008. It had suspended the remaining operations at Hamilton and the Nanticoke operation in March 2009 due to a drop in demand. Both the facilities were running at less than half their capacity.<br />
<br />
Net losses for Nucor Corporation, the largest recycler of steel scrap in the U.S., narrowed to $29.5 million, or 10 cents per share, for the third quarter of 2009. The result was more positive than the Zacks Consensus Estimate of a loss of 14 cents. Long-term contracts, cost reduction efforts and a dominant acquisition strategy inspire optimism about the company&#8217;s performance in the coming quarters.<br />
<br />
The third largest steel maker in the U.S., Steel Dynamics Inc. reported net income of $69 million -- 30 cents per share -- for the third quarter of 2009, after reporting losses for three consecutive quarters. The earnings, which were driven by cost reduction through higher production and shipping volumes at the Flat Roll Division and better-than-expected performance in the Metals Recycling segment, were higher than the Zacks Consensus Estimate of 23 cents. However, on a year-over-year basis, earnings were down 69%.<br />
<br />
<strong>WEAKNESSES</strong><br />
<br />
The global steel industry is cyclical, highly competitive and has historically been characterized by overcapacity. Production cuts of up to 35% are occurring to keep operating rates in the low-80s and keep the market balanced. The U.S. domestic production capacity utilization has fallen dramatically since August 2008. Capacity utilization peaked in February 2008 at a level of 91.6%. In May 2009, estimated capacity utilization was 44.3%, less than half of its level six months ago. Capacity utilization reached its lowest point, 40.9%, in December 2008, though it has increased again since May 2009.<br />
<br />
Overcapacity in the global steel industry could increase the level of steel imports and result in downward pressure on steel prices. Overcapacity in China has the potential to result in a further increase in imports of low-priced, unfairly traded steel and steel products to the U.S. In recent years, capacity growth in China has significantly exceeded the growth in Chinese market demand. A continuation of this unbalanced growth trend or a significant decrease in China&#8217;s rate of economic expansion could result in China increasing steel exports.<br />
<br />
Key steel consuming industries such as auto, shipbuilding and construction had been experiencing weak demand in the last quarters, forcing global steel makers to slacken production levels. U.S. Steel, the eighth largest steel producer in the world, the largest integrated steel producer headquartered in North America, and one of the largest integrated flat-rolled producers in Central Europe, slashed production by almost 62% during the second quarter of 2009, while Korean steel maker POSCO cut production by about 15% in December last year. This was the first time in its history that POSCO was forced to take such a measure, proof of the very bad operating environment.<br />
<br />
The current low demand from the automotive and residential sectors and rising labor costs are affecting producers in the steel industry. Weak demand and significantly lower operating rates have forced producers to shut down facilities. The slowdown in the U.S./Europe/Japanese economies remains a negative issue facing steel producers. The automotive market has yet to recover fully. Steel shipments are off at a double-digit rate.<br />
<br />
As a whole, the steel industry posted weak results in the third quarter of 2009. U.S. Steel Corporation recorded its third sequential loss -- $3.03 billion, or $2.11 per share -- in the third quarter of 2009, in contrast to a net income of $9.19 billion or $7.79 per share in the third quarter of 2008. Commercial metals company AK Steel posted a negligible income of $6.2 million compared to $188.3 million in the same quarter of 2008. <br />
<br />
Despite a sharp rise in steel prices in September 2009, the future pricing remains uncertain, and we believe continued demand weakness, production resumption by some mills and lower iron ore and coking coal prices in the second half of 2009 would drive monthly prices down again. The recent significant reduction in global steel production in late 2008 and into 2009 has resulted in decreases in many raw material prices.<br />
<br />
We expect that such prices will rebound when global steel production returns to more customary levels. In contrast, prices for steelmaking commodities such as steel scrap, coal, coke, iron ore, zinc, tin and other metallic additions have escalated significantly over the last several years due primarily to growth in worldwide steel production, especially in China.<a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/steel-industry-industry-outlook-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Applied Beats on Revs and Margins &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/applied-beats-on-revs-and-margins-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/applied-beats-on-revs-and-margins-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 20:39:40 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[ASML Holdings]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Guidance Management]]></category>
		<category><![CDATA[Korea]]></category>
		<category><![CDATA[Lam Research]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[SGD]]></category>
		<category><![CDATA[Silicon Systems]]></category>
		<category><![CDATA[technology transitions]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27249/Applied+Beats+on+Revs+and+Margins+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Applied Materials&#8217;</strong> (<a href="http://www.zacks.com/stock/quote/amat">AMAT</a>) fourth quarter earnings beat the Zacks Consensus Estimate by 12 cents. Revenue beat the consensus by 15.6%. All the peer companies -- <strong>ASML Holdings</strong> (<a href="http://www.zacks.com/stock/quote/asml">ASML</a>),<strong> KLA Tencor </strong>(<a href="http://www.zacks.com/stock/quote/klac">KLAC</a>) and <strong>Lam Research</strong> (<a href="http://www.zacks.com/stock/quote/lrcx">LRCX</a>) -- reported results that also beat the consensus. The general improvement in results is proof of the growing momentum in the semiconductor capital equipment market.<br />
<br />
<em><strong>Revenue</strong></em><br />
<br />
Revenue of $1.53 billion was up 34.6% sequentially and down 25.3% year over year. The year-over-year decline in revenue moderated with respect to the three preceding quarters.<br />
<br />
<em><strong>Revenue by Segment</strong></em><br />
<br />
All segments contributed to the sequential increase, as well as the year over year decline in revenue.<br />
<br />
Silicon Systems (SSG) remains the largest segment, with a 43% revenue revenue share. Segment revenue increased 31.7% sequentially and declined 11.8% year over year. Capacity expansion and technology transitions at foundry customers were the drivers behind the revenue increase in the last quarter. Management stated that utilization rates were also on the rise, which along with stronger DRAM and NAND prices were driving demand at memory and logic manufacturers.<br />
<br />
The second largest segment was Applied Global Services (AGS), which generated 26% of total revenue. Segment revenue increased 13.7% sequentially and declined 26.1% year over year. The company saw strength in spares sales, which have been rising steadily over the last two quarters.<br />
<br />
Energy and Environmental Systems (EES) was third, with an 18% revenue share, increasing 25.0% sequentially and declining 36.1% year over year. The solar photovoltaic market started looking up in the last quarter, with the pressure on module prices letting up a bit and the broader availability of financing.<br />
<br />
The smallest segment, Display, witnessed the strongest sequential growth and year-over-year decline. The segment generated around 13% of revenue, up 189.9% sequentially and down 40.1% year over year. Management stated that demand for TVs and LCD monitors were very strong, especially in China. With utilization rates remaining high and its largest customers returning to profitability, strength in this market should be sustained.<br />
<br />
<strong>Orders</strong><br />
<br />
All segments witnessed sequential increases in orders, although the strongest growth was in EES. Display also increased strong double-digits, followed by SSG and then AGS. However, book-to-bill (BTB) was well below unity in display, indicating that there was not much addition to backlog. AGS and SSG also had BTB below unity. The sharp increase in EES orders resulted in a BTB of 1.28, indicating continued strength in the next quarter.<br />
<br />
The sequntial increase in orders came from Korea, South East Asia &#38; China and North America, in that order. Other regions declined, with particular weakness in Europe.<br />
<br />
<em><strong>Operating Margin</strong></em><br />
<br />
Gross margin for the quarter was 38.1%, up 745 basis points (bps) from the previous quarter&#8217;s 30.6%. The gross margin improvement was due to a better mix of business, as the higher-margin businesses performed relatively better. The gross margin was down 273 bps from the year-ago quarter, mainly due to lower volumes.<br />
<br />
The operating expenses of $358.5 million were flattish in comparison to the previous quarter&#8217;s $358.7 million. However, the operating margin expanded 1,560 bps sequentially and declined 322 bps year over year. The sequential improvement was primarily attributable to the higher gross margin, although lower R&#38;D also declined significantly as a pecentage of sales. Lower G&#38;A and S&#38;M ( as a percentage of sales) also contributed.<br />
<br />
SSG operating margin improved 1,284 bps, AGS improved 941 bps, Display 2,875 bps and EES 1,295 bps.<br />
<em><strong><br />
Net Margin</strong></em><br />
<br />
On a pro forma basis, AMAT had a net income of $207.5 million, or a 13.6% net income margin, compared to a loss of $1.6 million, or 0.1% in the previous quarter and profit of $293.4 million, or 14.4%, in the fourth quarter of last year.<br />
<br />
Fully diluted pro forma earnings per share (EPS) were $0.15 compared to $0.00 in the Jul 2009 quarter and $0.22 in the comparable prior-year quarter. Our pro forma estimate excludes restructuring charges, acquisition-related charges, stock-based compensation expenses and impairment of investments on a tax-adjusted basis in the last quarter. Our pro forma estimate may not match management&#8217;s presentation due to the addition/exclusion of some items not considered by management.<br />
<br />
On a fully diluted GAAP basis, the company recorded a net income of $137.9 million ($0.10 per share) compared to a loss of $54.9 million (-$0.04 per share) in the previous quarter and a net profit of $231.1 million ($0.17 per share) in the prior-year quarter.<br />
<em><strong><br />
Balance Sheet</strong></em><br />
<br />
Inventories were down 6.9% sequentially, with inventory turns increasing from 1.8x to 2.3x. Days sales outstanding (DSOs) were around 62 days, down from 67 days at the end of the Jul quarter. The cash and short-term investments balance was $2.21 billion at quarter-end, up $76.1 million during the quarter. The company generated $240.6 million of cash from operations and spent $80.5 million on dividends. At quarter-end, Applied Materials had $200.6 million of debt on its balance sheet, or a net cash position of $2.01 billion.<br />
<br />
<em><strong>Guidance</strong></em><br />
<br />
Management provided guidance for the first quarter. Accordingly, revenue is expected to increase 10-25%, with SSG growing 20%, AGS growing modestly, display down and EES up more than 20%. The tax rate is expected to be around 29%. Including restructuring charges of 6-7 cents a share, the GAAP EPS is expected to be 4-8 cents a share.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AMAT">Read the full analyst report on "AMAT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ASML">Read the full analyst report on "ASML"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=KLAC">Read the full analyst report on "KLAC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LRCX">Read the full analyst report on "LRCX"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/applied-beats-on-revs-and-margins-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TOTAL Tops Zacks Estimate &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/total-tops-zacks-estimate-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/total-tops-zacks-estimate-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 20:30:40 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Chemicals]]></category>
		<category><![CDATA[Chemicals revenues]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[gas  production;]]></category>
		<category><![CDATA[gas realizations]]></category>
		<category><![CDATA[Libya]]></category>
		<category><![CDATA[lower gas demand]]></category>
		<category><![CDATA[Nigeria]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[oil and gas prices]]></category>
		<category><![CDATA[oil equivalent]]></category>
		<category><![CDATA[Organization Of Petroleum Exporting Countries]]></category>
		<category><![CDATA[TOTAL SA]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Venezuela]]></category>
		<category><![CDATA[weaker chemicals]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27235/TOTAL+Tops+Zacks+Estimate+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>TOTAL SA</strong> (<a href="http://www.zacks.com/stock/quote/TOT">TOT</a>) reported third-quarter earnings of &#8364;0.84 per share ($1.20 per share), above the Zacks Consensus Estimate of $1.12 and second-quarter profit of &#8364;0.77. However, earnings declined from &#8364;1.81 reported a year ago. Earnings improved sequentially based on higher production, better realizations and lower costs.<br />
 <br />
Total revenues declined 31% from the year-ago quarter but improved 7% sequentially to &#8364;33.6 billion. The decline was caused mainly by lower realized oil and gas prices in the Upstream segment, reduced throughput volumes in the Downstream segment and a revenue decline at the chemicals segment.<br />
 <br />
Total hydrocarbon production averaged 2,243 thousand barrels of oil equivalent (MBOE) per day, up 0.5% from last year and 2.8% from the previous quarter. The increase was mainly due to production improvements and start-ups of new fields; offset by OPEC reductions and lower gas demand, disruptions in Nigeria, and changes in portfolio essentially in Venezuela and Libya.<br />
 <br />
Liquids and gas production averaged 1,379 thousand barrels (MBbls) per day (down 2%) and 4,726 thousand cubic feet (Mcf) per day, respectively. Realized hydrocarbon prices declined 40% year over year in the quarter, with liquids and gas realizations down 40% and 39%, respectively. However, total hydrocarbon realizations improved 15% sequentially.<br />
 <br />
Total refinery throughput was 2,142 MBbls per day, down 10% year over year and 2% sequentially, driven by scheduled refinery turnarounds and voluntary throughput reductions to adjust to the economic environment. Crude and other feedstock based utilization rates in the quarter declined to 82% from 92% last year.<br />
 <br />
Chemicals revenues declined 28% from the year ago quarter to &#8364;3.9 billion, driven by weaker chemicals demand in Europe and North America, offset by improved margins for petrochemicals.<br />
 <br />
In the reported quarter, TOTAL generated net cash flow of $3 billion and reduced its net debt-to-equity ratio to 21% from 25% at the end of the previous quarter. Net investments declined 12% from last year to $3,503 million, including acquisitions worth $83 million (down 87%) and asset sales of $1,004 million (up 27%). At quarter-end, TOTAL had &#8364;13,775 million of cash and cash equivalents.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TOT">Read the full analyst report on "TOT"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/total-tops-zacks-estimate-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CVAT, CSRH,  DrStockPick.com Stock Report! Cavitation Technologies Inc. and Consorteum Holdings Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/cvat-csrh-drstockpick-com-stock-report-cavitation-technologies-inc-and-consorteum-holdings-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/cvat-csrh-drstockpick-com-stock-report-cavitation-technologies-inc-and-consorteum-holdings-inc/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 19:57:03 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CTI Nano-Cavitation Process Systems]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4726</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Thursday November 12, 2009
DrStockPick.com Stock Report!
CVAT, Cavitation Technologies Inc, CVAT.OB
CSRH, Consorteum Holdings Inc, CSRH.OB
**************************************************************
CTI Enters Into Strategic Alliance With Agri Process Innovations, Inc. for CTI Nano-Cavitation Process Systems.
Cavitation Technologies, Inc. (CTI); (OTCBB: CVAT) is a “Green-Tech” company, established in 2006 to become a world [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/cvat-csrh-drstockpick-com-stock-report-cavitation-technologies-inc-and-consorteum-holdings-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>American Refiners Have a Problem… And the Government is Making it Worse</title>
		<link>http://www.straightstocks.com/investing-lessons/american-refiners-have-a-problem%e2%80%a6-and-the-government-is-making-it-worse/</link>
		<comments>http://www.straightstocks.com/investing-lessons/american-refiners-have-a-problem%e2%80%a6-and-the-government-is-making-it-worse/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 19:24:07 +0000</pubDate>
		<dc:creator>Investment U</dc:creator>
				<category><![CDATA[Contrarian Perspectives]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Contributing Editor]]></category>
		<category><![CDATA[Energy Security]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[European Union]]></category>
		<category><![CDATA[Gas Station]]></category>
		<category><![CDATA[InvestmentU]]></category>
		<category><![CDATA[petroleum products]]></category>
		<category><![CDATA[Senate]]></category>
		<category><![CDATA[Sheena Martin]]></category>
		<category><![CDATA[Shell gas station]]></category>
		<category><![CDATA[Shell’s  refinery]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investmentu.com/IUEL/2009/November/govt-making-american-refiners-problems-worse.html</guid>
		<description><![CDATA[American Refiners Have a Problem&#8230; And the Government is Making it Worse
by Sheena  Martin, Investment U Contributing Editor
America&#8217;s refining  companies are under severe financial pressure.
As the recession has  blanketed the markets, demand for petroleum products has collapsed, causing  refiners to scale back production.
And a bill currently  working its way through [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/american-refiners-have-a-problem%e2%80%a6-and-the-government-is-making-it-worse/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Telefonica Tops on Lighter Sales &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/telefonica-tops-on-lighter-sales-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/telefonica-tops-on-lighter-sales-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 18:05:41 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3g]]></category>
		<category><![CDATA[3G wireless;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Argentina]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[broadband]]></category>
		<category><![CDATA[broadband access;]]></category>
		<category><![CDATA[broadband network]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[China Unicom]]></category>
		<category><![CDATA[Czech Republic]]></category>
		<category><![CDATA[Deutsche Telekom]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France Telecom]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[GVT Holding SA]]></category>
		<category><![CDATA[HSPA+ technology]]></category>
		<category><![CDATA[Ireland]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[mobile broadband network]]></category>
		<category><![CDATA[Palm Inc]]></category>
		<category><![CDATA[Pay TV]]></category>
		<category><![CDATA[retail broadband access]]></category>
		<category><![CDATA[Spain]]></category>
		<category><![CDATA[telecom operator]]></category>
		<category><![CDATA[TELEFONICA]]></category>
		<category><![CDATA[Telefonica Europe]]></category>
		<category><![CDATA[Telefonica Latin America]]></category>
		<category><![CDATA[Telesp;]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vivo]]></category>
		<category><![CDATA[Vodafone]]></category>
		<category><![CDATA[wireless access]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[Wireless Customers]]></category>
		<category><![CDATA[wireless market]]></category>
		<category><![CDATA[wireless operation]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27243/Telefonica+Tops+on+Lighter+Sales+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Telefonica </strong>(<a href="http://www.zacks.com/stock/quote/tef">TEF</a>) reported third-quarter 2009 results with earnings per ADS of US$1.88, comfortably beating the Zacks Consensus Estimate of US$1.49. The Spanish telecom giant reported net income of &#8364;1.99 billion (US$2.85 billion), down 0.6% year over year, due to lower sales as a result of the beleaguered economy, especially in Spain.<br />
<em><strong><br />
Revenue</strong></em><br />
<br />
Consolidated revenue fell 5.7% year over year to &#8364;14.1 billion (US$20.2 billion). Revenue was impacted by weak contributions from domestic and European markets due to the recession. Latin America contributed 40% of the group revenues followed by Spain at 35% and Europe at 25%.<br />
<u><strong><br />
Result by Segments</strong></u><br />
<br />
<em><strong>Telefonica Espana</strong></em><br />
<br />
The company&#8217;s Spanish revenue declined 8.9% to &#8364;4.9 billion (US$7 billion), impacted by a reduction in mobile termination rates (inter-operator fees) and the economic downturn. Wireline business revenues fell 9.4% year over year to &#8364;2.9 billion (US$4.1 billion) while revenue from wireless operation declined 6.4% to &#8364;2.3 billion (US$3.3 billion).<br />
<br />
<em><strong>Telefonica Europe</strong></em><br />
<br />
Revenue from Europe declined 5.5% year over year to &#8364;3.5 billion (US$5 billion), especially due to lower revenue from the UK operation. Reported revenue from O2 UK (the company&#8217;s UK wireless operation and highest contributor to European sales) was &#8364;1.7 billion (US$2.4 billion), down 7% over the year-ago quarter, due to competition and termination rate cuts. Revenue from Germany increased 5.5% while in the Czech Republic they declined 15.7%.<br />
<br />
O2 UK continues to struggle, with declining revenues as the operator faces intense competition, especially from its biggest rival <strong>Vodafone </strong>(<a href="http://www.zacks.com/stock/quote/vod">VOD</a>). Competition is set to intensify in the British mobile market as the other two major carriers <strong>Deutsche Telekom </strong>(<a href="http://www.zacks.com/stock/quote/dt">DT</a>) and <strong>France Telecom </strong>((<a href="http://www.zacks.com/stock/quote/fte">FTE</a>) have finalized an agreement to merge their UK operations. The integrated company will dethrone Telefonica as the largest wireless carrier in the UK.<br />
<em><strong><br />
Telefonica Latin America</strong></em><br />
<br />
Revenue from Latin America, which has been the principal growth engine for Telefonica in the past quarters, also fell 2.3% year over year to &#8364;5.6 billion (US$8 billion). This is due to revenue declines across key markets such as Brazil, Argentina and Chile. Revenue in Brazil (the largest market) declined 8.9% year over year to &#8364;2.2 billion (US$3.1 billion), due to weaker contribution from its Brazilian subsidiaries, Vivo and Telesp.<br />
<br />
Telefonica continues to lead the Brazilian wireless market with approximately 30% market share. The company recently made an all-cash bid to acquire Brazilian telecom operator GVT Holding SA in an effort to expand its presence in the lucrative Brazilian telecom market.<br />
<br />
<em><strong>Subscriber Results</strong></em><br />
<br />
At the end of the third quarter, total customer access points reached approximately 268.6 million, up 6.6% year over year. Subscriber accretion was driven by healthy growth in wireless, broadband and Pay TV services.<br />
<br />
Total retail broadband access grew 9.8% year over year to 13.2 million, boosted by the rapid adoption of bundled services (dual or triple play service packages). Total wireless access reached 205.9 million, with roughly 5 million net additions made during the quarter, driven by contributions from Brazil, Germany, Mexico and the UK. Pay TV access was 2.5 million, up 15.1% year over year.<br />
<br />
Spain exited the quarter with 47.3 million access lines and 24 million wireless customers. Total customer access in Latin America reached 163.7 million with nearly 3 million net additions in the quarter. Europe registered 48.6 million accesses (up 8% year over year), with the mobile customer base growing 7.3% year over year to 43.5 million.<br />
<em><strong><br />
Outlook</strong></em><br />
<br />
Telefonica has reaffirmed its financial guidance for 2009 as it expects continued increases in consolidated revenues with annual OIBDA growth projected in the range of 1 - 3%. Annual operating cash flow growth is expected in the range of 8 - 11%. Capital expenditure for 2009 is projected below &#8364;7.5 billion (US$10.2 billion), lower than 2008 level, as the company is increasingly focused on reducing spending to improve cash flow generation.<br />
<br />
The company remains committed to expanding its 3G wireless business as it has reportedly begun a commercial roll-out of its HSPA+ technology based 3G mobile broadband network in Spain that offers peak downlink speeds of 21 megabits per second. Telefonica is also set to conduct 4G network trials in six countries across Europe and Latin America during the next six months.<br />
<br />
Telefonica has expanded its handset portfolio with the recent launch of<strong> Palm Inc&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/palm">PALM</a>) Pre smartphone in the UK, Spain, Ireland and Germany. The company is also aggressively pursuing expansion initiatives into other emerging markets as it recently strengthened its foothold in China through an increased stake holding in <strong>China Unicom </strong>(<a href="http://www.zacks.com/stock/quote/chu">CHU</a>).<br />
<br />
The company&#8217;s dominant position in the Spanish telecom market, attractive growth prospects in Latin America and healthy dividend payouts remain positive factors for investment considerations. However, we remain cautious with regard to Telefonica&#8217;s declining wireline business, aggressive acquisition strategy and highly leveraged balance sheet.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEF">Read the full analyst report on "TEF"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VOD">Read the full analyst report on "VOD"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DT">Read the full analyst report on "DT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FTE">Read the full analyst report on "FTE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PALM">Read the full analyst report on "PALM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CHU">Read the full analyst report on "CHU"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/telefonica-tops-on-lighter-sales-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hewitt Tops on Lower Revenue &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/hewitt-tops-on-lower-revenue-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/hewitt-tops-on-lower-revenue-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 16:45:42 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Hewitt Associates Inc]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Organizational Consulting]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27212/Hewitt+Tops+on+Lower+Revenue+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Hewitt Associates Inc.</strong> (<a href="http://www.zacks.com/stock/quote/HEW">HEW)</a> reported fourth quarter 2009 EPS of 68 cents per share, exceeding the Zacks Consensus Estimate of 63 cents per share. <br />
<br />
<u>Revenue</u> <br />
Revenue of $757.7 million was down 6.0% from $806.7 million reported in the year-ago quarter. This revenue decline may be attributed to lower revenue across all its segments, except the benefits outsourcing division. Excluding third party supplier revenue, $16.9 million of unfavorable foreign currency translation, $6.8 million contribution from an acquisition in the quarter and a $9.4 million contribution from the HR BPO business in the prior-year quarter, net revenue declined 4.0%. <br />
<br />
<u>Revenue Segments</u> <br />
The Benefits Outsourcing segment revenue for the quarter was $388.7 million, flat compared with $387.9 million in the prior-year quarter. Revenue was up 1% after adjusting for $2.3 million of unfavorable foreign currency translation. Revenue growth on an adjusted basis was principally driven by growth in large-market and mid-market clients, offset to a certain extent by lower project revenue. <br />
<br />
The Human Resource Business Process Outsourcing segment reported revenue of $113.9 million, down 16.0% compared to $135.1 million in the prior-year quarter. Revenue decreased 10% after excluding third-party supplier revenues in both periods and adjusting for $2.3 million of unfavorable foreign currency translation and $9.4 million comparable contribution from divested businesses. <br />
<br />
The Consulting segment revenue was $265.2 million, down 10% compared with $295.8 million in the prior-year quarter. Consulting revenues declined 9% after adjusting for $12.3 million of unfavorable foreign currency translation and a $6.8 million contribution from an acquisition, both in the current year. Revenue in this segment declined as a result of Talent and Organizational Consulting services across all regions and in Communication and Health Management services in North America. This was partially offset by growth in Retirement and Financial Management services in North America and Europe. <br />
<br />
<u>Operating Results</u> <br />
Operating income for the quarter was $105.8 million, up 95% compared to $54.3 million in the prior-year quarter. Reported operating margin was 14.0%, compared with 6.7% in the prior-year quarter. Operating margin improved as a result of lower performance-based compensation, staffing leverage, and lower selling, general and administrative expenses. <br />
<br />
Net income for the quarter was $64.4 million, or $0.68 per diluted share, up from $31.6 million or $0.32 per diluted share in the prior-year quarter. Underlying net income (after excluding unusual items) for the quarter was $64.4 million or $0.68 per share, compared to $48.3 million, or $0.49 per diluted share in the year-ago quarter. <br />
<br />
<u>Balance Sheet &#038; Share Repurchase</u> <br />
The company exited the quarter with cash, cash equivalents and short term investments of $642.6 million. Debt and capital lease obligations (including current portion) for the quarter was $654.84 million. During the recently concluded quarter the company repurchased 1.0 million of its outstanding common shares at an average price of $30.19 per share, or a total cost of $30.1 million. <br />
<br />
<u>Fiscal Year 2009 Result</u> <br />
For the full year 2009, net revenue was $3.00 billion, down 5.0% compared with $3.15 billion in the prior year. Net revenues were flat after adjusting for foreign currency translation, acquisitions and divestitures, HR Business Process Outsourcing (HR BPO) contract restructurings in the prior year and third-party revenues. Reported operating income for the full year grew to $434.1 million, up 39% compared with $312.8 million in the prior year. The company reported net income of $265.1 million, or $2.78 per diluted share, up from $188.1 million, or $1.85 per diluted share in the prior year. <br />
<br />
For fiscal year 2009, the company generated operating cash flow of $433.0 million, compared with $327.9 million in the prior year. Free cash flow for the year on a non-GAAP basis calculated as cash flow from operations less capital expenditures and capitalized software costs, was $305.1 million, compared with $210.3 million in the prior year. The improvement in free cash flow can be attributed to improved receivables collections and stronger operating performance, partially offset by lower outsourcing net deferrals and higher performance-based compensation related to fiscal 2008 performance. <br />
<br />
<u>Guidance</u> <br />
For the fiscal year 2010, the company expects low to mid single-digit net revenue growth, with good growth in consulting, flattish outsourcing and a decline in HR BPO. Diluted earnings per share are expected to be in the range of $2.85 to $2.95.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#038;d_alert=rd_final_rank&#038;ADID=GENSYND_ZER&#038;t=HEW">Read the full analyst report on "HEW"</a><br /><a href="http://www.zacks.com" alt="Investment Research">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hewitt-tops-on-lower-revenue-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wal-Mart Sales Up in U.S., Europe &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/wal-mart-sales-up-in-u-s-europe-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/wal-mart-sales-up-in-u-s-europe-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 16:15:45 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Brazil]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wal Mart]]></category>
		<category><![CDATA[Wal Mart Stores Inc]]></category>
		<category><![CDATA[Wal-Mart U.S.]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27230/Wal-Mart+Sales+Up+in+U.S.%2C+Europe+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Wal-Mart Stores Inc.</strong> (<a href="http://www.zacks.com/stock/quote/wmt">WMT</a>) reported strong fiscal third-quarter earnings of 84 cents per share, which surpassed the Zacks Consensus Estimate of 81 cents. Earnings grew 9.1% year over year from 77 cents recorded in the year-ago quarter, and exceeded management&#8217;s guidance of 78 cents to 82 cents per share.<br />
<br />
Wal-Mart&#8217;s net sales recorded a growth of 1.1% year over year to $98.7 billion, as a 1.2% expansion in Wal-Mart's U.S. segment coupled with a 1.6% increase in the International segment was partially offset by 0.7% decline in the Sam&#8217;s Club segment. The growth in International sales was driven by robust performance in the U.K., Mexico and Brazil, but was limited by unfavorable currency fluctuations.<br />
<br />
The retailing behemoth, widely considered as a barometer of the country&#8217;s economy, said U.S. same-store sales dipped 0.5% year-over-year, while that for Sam&#8217;s Club rose by 0.1%.<br />
<br />
Customers battered by the worst recession in decades are shopping more often in discount department stores such as Wal-Mart, as opposed to non discount-oriented retailers. However, the company remains affected by rising unemployment, which has adversely affected consumers' disposable incomes.<br />
<br />
For the first nine months of the fiscal year, the company generated a robust free cash flow of $3.6 billion, compared to $2.3 billion in the year-ago period, primarily due to improved inventory management.<br />
<br />
Moving forward, Wal-Mart lifted its guidance for the full year ending January 2010 after better-than-expected quarterly results, and now expects to post earnings of $3.57 to $3.61 per share, up from $3.50 to $3.60 per share predicted earlier. The Zacks Consensus Estimate, derived from 22 covering analysts, is currently pegged at $3.58 per share.<br />
<br />
For the fourth quarter of the fiscal year, earnings are expected to range between $1.08 and $1.12 per share, in-line with the Zacks Consensus Estimate of $1.12. Same-store sales for Wal-Mart U.S. in the fourth quarter are expected to be flat, +/- 1%, while Sam&#8217;s Club same-store sales during the same period are also forecasted to be flat, +/- 1%.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#038;d_alert=rd_final_rank&#038;ADID=GENSYND_ZER&#038;t=WMT">Read the full analyst report on "WMT"</a><br /><a href="http://www.zacks.com" alt="Investment Research">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/wal-mart-sales-up-in-u-s-europe-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CTIC Reports, Awaiting FDA Decision &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/ctic-reports-awaiting-fda-decision-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/ctic-reports-awaiting-fda-decision-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 16:15:26 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[lead pipeline candidate]]></category>
		<category><![CDATA[Lymphoma]]></category>
		<category><![CDATA[U.S. Food and Drug  Administration]]></category>
		<category><![CDATA[U.S. Food and Drug Administration]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27209/CTIC+Reports%2C+Awaiting+FDA+Decision+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Cell</strong> <strong>Therapeutics</strong>&#8217; (<a href="http://www.zacks.com/stock/quote/CTIC">CTIC</a>) third quarter loss per share came in at 8 cents compared to a loss of $1.14 reported in the year ago period. The company does not have any marketed product at present; it derives revenues primarily in the form of license and contract revenues. Cell Therapeutics recorded revenues of $0.02 million compared to $2.6 million in the third quarter of 2009. <br />
<br />
Revenues in the year ago period consisted of product sales of Zevalin, which the company sold to Spectrum Pharmaceuticals earlier in 2009. Operating expenses during the quarter increased 32.5% to $27 million primarily on account of more than 150% increase in SG&#038;A expenses. Cell Therapeutics has started preparing for the launch of pixantrone in 2010 by recruiting key persons and conducting market research; which has pushed SG&#038;A expenses higher. <br />
<br />
As a reminder, in August, the US Food and Drug Administration (FDA) had accepted for review the New Drug Application (NDA) filed by Cell Therapeutics. The company is seeking FDA approval (NDA filed in June 2009) for pixantrone for the treatment of relapsed and refractory non-Hodgkin&#8217;s lymphoma (NHL). We believe current investor focus is more on the outcome of the US Food and Drug Administration&#8217;s (FDA) decision regarding its lead candidate pixantrone, which is Cell Therapeutics&#8217; lead pipeline candidate. The company was granted a ten month standard review and has been assigned a Prescription Drug User Fee Act (PDUFA) date of April 23, 2010. <br />
<br />
Additionally, in July 2009, Cell Therapeutics initiated the process of obtaining marketing approval for pixantrone in Europe for the treatment of relapsed or refractory aggressive NHL. <br />
<br />
Although the picture is not so gloomy on the product development front, we remain concerned about Cell Therapeutics&#8217; liquidity position. Cash and cash equivalents including securities available for sale were $54.9 million. The company is under great pressure to raise additional cash to fund its operations, especially at a time when the company is preparing for the potential launch of pixantrone in 2010. <br />
<br />
During the quarter, Cell Therapeutics reduced debt through the exchange of $4.5 million principal in debt for common stock resulting in a total of $57.4 million principal reduction in debt through exchanges so far in 2009. Although the company has brought down its debt burden by exchanging it against common stock, we remain concerned about significant dilution in shareholder value.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#038;d_alert=rd_final_rank&#038;ADID=GENSYND_ZER&#038;t=CTIC">Read the full analyst report on "CTIC"</a><br /><a href="http://www.zacks.com" alt="Investment Research">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/ctic-reports-awaiting-fda-decision-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Glaxo Reports Higher Revenues &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/glaxo-reports-higher-revenues-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/glaxo-reports-higher-revenues-analyst-blog/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 14:01:15 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bristol Myers Squibb]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[Glaxosmithkline Plc]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Pfizer]]></category>
		<category><![CDATA[Reddy]]></category>
		<category><![CDATA[Stiefel]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Wellbutrin Xl]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27206/Glaxo+Reports+Higher+Revenues+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>GlaxoSmithKline, plc</strong> (<a href="http://www.zacks.com/stock/quote/gsk">GSK</a>) reported third quarter income of 92 cents per American Depository Share (ADS), 3 cents below the Zacks Consensus Estimate. The company reported earnings of 94 cents in the year-ago period.<br />
<br />
Third quarter 2009 revenue increased 3%, with growth being driven by strong performances in emerging markets (up 25%), Japan (up 19%) and Consumer Healthcare (up 8%). We were pleased to see growth in Consumer Healthcare revenue despite the global slowdown.<br />
<br />
Meanwhile, US sales continued to be impacted by generic competition with revenue declining 12%. Sales of products like Imigran (down 74%), Lamictal (down 21%) and Requip (down 30%) and Wellbutrin XL (down 81%) kept declining.<br />
<br />
Pharmaceutical product revenue increased 2% with sales being driven by Advair/Seretide (up 5%) and Relenza. Relenza benefited from continued orders from several governments for stockpiling. <br />
<br />
Although vaccine sales were lower in the third quarter due to phasing of shipments, we expect strong vaccine segment revenue in the fourth quarter of 2009. In addition to strong influenza product sales, the company has made significant progress in expanding its vaccine product portfolio. The approval of cervical cancer vaccine Cervarix in the US and Japan, H1N1 vaccine Pandemrix in Europe, and the H1N1 vaccine in the US should all help drive vaccine segment revenue.<br />
<br />
GlaxoSmithKline continued to make progress with its cost-cutting initiative, which should help offset the impact of increasing generic competition in the next few years and help earnings grow faster than revenues. The company&#8217;s restructuring program is expected to deliver £1.7 billion in annual savings. GlaxoSmithKline announced that it has achieved annualized cost savings of about £1 billion.<br />
<br />
In our view, GlaxoSmithKline possesses one of the strongest late-stage pipelines in large-cap pharma. We believe that the company remains interested in accelerating growth through acquisitions and partnering arrangements.<br />
<br />
The company&#8217;s HIV partnership with<strong> Pfizer</strong> (<a href="http://www.zacks.com/stock/quote/gsk">GSK</a>) and the Stiefel acquisition are the beginning of a trend which we expect to continue. GlaxoSmithKline has also been active in expanding its presence in emerging markets as evident by its recent deals with companies like <strong>Bristol-Myers Squibb</strong> (<a href="http://www.zacks.com/stock/quote/bmy">BMY</a>) and <strong>Dr. Reddy&#8217;s Laboratories</strong> (<a href="http://www.zacks.com/stock/quote/rdy">RDY</a>), among others.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GSK">Read the full analyst report on "GSK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PFE">Read the full analyst report on "PFE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BMY">Read the full analyst report on "BMY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=RDY">Read the full analyst report on "RDY"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/glaxo-reports-higher-revenues-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Southern Copper Corporation, Logitech International, Cisco Systems Inc., Microsoft Corp. and Koninklijke Philips Electronics NV &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-southern-copper-corporation-logitech-international-cisco-systems-inc-microsoft-corp-and-koninklijke-philips-electronics-nv-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-southern-copper-corporation-logitech-international-cisco-systems-inc-microsoft-corp-and-koninklijke-philips-electronics-nv-press-releases/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 12:55:28 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Americas]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Apples]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Austin]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Cisco Systems Inc]]></category>
		<category><![CDATA[copper producers]]></category>
		<category><![CDATA[Cuajone mine]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[expensive systems]]></category>
		<category><![CDATA[Internet connections]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV;]]></category>
		<category><![CDATA[La Caridad mine]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[less expensive videoconferencing tools]]></category>
		<category><![CDATA[LifeSize]]></category>
		<category><![CDATA[Logitech International;]]></category>
		<category><![CDATA[Mexico]]></category>
		<category><![CDATA[Microsoft Corp]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Peru]]></category>
		<category><![CDATA[public healthcare]]></category>
		<category><![CDATA[Southern Copper Corporation]]></category>
		<category><![CDATA[Switzerland]]></category>
		<category><![CDATA[Tandberg]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[Toquepala mine]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[video communication solutions]]></category>
		<category><![CDATA[video communications]]></category>
		<category><![CDATA[video conferencing]]></category>
		<category><![CDATA[voip]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27198/Zacks+Analyst+Blog+Highlights%3A+Southern+Copper+Corporation%2C+Logitech+International%2C+Cisco+Systems+Inc.%2C+Microsoft+Corp.+and+Koninklijke+Philips+Electronics+NV+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 12, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Southern Copper Corporation </strong>(<a href="void(0)">PCU</a>), <strong>Logitech International </strong>(<a href="void(0)">LOGI</a>), <strong>Cisco Systems Inc. </strong>(<a href="void(0)">CSCO</a>), <strong>Microsoft Corp.</strong> (<a href="void(0)">MSFT</a>) and <strong>Koninklijke Philips Electronics NV </strong>(<a href="void(0)">PHG</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Wednesday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Southern Copper&#8217;s Earnings Jump</strong></p>
<p align="left"><strong>Southern Copper Corporation </strong>(<a href="void(0)">PCU</a>), one of the leading copper producers in the world, posted net earnings of 37 cents in the third quarter of 2009, better than the Zacks Consensus Estimate of 31 cents. Earnings jumped 78.6% from 21 cents sequentially while it declined 22.3% from 47 cents year on year. The company attributed lower costs for driving earnings. Operating costs decreased 15.8% year over year due to higher productivity.</p>
<p align="left">Copper production in the quarter improved 1.3% to 120,240 tons from 118,657 tons, driven by higher production at the La Caridad mine in Mexico and the Peruvian mines, on the back of better ore grades. Molybdenum production increased 14.3% to 5,191 tons, compared to 4,541 tons in the year-ago quarter. Higher ore grades and recoveries lead to an increase of 631 tons at La Caridad and 734 tons production at the Cuajone mine in Peru. These increases were partially offset by 715 tons of lower production at the Toquepala mine in Peru due to lower ore grades.</p>
<p align="left"><strong>Logitech Acquires LifeSize</strong></p>
<p align="left"><strong>Logitech International </strong>(<a href="void(0)">LOGI</a>) announced that it has agreed to acquire privately held LifeSize Communications of Austin, Texas for $405 million in cash. LifeSize is a global leader in high definition (HD) video communication solutions, with more than 9,000 video conferencing customers across 80 countries in large enterprises, small-to-medium businesses (SMBs) and public healthcare, education and government organizations.</p>
<p align="left">The acquisition will enable Logitech to extend its leadership in video communication beyond the desktop.</p>
<p align="left">Logitech and LifeSize plan to pursue existing and new relationships with unified communications, collaboration and VoIP industry partners and competitors to drive the development of an open eco-system for interoperable video communication.</p>
<p align="left">LifeSize expects approximately $90 million in revenues in CY 2009, with CY 2010 revenues expected to grow between 40% and 60%. Logitech expects the acquisition to be neutral to slightly positive to its operating income (excluding acquisition-related charges) in FY 2011, ending March 31, 2011, and positive thereafter.</p>
<p align="left">For a long time, videoconferencing was limited to big businesses that could afford to build expensive systems in their conference rooms. But videoconferencing has become more accessible because Internet connections are commonplace, video has become more efficient and the price has dropped for high-definition cameras and displays.</p>
<p align="left">Now, many companies are trying to reach small businesses and individuals that previously used low-quality webcams on PCs. In the previous month, <strong>Cisco Systems Inc. </strong>(<a href="void(0)">CSCO</a>) announced its intension to buy Tandberg, a Norwegian video communications company, for $3 billion. Tandberg makes smaller and less expensive videoconferencing tools that can be fitted on desks.</p>
<p align="left">Logitech engages in design, manufacture, and marketing of personal peripherals for personal computers and other digital platforms in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company was founded in 1981 and is based in Apples, Switzerland. Major competitors include <strong>Microsoft Corp.</strong> (<a href="void(0)">MSFT</a>) and <strong>Koninklijke Philips Electronics NV </strong>(<a href="void(0)">PHG</a>).</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-southern-copper-corporation-logitech-international-cisco-systems-inc-microsoft-corp-and-koninklijke-philips-electronics-nv-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Vodafone Group Plc, Telefonica, Deutsche Telekom, France Telecom and Verizon &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-vodafone-group-plc-telefonica-deutsche-telekom-france-telecom-and-verizon-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-vodafone-group-plc-telefonica-deutsche-telekom-france-telecom-and-verizon-press-releases/#comments</comments>
		<pubDate>Thu, 12 Nov 2009 12:45:15 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Deutsche Telekom]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France Telecom]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Iphone]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[mobile carrier;]]></category>
		<category><![CDATA[Romania]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[Spain]]></category>
		<category><![CDATA[TELEFONICA]]></category>
		<category><![CDATA[The Netherlands]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[Verizon Wireless;]]></category>
		<category><![CDATA[Vodafone Group PLC;]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[wireless customer base;]]></category>
		<category><![CDATA[wireless services]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27197/Zacks+Analyst+Blog+Highlights%3A+Vodafone+Group+Plc%2C+Telefonica%2C+Deutsche+Telekom%2C+France+Telecom+and+Verizon+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 12, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Vodafone Group Plc </strong>(<a href="void(0)">VOD</a>), <strong>Telefonica </strong>(<a href="void(0)">TEF</a>), <strong>Deutsche Telekom </strong>(<a href="void(0)">DT</a>), <strong>France Telecom </strong>(<a href="void(0)">FTE</a>) and <strong>Verizon </strong>(<a href="void(0)">VZ</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Wednesday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>Vodafone Profit Leaps, Lifts Savings</strong></p>
<p align="left"><strong>Vodafone Group Plc </strong>(<a href="void(0)">VOD</a>), the largest wireless carrier in the world by revenue, has announced interim results for fiscal year 2010 with adjusted net income of £4.58 billion (US$7.3 billion) increasing 15% year over year from £3.99 billion (US$6.4 billion) reported a year ago, driven by favorable exchange rate movements and reduced tax. Adjusted earnings exclude one-time items such as impairment losses.</p>
<p align="left">The telecom giant reported consolidated revenues of £21.8 billion (US$34.8 billion) for the period, representing a 9.3% year over year growth. Favorable exchange rate (euro-sterling) swings and net impact of merger and acquisition initiatives contributed to this growth. Excluding these impacts (organic basis), revenue declined 3% year over year.</p>
<p align="left">Group service revenue declined 2.6% year over year on an organic basis to £20.5 billion (US$32.7 billion), primarily due to weaker contributions from European markets as recessionary conditions curbed demand for wireless services. Adjusted EBITDA increased 2.9% year over year to £7.5 billion (US$12 billion) driven by cost control.</p>
<p align="left">Revenues for the European segment increased 3% year over year (down 5.1% on organic basis) to £14.9 billion (US$23.8 billion). Service revenue in Europe declined 4.5% organically as growth in Italy and the Netherlands was more than offset by decreases across Spain, Germany and the UK due to a weaker economy, regulatory pressure and intense competition.</p>
<p align="left">Decline in voice revenue continues to offset growth in data. Revenue in Germany and the UK remains under pressure due to mobile termination rate (inter-operator fees) cuts. Vodafone is also losing customers in the UK as subscribers switch to its major rival <strong>Telefonica&#8217;s </strong>(<a href="void(0)">TEF</a>) O2 which is marketing iPhone in the UK.</p>
<p align="left">Moreover, <strong>Deutsche Telekom </strong>(<a href="void(0)">DT</a>) and <strong>France Telecom </strong>(<a href="void(0)">FTE</a>) have recently finalized an agreement to combine their UK units, which will create the largest mobile carrier in the UK.</p>
<p align="left">This segment posted revenues of £3.7 billion (US$5.9 billion), up 36% year over year. Organically, service revenue fell 3.2% as consistent growth at Vodacom (South Africa) and increase in subscriber count were partly offset by weak contributions from Romania and Turkey. Service revenue at Vodacom increased 4.2% on an organic basis as a result of healthy subscriber accretion.</p>
<p align="left">Asia Pacific &#38; Middle East segment continues to perform in line with expectation. Revenue surged 15.9% year over year (11.3% organically) to £3.1 billion (US$4.9 billion), driven by continued strong growth in India , the single biggest contributor to organic revenue growth. Service revenue in India increased 20.5% organically boosted by roughly 55% growth in wireless customer base amid intense price competition.</p>
<p align="left">During the six-month period, Vodafone registered roughly 20.6 million net new mobile connections across its operations, bringing the total subscriber base to 323.3 million (83.5% represented by prepaid). India continues to be a key driver for subscriber growth with a net addition of 14 million customers in the first six months of fiscal 2010.</p>
<p align="left">In Europe, the company registered a net loss of 262,000 subscribers during the half-year period. <strong>Verizon&#8217;s</strong> (<a href="void(0)">VZ</a>) mobile unit, Verizon Wireless, in which Vodafone holds a 45% stake, however, posted a net addition of 1.1 million customers.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-vodafone-group-plc-telefonica-deutsche-telekom-france-telecom-and-verizon-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>ValueClick: Lower Target but Neutral &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/valueclick-lower-target-but-neutral-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/valueclick-lower-target-but-neutral-analyst-blog/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 22:54:51 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[above management;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[google]]></category>
		<category><![CDATA[Internet advertising industry;]]></category>
		<category><![CDATA[large Web portals]]></category>
		<category><![CDATA[Msn]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[ValueClick Inc.]]></category>
		<category><![CDATA[Yahoo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27192/ValueClick%3A+Lower+Target+but+Neutral+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
We are lowering our six-month price target on <strong>ValueClick Inc.</strong> (<a href="http://www.zacks.com/stock/quote/vclk">VCLK</a>) to $11.00 but maintaining our Neutral rating on the stock.<br />
<br />
The company provided disappointing guidance for the coming quarter, which was much below Zacks Consensus Estimates. The unexpected weakness in the Comparison Shopping segment and slower international business, particularly in Europe, will have a negative impact on revenue growth going forward. Thus we are lowering our revenue estimates for the fourth quarter and full year 2009.<br />
<br />
The Comparison shopping segment is expected to decline in the mid-to-high teen percentage range in the coming quarter, affected by <strong>Yahoo!'s</strong> (<a href="http://www.zacks.com/stock/quote/yhoo">YHOO</a>) new ad quality ranking system. Moreover, large Web portals such as <strong>Google</strong> (<a href="http://www.zacks.com/stock/quote/goog">GOOG</a>), Yahoo! and MSN will increase competition for ValueClick&#8217;s display ad business.<br />
<br />
ValueClick&#8217;s third quarter earnings were above Zacks Consensus Estimates as well as above management&#8217;s expectations, as Comparison Shopping remained strong while Lead Generation performed better than our expectations. The results further demonstrate the company&#8217;s focus on driving bottom-line growth.<br />
<br />
Moreover, with impressive cash flow, share repurchases and a strong balance sheet, the company is focused on driving shareholder wealth.<br />
<br />
A growing Search segment, stabilization in the lead generation business, significant long-term growth opportunities in the Internet advertising industry and increasing display ad trends in the U.S. are other positives to the stock.<br />
<br />
Over the long term, we are very positive on online advertising growth. However, current economic conditions and the company&#8217;s decreasing revenue growth are creating significant headwinds for ValueClick.<br />
<br />
Much of the downside is already priced into ValueClick&#8217;s share price and we do not expect much upside to the company&#8217;s share price in the near term. Thus we believe it is not advisable to get involved with the stock in the six-month time frame and remain on the sidelines until we see momentum in the company&#8217;s Lead Generation business.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VCLK">Read the full analyst report on "VCLK"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=YHOO">Read the full analyst report on "YHOO"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GOOG">Read the full analyst report on "GOOG"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/valueclick-lower-target-but-neutral-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSRH, CVAT,  DrStockPick.com Stock Report! Consorteum Holdings Inc. and Cavitation Technologies Inc.</title>
		<link>http://www.straightstocks.com/stock-watch/csrh-cvat-drstockpick-com-stock-report-consorteum-holdings-inc-and-cavitation-technologies-inc/</link>
		<comments>http://www.straightstocks.com/stock-watch/csrh-cvat-drstockpick-com-stock-report-consorteum-holdings-inc-and-cavitation-technologies-inc/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 22:43:52 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[(818) 718-0905]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[Agri Process Innovations Inc.]]></category>
		<category><![CDATA[beverage]]></category>
		<category><![CDATA[Cavitation Technologies Inc.]]></category>
		<category><![CDATA[chemical industries]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[CTI Nano-Cavitation Process Systems]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[leader in the development]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[vegetable oil refining]]></category>
		<category><![CDATA[www.apinnovations.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4700</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Wednesday November 11, 2009
DrStockPick.com Stock Report!
CVAT, Cavitation Technologies Inc, CVAT.OB
CSRH, Consorteum Holdings Inc, CSRH.OB
**************************************************************
CTI Enters Into Strategic Alliance With Agri Process Innovations, Inc. for CTI Nano-Cavitation Process Systems.
Cavitation Technologies, Inc. (CTI); (OTCBB: CVAT) is a “Green-Tech” company, established in 2006 to become a world [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/csrh-cvat-drstockpick-com-stock-report-consorteum-holdings-inc-and-cavitation-technologies-inc/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Isis Loss Widens &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/isis-loss-widens-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/isis-loss-widens-analyst-blog/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:59:22 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Alnylam Pharmaceuticals;]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[antisense technology;]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Diabetes]]></category>
		<category><![CDATA[diabetes candidate]]></category>
		<category><![CDATA[Drug Discovery]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[familial hypercholesterolemia;]]></category>
		<category><![CDATA[Genzyme]]></category>
		<category><![CDATA[hypercholesterolemia]]></category>
		<category><![CDATA[ISIS Pharmaceuticals Inc.]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[lead pipeline candidate]]></category>
		<category><![CDATA[mipomersen]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27186/Isis+Loss+Widens+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Isis Pharmaceuticals Inc.</strong> (<a href="http://www.zacks.com/stock/quote/ISIS">ISIS</a>) reported a net loss of 7 cents per share in the third quarter, which was wider than the Zacks Consensus Estimate of a net loss of 5 cents. The company had reported a net income of 2 cents in the year ago period. The wider-than-expected loss was due to lower revenues and higher operating expenses. <br />
<br />
Revenues declined 9.1% to $26.8 million. Revenues include license fees, milestone-related payments and other payments. Revenues declined during the reported quarter as the company finished amortizing the revenue associated with the $50 million upfront payment received from <strong>Johnson &#38; Johnson</strong>&#8217;s (<a href="http://www.zacks.com/stock/quote/JNJ">JNJ</a>) Ortho-McNeil-Janssen in 2007. <br />
<br />
The company reported higher expenses during the quarter mainly due to the expansion of its clinical development programs, including additional expenses associated with the phase III clinical program for mipomersen, expenses for Regulus as it builds its core team and expenses related to the company's expansion of its drug discovery activities into new therapeutic areas. Regulus Therapeutics has been established in collaboration with <strong>Alnylam Pharmaceuticals </strong>(<a href="http://www.zacks.com/stock/quote/ALNY">ALNY</a>). <br />
<br />
We expect operating expenses to continue increasing as the company expands its research and development activities. Isis recently presented positive phase II data on type II diabetes candidate, ISIS 113715, which should move into the advanced stages of development. <br />
<br />
Isis also continued to make progress with its lead pipeline candidate, mipomersen. Collaboration partner <strong>Genzyme </strong>(<a href="http://www.zacks.com/stock/quote/GENZ">GENZ</a>) intends to file the first new drug application (NDA) for mipomersen in the U.S. for homozygous familial hypercholesterolemia (FH) in the second half of 2010, with a similar filing in Europe shortly afterwards. <br />
<br />
Meanwhile, Isis expects to present data from its phase III study in severe hypercholesterolemia patients ahead of the initial NDA filing in the U.S. Positive results would allow the company to file for a broader indication. A potential second filing in Europe will involve a broader patient population, namely, heterozygous FH patients. <br />
<br />
Isis exited the quarter with a strong cash position of $607.8 million. The company averred that it remains on track to exit the year with more than $550 million of cash. The company intends to expand its pipeline by moving at least three new drugs into development in 2009. <br />
<br />
Although we believe that Isis&#8217; antisense technology represents an exciting and potentially revolutionary platform for developing therapeutic candidates to treat a wide margin of diseases, we remain concerned about the company&#8217;s dependence on mipomersen for future growth. Any delay in the development and commercialization of the candidate would weigh heavily on the stock. We currently have a Neutral recommendation on the company.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ISIS">Read the full analyst report on "ISIS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ALNY">Read the full analyst report on "ALNY"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GENZ">Read the full analyst report on "GENZ"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=JNJ">Read the full analyst report on "JNJ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/isis-loss-widens-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wind Works Power Corp. Signs Option to Acquire 100% Interest in 50MW Wind Energy Project in Hungary</title>
		<link>http://www.straightstocks.com/investing-lessons/wind-works-power-corp-signs-option-to-acquire-100-interest-in-50mw-wind-energy-project-in-hungary/</link>
		<comments>http://www.straightstocks.com/investing-lessons/wind-works-power-corp-signs-option-to-acquire-100-interest-in-50mw-wind-energy-project-in-hungary/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:07:38 +0000</pubDate>
		<dc:creator>Stuart T. Smith</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Belgium]]></category>
		<category><![CDATA[CEO and director]]></category>
		<category><![CDATA[CEO and director of Wind Works]]></category>
		<category><![CDATA[director of Wind Works]]></category>
		<category><![CDATA[Ecsed]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Frankfurt]]></category>
		<category><![CDATA[Honelles]]></category>
		<category><![CDATA[Hungary]]></category>
		<category><![CDATA[Ingo Stuckmann]]></category>
		<category><![CDATA[megawatt wind energy project]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Ontario]]></category>
		<category><![CDATA[Ottawa]]></category>
		<category><![CDATA[Power Corp.]]></category>
		<category><![CDATA[renewable wind energy projects]]></category>
		<category><![CDATA[smallcapvoice]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wind energy project]]></category>
		<category><![CDATA[Wind Energy Projects]]></category>
		<category><![CDATA[Wind Park]]></category>
		<category><![CDATA[www.windworkspower.com]]></category>

		<guid isPermaLink="false">http://smallcapvoice.com/blog/?p=3054</guid>
		<description><![CDATA[OTTAWA, ONTARIO &#8212; (Marketwire) &#8212; 11/11/09 &#8212; Wind Works Power Corp. (OTCBB: WWPW)(FRANKFURT: R5E1)(WKN: AOKE72) is pleased to announce that they have signed an option agreement to acquire a 100% interest in Ecsed, a 50 megawatt wind energy project located in Hungary. In consideration for the 100% interest, Wind Works will make an initial cash [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/wind-works-power-corp-signs-option-to-acquire-100-interest-in-50mw-wind-energy-project-in-hungary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Brazilian Airlines Flying Higher &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/brazilian-airlines-flying-higher-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/brazilian-airlines-flying-higher-analyst-blog/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 20:28:54 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Argentina]]></category>
		<category><![CDATA[Chile]]></category>
		<category><![CDATA[Chilean government;]]></category>
		<category><![CDATA[Ecuador]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[I.R.I.S. s.a. TG3Z3510AFCS Headset]]></category>
		<category><![CDATA[LAN]]></category>
		<category><![CDATA[Lan Airlines S.A.]]></category>
		<category><![CDATA[Latin America]]></category>
		<category><![CDATA[Peru]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27174/Brazilian+Airlines+Flying+Higher+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
Earlier this week, <strong>LAN Airlines S.A.</strong> (<a href="http://www.zacks.com/stock/quote/LFL">LFL</a>) and its subsidiaries released its preliminary monthly traffic statistics and punctuality indicators for October. Passenger traffic rose 15.7% year over year while capacity jumped 10.1%. Its load factor increased 3.9 points to 80.2%.<br />
 <br />
International passenger traffic accounted for almost 69% of total passenger traffic, with the rest coming from domestic passengers.<br />
 <br />
Domestic passenger traffic in Chile, Argentina, Peru and Ecuador rose 14.1% and international passenger traffic rose 16.5%. Domestic capacity increased 8.6% and international capacity increased 10.8%. International capacity was mainly driven by a surge in operations in Europe and certain regional routes.<br />
 <br />
In line with the global decline in import and export markets cargo traffic fell 6.2% mainly due to the slowdown in import and export markets in Latin America, as well as the reduction of salmon exports from Chile. In line with the decrease in demand, capacity fell 4.8%. The cargo load factor reached its highest level this year at 70.7%.<br />
 <br />
The company&#8217;s near-term outlook is not as bright as it was a few months ago primarily due to the international economic crisis. However, we believe Chile will perform reasonably during 2009.<br />
 <br />
In fact, the Chilean Government has already announced a $4 billion economic stimulus package that represents 2.8% of the country's GDP. The plan will be funded by the country's sovereign wealth fund. As the most organized and developed economy in Latin America, Chile is now capable of pursuing a truly anti-cyclical policy.<br />
 <br />
The company accounts for more than one half of Chile&#8217;s international passenger traffic and nearly three-quarters of its domestic traffic. Moreover, consistent positive results and solid financial and liquidity positions will enable LAN to move ahead with a number of long-term initiatives.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LFL">Read the full analyst report on "LFL"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/brazilian-airlines-flying-higher-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Logitech Acquires LifeSize &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/logitech-acquires-lifesize-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/logitech-acquires-lifesize-analyst-blog/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 18:45:55 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Americas]]></category>
		<category><![CDATA[Apples]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Cisco Systems Inc]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[expensive systems]]></category>
		<category><![CDATA[Internet connections]]></category>
		<category><![CDATA[Koninklijke Philips Electronics NV;]]></category>
		<category><![CDATA[less expensive videoconferencing tools]]></category>
		<category><![CDATA[Microsoft Corp]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Switzerland]]></category>
		<category><![CDATA[Tandberg]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[video communications]]></category>
		<category><![CDATA[video conferencing]]></category>
		<category><![CDATA[voip]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27168/Logitech+Acquires+LifeSize+-+Analyst+Blog</guid>
		<description><![CDATA[<p><strong>Logitech International</strong> (<a href="http://www.zacks.com/stock/quote/LOGI">LOGI</a>) announced that it has agreed to acquire privately held LifeSize Communications of Austin, Texas for $405 million in cash. LifeSize is a global leader in high definition (HD) video communication solutions, with more than 9,000 video conferencing customers across 80 countries in large enterprises, small-to-medium businesses (SMBs) and public healthcare, education and government organizations.<br />
 <br />
The acquisition will enable Logitech to extend its leadership in video communication beyond the desktop.</p>
<p>Logitech and LifeSize plan to pursue existing and new relationships with unified communications, collaboration and VoIP industry partners and competitors to drive the development of an open eco-system for interoperable video communication.</p>
<p>LifeSize expects approximately $90 million in revenues in CY 2009, with CY 2010 revenues expected to grow between 40% and 60%. Logitech expects the acquisition to be neutral to slightly positive to its operating income (excluding acquisition-related charges) in FY 2011, ending March 31, 2011, and positive thereafter.</p>
<p>For a long time, videoconferencing was limited to big businesses that could afford to build expensive systems in their conference rooms. But videoconferencing has become more accessible because Internet connections are commonplace, video has become more efficient and the price has dropped for high-definition cameras and displays.</p>
<p>Now, many companies are trying to reach small businesses and individuals that previously used low-quality webcams on PCs. In the previous month, <strong>Cisco Systems Inc. </strong>(<a href="http://www.zacks.com/stock/quote/CSCO">CSCO</a>) announced its intension to buy Tandberg, a Norwegian video communications company, for $3 billion. Tandberg makes smaller and less expensive videoconferencing tools that can be fitted on desks.</p>
<p>Logitech engages in design, manufacture, and marketing of personal peripherals for personal computers and other digital platforms in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company was founded in 1981 and is based in Apples, Switzerland. Major competitors include <strong>Microsoft Corp.</strong> (<a href="http://www.zacks.com/stock/quote/MSFT">MSFT</a>) and <strong>Koninklijke Philips Electronics NV</strong> (<a href="http://www.zacks.com/stock/quote/PHG">PHG</a>).</p>
<p>We currently have a Neutral recommendation on LOGI.</p><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=LOGI">Read the full analyst report on "LOGI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CSCO">Read the full analyst report on "CSCO"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MSFT">Read the full analyst report on "MSFT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=PHG">Read the full analyst report on "PHG"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/logitech-acquires-lifesize-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Wind Works Power Corp. (WWPW.OB) to Acquire 50MW Wind Energy Project in Hungary</title>
		<link>http://www.straightstocks.com/investing-lessons/wind-works-power-corp-wwpw-ob-to-acquire-50mw-wind-energy-project-in-hungary/</link>
		<comments>http://www.straightstocks.com/investing-lessons/wind-works-power-corp-wwpw-ob-to-acquire-50mw-wind-energy-project-in-hungary/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 18:27:20 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[Belgium]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Director and CEO]]></category>
		<category><![CDATA[Ecsed]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[energy development projects]]></category>
		<category><![CDATA[energy project]]></category>
		<category><![CDATA[Energy Projects]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Honelles]]></category>
		<category><![CDATA[Hungary]]></category>
		<category><![CDATA[Ingo Stuckmann]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wind Works Power Corp.]]></category>
		<category><![CDATA[Zero Emission People]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19223</guid>
		<description><![CDATA[Canadian-based Wind Works Power Corp. announced today that they have signed an option agreement to acquire a 100% interest in Ecsed, a 50 megawatt wind energy project in Hungary, for $500,000. This transaction followed on the heels of another announcement Monday in which the company announced they signed an option agreement to acquire a 100% [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/wind-works-power-corp-wwpw-ob-to-acquire-50mw-wind-energy-project-in-hungary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Cereplast, Inc. (CERP.OB) Projects Bio-Plastics to Capture 30% of U.S. Market, Topping $10B by 2020</title>
		<link>http://www.straightstocks.com/investing-lessons/cereplast-inc-cerp-ob-projects-bio-plastics-to-capture-30-of-u-s-market-topping-10b-by-2020/</link>
		<comments>http://www.straightstocks.com/investing-lessons/cereplast-inc-cerp-ob-projects-bio-plastics-to-capture-30-of-u-s-market-topping-10b-by-2020/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 16:31:22 +0000</pubDate>
		<dc:creator>QualityStocks</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Small & Micro Cap]]></category>
		<category><![CDATA[algae-based bio-plastics]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[bio-plastics]]></category>
		<category><![CDATA[biodegradable products;]]></category>
		<category><![CDATA[CEO and founder]]></category>
		<category><![CDATA[Cereplast Inc]]></category>
		<category><![CDATA[Coca Cola]]></category>
		<category><![CDATA[Consumer Electronics]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food service]]></category>
		<category><![CDATA[Frederic Scheer]]></category>
		<category><![CDATA[Kaiser Consultancy]]></category>
		<category><![CDATA[Obama administration]]></category>
		<category><![CDATA[Plastics]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wal Mart]]></category>

		<guid isPermaLink="false">http://Blog.QualityStocks.net/?p=19217</guid>
		<description><![CDATA[Cereplast, Inc., a pioneer in the manufacture of plastics which derive largely from resins based on plant starches, released news announcing projections for its market sector. 
Expecting a ten-fold sales increase in the U.S. bio-plastics market by 2020, the Company cited the $1B sales figures from 2007 and estimates which show that, within ten years, [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/cereplast-inc-cerp-ob-projects-bio-plastics-to-capture-30-of-u-s-market-topping-10b-by-2020/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Vodafone Profit Leaps, Lifts Savings &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/vodafone-profit-leaps-lifts-savings-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/vodafone-profit-leaps-lifts-savings-analyst-blog/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 14:33:46 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[3g]]></category>
		<category><![CDATA[3g Network]]></category>
		<category><![CDATA[3G wireless service deployments;]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[broadband network]]></category>
		<category><![CDATA[Deutsche Telekom]]></category>
		<category><![CDATA[Eastern Europe]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[France Telecom]]></category>
		<category><![CDATA[Gbp]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[HSDPA technology]]></category>
		<category><![CDATA[India]]></category>
		<category><![CDATA[Iphone]]></category>
		<category><![CDATA[Italy]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[mobile carrier;]]></category>
		<category><![CDATA[Romania]]></category>
		<category><![CDATA[Segment Europe]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[Spain]]></category>
		<category><![CDATA[TELEFONICA]]></category>
		<category><![CDATA[The Netherlands]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Verizon]]></category>
		<category><![CDATA[Verizon Wireless;]]></category>
		<category><![CDATA[Vodafone]]></category>
		<category><![CDATA[Vodafone Group PLC;]]></category>
		<category><![CDATA[Wireless Carrier]]></category>
		<category><![CDATA[wireless customer base;]]></category>
		<category><![CDATA[wireless services]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27159/Vodafone+Profit+Leaps%2C+Lifts+Savings+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Vodafone Group Plc </strong>(<a href="http://www.zacks.com/stock/quote/vod">VOD</a>), the largest wireless carrier in the world by revenue, has announced interim results for fiscal year 2010 with adjusted net income of £4.58 billion (US$7.3 billion) increasing 15% year over year from £3.99 billion (US$6.4 billion) reported a year ago, driven by favorable exchange rate movements and reduced tax. Adjusted earnings exclude one-time items such as impairment losses.<br />
<br />
<u><strong>Group Revenue &#38; EBITDA</strong></u><br />
<br />
The telecom giant reported consolidated revenues of £21.8 billion (US$34.8 billion) for the period, representing a 9.3% year over year growth. Favorable exchange rate (euro-sterling) swings and net impact of merger and acquisition initiatives contributed to this growth. Excluding these impacts (organic basis), revenue declined 3% year over year.<br />
<br />
Group service revenue declined 2.6% year over year on an organic basis to £20.5 billion (US$32.7 billion), primarily due to weaker contributions from European markets as recessionary conditions curbed demand for wireless services. Adjusted EBITDA increased 2.9% year over year to £7.5 billion (US$12 billion) driven by cost control.  <br />
<br />
<u><strong>Results by Segment</strong></u><br />
<br />
<em><strong>Europe</strong></em><br />
<br />
Revenues for the European segment increased 3% year over year (down 5.1% on organic basis) to £14.9 billion (US$23.8 billion). Service revenue in Europe declined 4.5% organically as growth in Italy and the Netherlands was more than offset by decreases across Spain, Germany and the UK due to a weaker economy, regulatory pressure and intense competition.<br />
<br />
Decline in voice revenue continues to offset growth in data. Revenue in Germany and the UK remains under pressure due to mobile termination rate (inter-operator fees) cuts. Vodafone is also losing customers in the UK as subscribers switch to its major rival <strong>Telefonica&#8217;s</strong> (<a href="http://www.zacks.com/stock/quote/tef">TEF</a>) O2 which is marketing iPhone in the UK.<br />
<br />
Moreover,<strong> Deutsche Telekom </strong>(<a href="http://www.zacks.com/stock/quote/dt">DT</a>) and <strong>France Telecom </strong>(<a href="http://www.zacks.com/stock/quote/fte">FTE</a>) have recently finalized an agreement to combine their UK units, which will create the largest mobile carrier in the UK.<br />
<br />
<em><strong>Africa &#38; Central Europe</strong></em><br />
<br />
This segment posted revenues of £3.7 billion (US$5.9 billion), up 36% year over year. Organically, service revenue fell 3.2% as consistent growth at Vodacom (South Africa) and increase in subscriber count were partly offset by weak contributions from Romania and Turkey. Service revenue at Vodacom increased 4.2% on an organic basis as a result of healthy subscriber accretion.  <br />
<br />
<em><strong>Asia Pacific &#38; Middle East</strong></em><br />
<br />
Asia Pacific &#38; Middle East segment continues to perform in line with expectation. Revenue surged 15.9% year over year (11.3% organically) to £3.1 billion (US$4.9 billion), driven by continued strong growth in India , the single biggest contributor to organic revenue growth. Service revenue in India increased 20.5% organically boosted by roughly 55% growth in wireless customer base amid intense price competition.<br />
<em><strong><br />
Subscriber Trends</strong></em><br />
<br />
During the six-month period, Vodafone registered roughly 20.6 million net new mobile connections across its operations, bringing the total subscriber base to 323.3 million (83.5% represented by prepaid). India continues to be a key driver for subscriber growth with a net addition of 14 million customers in the first six months of fiscal 2010.<br />
<br />
In Europe, the company registered a net loss of 262,000 subscribers during the half-year period.<strong> Verizon&#8217;s </strong>(<a href="http://www.zacks.com/stock/quote/vz">VZ</a>) mobile unit, Verizon Wireless, in which Vodafone holds a 45% stake, however, posted a net addition of 1.1 million customers.<br />
<br />
<em><strong>Outlook</strong></em><br />
<br />
Management has confirmed its outlook for fiscal 2010 with adjusted operating profit projected in the range of £11.0 billion to £11.8 billion (US$17.5 billion to US$18.8 billion), assuming a favorable foreign exchange environment. Free cash flow is projected between £6.0 billion and £6.5 billion (US$9.6 billion to US$10.4 billion).<br />
<br />
Vodafone is aggressively pursuing its cost reduction program that includes workforce reduction in Europe . The company has increased its annual savings target to £2 billion (US$3.2 billion) by 2012 from £1 billion (US$1.6 billion) as per earlier expectation. Roughly 50% of the total savings is expected to be realized in 2011.<br />
<br />
Moreover, Vodafone continues to accelerate 3G wireless service deployments and expand network availability across Asia, Eastern Europe and Africa. The company&#8217;s HSDPA technology based 3G mobile broadband network offers network speeds of 7.2 megabits per second (Mbps) across Europe.<br />
<br />
Vodafone has recently upgraded its 3G network in the UK to offer peak download speeds of 14.4 Mbps. Efforts are underway to further upgrade the existing 3G HSDPA network to HSPA+ standard, which will offer future throughput up to 42 Mbps. Moreover, Vodafone is set to launch iPhone in the UK in early 2010.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VOD">Read the full analyst report on "VOD"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DT">Read the full analyst report on "DT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FTE">Read the full analyst report on "FTE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TEF">Read the full analyst report on "TEF"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=VZ">Read the full analyst report on "VZ"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/vodafone-profit-leaps-lifts-savings-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Company News for November 11, 2009 &#8211; Corporate Summary</title>
		<link>http://www.straightstocks.com/stock-watch/company-news-for-november-11-2009-corporate-summary/</link>
		<comments>http://www.straightstocks.com/stock-watch/company-news-for-november-11-2009-corporate-summary/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 13:50:13 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Adobe Systems]]></category>
		<category><![CDATA[Ambac Financial Group]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Bartz]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[ceo]]></category>
		<category><![CDATA[Cytec Industries;]]></category>
		<category><![CDATA[Deutsche Bank]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Flowers Foods;]]></category>
		<category><![CDATA[General Electric]]></category>
		<category><![CDATA[Goldman Sachs]]></category>
		<category><![CDATA[JP-Morgan]]></category>
		<category><![CDATA[late-cycle aerospace industry]]></category>
		<category><![CDATA[Monsanto]]></category>
		<category><![CDATA[security systems]]></category>
		<category><![CDATA[Smithfield Foods]]></category>
		<category><![CDATA[soybean products;]]></category>
		<category><![CDATA[Toll Brothers]]></category>
		<category><![CDATA[United Technologies]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wells fargo]]></category>
		<category><![CDATA[Yahoo]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27152/Company+News+for+November+11%2C+2009+-+Corporate+Summary</guid>
		<description><![CDATA[<p align="justify">&#8226; Goldman Sachs (NYSE:GS) added Cytec Industries (NYSE:CYT) to its Conviction Sell List, with a target of $31.  The analyst warned of the bleak outlook for the late-cycle aerospace industry, and economic uncertainties in Europe, which represents 40% of sales</p>
<p align="justify">&#8226; JP Morgan (NYSE:JPM) plans to reinstate 401K matching programs starting with 2009 as well as plans to hire 1,200 mortgage officers</p>
<p align="justify">&#8226; Yahoo (NASDAQ:YHOO) CEO Bartz said the company is hiring again as the firm expects to increase its operating profit margin to the 15-20% range on cost cutting and sales growth</p>
<p align="justify">&#8226; Adobe Systems (NASDAQ:ADBE) said it plans to cut 680 jobs, or about 9% of its workforce, as part of a restructuring plan.  The company said the move would result in pre-tax charges of $65 million to $71 million, with $18 million to $20 million to be taken in the fourth quarter</p>
<p align="justify">&#8226; Monsanto (NYSE:MON) confirmed its full-year 2010 earnings outlook and said it still sees a 2012 gross profit of at least $8.6 billion, claiming an accelerated launch of new corn and soybean products</p>
<p align="justify">&#8226; Bond insurer, Ambac Financial Group (NYSE:ABK) warned of a possible bankruptcy protection filing in its 10-Q</p>
<p align="justify">&#8226; Reports said General Electric (NYSE:GE) is in talks with United Technologies (NYSE:UTX) to sell its security systems unit for over $1.5 billion</p>
<p align="justify">&#8226; Wells Fargo (NYSE:WFC) upgraded Toll Brothers (NYSE:TOL) with a price target range of $24-$26</p>
<p align="justify">&#8226; Deutsche Bank (NYSE:DB) upgraded Smithfield Foods (NYSE:SFD) raising the price target from $12 to $20 due to an improving pork market</p>
<p align="justify">&#8226; Flowers Foods (NYSE:FLO) reported inline earnings of 34 cents a share on revenues of $603 million, off Zacks estimates of $617 million</p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/company-news-for-november-11-2009-corporate-summary/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Bull and Bear of the Day Highlights: Amdocs Ltd., Molina Healthcare, Inc., Fannie Mae, Freddie Mac and Ford &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-amdocs-ltd-molina-healthcare-inc-fannie-mae-freddie-mac-and-ford-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-amdocs-ltd-molina-healthcare-inc-fannie-mae-freddie-mac-and-ford-press-releases/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 13:10:36 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Amdocs Ltd]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[bank loans]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fannie Mae]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Ford]]></category>
		<category><![CDATA[Freddie Mac]]></category>
		<category><![CDATA[H1N1]]></category>
		<category><![CDATA[H1N1 flu virus]]></category>
		<category><![CDATA[Janet Yellen]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[Molina Healthcare Inc.;]]></category>
		<category><![CDATA[technology integration products]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Equity Research]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27143/Zacks+Bull+and+Bear+of+the+Day+Highlights%3A+Amdocs+Ltd.%2C+Molina+Healthcare%2C+Inc.%2C+Fannie+Mae%2C+Freddie+Mac+and+Ford+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 11, 2009 &#8211; Zacks Equity Research highlights <strong>Amdocs Ltd.</strong> (<a href="http://www.zacks.com/stock/quote/DOX">DOX</a>) as the Bull of the Day and <strong>Molina Healthcare, Inc. </strong>(<a href="http://www.zacks.com/stock/quote/MOH">MOH</a>) the Bear of the Day. In addition, Zacks Equity Research provides analysis on <strong>Fannie Mae </strong>(<a href="http://www.zacks.com/stock/quote/FNM">FNM</a>), <strong>Freddie Mac </strong>(<a href="http://www.zacks.com/stock/quote/FRE">FRE</a>) and <strong>Ford </strong>(<a href="http://www.zacks.com/stock/quote/F">F</a>).</p>
<p align="left">Full analysis of all these stocks is available at <a href="http://at.zacks.com/?id=5506">http://at.zacks.com/?id=5506</a></p>
<p align="left">Here is a synopsis of all five stocks:</p>
<p align="left"><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=6">Bull of the Day</a>:</p>
<p align="left">We maintain our Outperform recommendation for <strong>Amdocs Ltd.</strong> (<a href="http://www.zacks.com/stock/quote/DOX">DOX</a>), following its strong results for the fiscal fourth quarter of 2009. The company has industry-leading technology integration products for managed services and large transformational projects.</p>
<p align="left">We believe long-term fundamentals for Amdocs remain firm due to the transition of telecom service providers to converged and consolidated solutions. Amdocs maintains a very strong financial position with healthy order backlog.</p>
<p align="left">Recently, the company has won a series of large managed services contracts in various parts of the world. Except Europe, operations in other regions have started gaining momentum.</p>
<p><a href="http://www.zacks.com/newsroom/commentary/index.php?type_id=7">Bear of the Day</a>:</p>
<p align="left"><strong>Molina Healthcare, Inc. </strong>(<a href="http://www.zacks.com/stock/quote/MOH">MOH</a>) reported third-quarter earnings of $0.33 per share, which was well below the Zacks Consensus Estimate of $0.53. The company earned $0.60 in the year-ago quarter.</p>
<p align="left">The decline in profit for the quarter was attributable to higher operating expenses coupled with losses from the company's California health plan. The increase in medical costs was attributable to the H1N1 flu virus and costs associated with recently enrolled members. The impact of the H1N1 epidemic is significant and has the potential to worsen in the coming quarters.</p>
<p align="left">We are also concerned about the intense competition facing Molina. We have an Underperform rating on the stock with a price target of $19.</p>
<p>Latest Posts on the Zacks <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a>:</p>
<p align="left"><em>Notes on Janet Yellen Speech</em></p>
<p align="left">These policies are likely to stay in place for a while to come, and will only gradually be lifted, particularly the low fed funds rate. What happens to mortgage rates once the Fed stops buying every scrap of paper ever issued or backed by <strong>Fannie Mae </strong>(<a href="http://www.zacks.com/stock/quote/FNM">FNM</a>) and <strong>Freddie Mac </strong>(<a href="http://www.zacks.com/stock/quote/FRE">FRE</a>) is very much of an open question. Oh, the buying of longer-term treasuries was just to bring private rates down -- it had nothing to do with keeping the interest costs to the government down .</p>
<p align="left">Big firms that can tap the credit markets on their own are in much better position than small firms that have to rely on bank loans. Remember that spreads on low-grade corporate debt last winter were higher than the spreads during the Great Depression. While the Fed intervention has not helped everyone, it clearly has helped many.</p>
<p align="left">It is hard to tease out how much of the increased demand for housing and autos is due to the government subsidies, and how much is "real" pent-up demand. The October auto sales were somewhat encouraging in this regard, since Cash for Clunkers was not a factor. The rebound to profits at <strong>Ford </strong>(<a href="http://www.zacks.com/stock/quote/F">F</a>) was real, even if it could be laid at the feet of the Clunkers program. The inventory bounce is real, but is probably temporary.</p>
<p align="left">Get the full analysis of all these stocks by going to <a href="http://at.zacks.com/?id=5507">http://at.zacks.com/?id=5507</a>.</p>
<p align="left"><strong>About the Bull and Bear of the Day</strong></p>
<p align="left">Every day, the analysts at Zacks Equity Research select two stocks that are likely to outperform (Bull) or underperform (Bear) the markets over the next 3-6 months.</p>
<p align="left"><strong>About the Analyst Blog</strong></p>
<p align="left">Updated throughout every trading day, the <a href="http://www.zacks.com/stock/news/AnalystBlog">Analyst Blog</a> provides analysis from Zacks Equity Research about the latest news and events impacting stocks and the financial markets.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous analyst coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks <a href="http://at.zacks.com/?id=5508">"Profit from the Pros"</a> e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting <a href="http://at.zacks.com/?id=5508">http://at.zacks.com/?id=5508</a>.</p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of <a href="http://www.zacks.com/">Zacks Investment Research</a>, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the <a href="http://www.zacks.com/rank/index.php">Zacks Rank</a>, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5509">http://at.zacks.com/?id=5509</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-bull-and-bear-of-the-day-highlights-amdocs-ltd-molina-healthcare-inc-fannie-mae-freddie-mac-and-ford-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Look At The Currency Markets</title>
		<link>http://www.straightstocks.com/investing-education-center/currency-trading/a-look-at-the-currency-markets/</link>
		<comments>http://www.straightstocks.com/investing-education-center/currency-trading/a-look-at-the-currency-markets/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 10:52:34 +0000</pubDate>
		<dc:creator>Rueben Gomez</dc:creator>
				<category><![CDATA[Currency Trading]]></category>
		<category><![CDATA[America]]></category>
		<category><![CDATA[author]]></category>
		<category><![CDATA[currency exchange]]></category>
		<category><![CDATA[Currency Market]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Forex]]></category>
		<category><![CDATA[forex broker]]></category>
		<category><![CDATA[forex-trading]]></category>
		<category><![CDATA[skilled trader]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.straightstocks.com/?p=76835</guid>
		<description><![CDATA[The buying and selling of currencies on the foreign exchange market is what is commonly known as currency trading. Forex trading does seem pretty complicated at first glance. It is in actuality a very uncomplicated concept to grasp and carry through.]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-education-center/currency-trading/a-look-at-the-currency-markets/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mobius: Taking a closer look at Russian markets</title>
		<link>http://www.straightstocks.com/investing-lessons/mobius-taking-a-closer-look-at-russian-markets/</link>
		<comments>http://www.straightstocks.com/investing-lessons/mobius-taking-a-closer-look-at-russian-markets/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 06:20:08 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[consumer products]]></category>
		<category><![CDATA[crude oil]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[executive chairman]]></category>
		<category><![CDATA[gas  production;]]></category>
		<category><![CDATA[gas supplier]]></category>
		<category><![CDATA[Gazprom]]></category>
		<category><![CDATA[integrated oil]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Mark Mobius]]></category>
		<category><![CDATA[MSCI BRIC]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[oil products]]></category>
		<category><![CDATA[producer]]></category>
		<category><![CDATA[Templeton Asset Management;]]></category>
		<category><![CDATA[USD]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13482</guid>
		<description><![CDATA[Emerging markets guru Mark Mobius shares his (bullish) ideas on Russia in this post. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/mobius-taking-a-closer-look-at-russian-markets/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Amdocs, Ltd. (DOX) &#8211; Bull of the Day</title>
		<link>http://www.straightstocks.com/stock-watch/amdocs-ltd-dox-bull-of-the-day-2/</link>
		<comments>http://www.straightstocks.com/stock-watch/amdocs-ltd-dox-bull-of-the-day-2/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 05:00:00 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/commentary/12699/Amdocs%2C+Ltd.+%28DOX%29+-+Bull+of+the+Day</guid>
		<description><![CDATA[We maintain our Outperform recommendation for Amdocs Ltd. (<a href="http://www.zacks.com/stock/quote/dox">DOX</a>), following its strong results for the fiscal fourth quarter of 2009. The company has industry-leading technology integration products for managed services and large transformational projects.
<p>
We believe long-term fundamentals for Amdocs remain firm due to the transition of telecom service providers to converged and
consolidated solutions. Amdocs maintains a very strong financial position with healthy order backlog. 
</p><p>
Recently, the company has won a series of large managed services contracts in various parts of the world. Except Europe, operations in other regions have started gaining momentum.<a href="http://www.zacks.com">Zacks Investment Research</a><br /></p>]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amdocs-ltd-dox-bull-of-the-day-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SOPW, HZHI, BOCL, DrStockPick.com Watch List! for Wednesday November 11, 2009, Solar Power, Inc., Bio-Clean Inc. and Horizon Health International Corp.</title>
		<link>http://www.straightstocks.com/stock-watch/sopw-hzhi-bocl-drstockpick-com-watch-list-for-wednesday-november-11-2009-solar-power-inc-bio-clean-inc-and-horizon-health-international-corp/</link>
		<comments>http://www.straightstocks.com/stock-watch/sopw-hzhi-bocl-drstockpick-com-watch-list-for-wednesday-november-11-2009-solar-power-inc-bio-clean-inc-and-horizon-health-international-corp/#comments</comments>
		<pubDate>Wed, 11 Nov 2009 03:22:24 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[2009 Samson Industries]]></category>
		<category><![CDATA[a ‘Home]]></category>
		<category><![CDATA[advertisment services]]></category>
		<category><![CDATA[Aerojet’s facility]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[assistive technology]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Bio-Clean Inc.]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Calgary]]></category>
		<category><![CDATA[California]]></category>
		<category><![CDATA[California Energy Commission;]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[disability products;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[e - commerce]]></category>
		<category><![CDATA[Electricity Production]]></category>
		<category><![CDATA[energy solution]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[ergonomic solutions]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[GenCorp]]></category>
		<category><![CDATA[Horizon Health International Corp.]]></category>
		<category><![CDATA[MEDIchair]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Office]]></category>
		<category><![CDATA[On-line sales]]></category>
		<category><![CDATA[order processing]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[restoration products]]></category>
		<category><![CDATA[Retail Stores]]></category>
		<category><![CDATA[Sacramento]]></category>
		<category><![CDATA[Samson Industries]]></category>
		<category><![CDATA[Solar Power Inc;]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Workplace Medical Equipment Specialist]]></category>
		<category><![CDATA[www.biocleanbocl.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.medichair-calgary.com]]></category>
		<category><![CDATA[www.solarpowerinc.net]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[Xplosivestocks.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4684</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

DrStockPick.com Watch List!
My Picks for Wednesday November 11, 2009 are:
**************************************************************
SOPW, Solar Power, Inc., SOPW.OB
SOPW is a vertically integrated solar energy solution provider offering the North American commercial and public sector building markets a complete solution through a single brand. Throughout Europe, Asia and Australia [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/sopw-hzhi-bocl-drstockpick-com-watch-list-for-wednesday-november-11-2009-solar-power-inc-bio-clean-inc-and-horizon-health-international-corp/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>CSRH, Consorteum Holdings Inc. Its Consumer Stored Value Rebate Card will Offer Manufacturers and Retailers a New Way to Process Mail-in Rebates</title>
		<link>http://www.straightstocks.com/stock-watch/csrh-consorteum-holdings-inc-its-consumer-stored-value-rebate-card-will-offer-manufacturers-and-retailers-a-new-way-to-process-mail-in-rebates-5/</link>
		<comments>http://www.straightstocks.com/stock-watch/csrh-consorteum-holdings-inc-its-consumer-stored-value-rebate-card-will-offer-manufacturers-and-retailers-a-new-way-to-process-mail-in-rebates-5/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 22:50:40 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[+1 866 824 8854]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[advertising services]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[Consorteum Holdings Inc.;]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[President & COO]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[Quent Rickerby;]]></category>
		<category><![CDATA[seasoned equity trader]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.BestOTC.com]]></category>
		<category><![CDATA[www.consorteum.com]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.crwenewswire.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.PennyOmega.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.stock-pr.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4682</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________
Tuesday November 10, 2009
DrStockPick.com Stock Report!
CSRH, Consorteum Holdings Inc, CSRH.OB
**********************************************************
Consorteum Holdings Inc. Launched Alternative Mail-In Rebate Program for Manufacturers and Retailers
Consorteum Holdings Inc. (OTCBB: CSRH) will build on its extensive expertise within the Payments and Transaction Industry in North America, Europe and Internationally. By [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/csrh-consorteum-holdings-inc-its-consumer-stored-value-rebate-card-will-offer-manufacturers-and-retailers-a-new-way-to-process-mail-in-rebates-5/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>EA Beats, Acquires Playfish &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/ea-beats-acquires-playfish-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/ea-beats-acquires-playfish-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 22:00:08 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Electronic Arts Inc.]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Facebook]]></category>
		<category><![CDATA[google]]></category>
		<category><![CDATA[Internet-derived]]></category>
		<category><![CDATA[Microsoft Corp]]></category>
		<category><![CDATA[News Corp]]></category>
		<category><![CDATA[Nintendo]]></category>
		<category><![CDATA[online-enabled packaged goods]]></category>
		<category><![CDATA[Playfish Ltd.]]></category>
		<category><![CDATA[Software Sales]]></category>
		<category><![CDATA[Sony Corp]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[wireless space]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27132/EA+Beats%2C+Acquires+Playfish+-+Analyst+Blog</guid>
		<description><![CDATA[<strong><em><br />
Strong Second-Quarter Results</em><br />
<br />
Electronic Arts Inc.</strong> (<a href="http://www.zacks.com/stock/quote/erts">ERTS</a>) reported better-than-expected second-quarter results with a steep rise in net earnings and growth in revenue.<br />
<br />
Net income, excluding non-recurring items of 6 cents per share increased 200% from the year-ago loss per share of 6 cents. Earnings also surpassed the Zacks Consensus Estimate of a loss of 6 cents. Effective cost management and a lower tax rate have driven earnings growth.<br />
<br />
Due to the higher cost of sales, gross margin on a non-GAAP basis declined to 48% from 51% in the year-ago period. However, lower operating expenses in the quarter resulted in a better-than-expected operating margin, which improved to 2% from -3% in the year-ago period.<br />
<br />
The company continues to experience a rise in the top-line. Total non-GAAP net revenue, adjusted for deferred revenue of $359 million related to certain online-enabled packaged goods and digital content, increased 1.7% year over year to $1.15 billion in the quarter. Revenue beat the Street expectation, and was driven by the launch of new game titles, which provided an edge to the company&#8217;s quarterly results.<br />
<br />
Sales from Publishing (70% of total revenue) slipped 3%, offset by an increase of 26% in Distribution (30% of total revenue) in the quarter. By geography, North American sales declined 14% from the year-ago period, offset by a growth of 36% in Europe and 19% in Asia.<br />
<br />
By products, packaged good software sales were impacted by weak consumer spending and as a result, declined 1% year over year. The company lowered its 2009 industry outlook for packaged good software sales. However, Wireless, Internet-derived and Advertising revenue increased 20% in the quarter.<br />
<br />
The company generated operating cash flow of $6 million in the quarter versus $328 million of cash used in the previous quarter. Electronic Arts ended the quarter with cash, short-term investments and marketable securities of $2 billion and no long-term debt.<br />
<br />
The gaming industry has been facing the brunt of the global meltdown, with sagging video game sales, lack of new game releases and intense price war among major gaming companies such as <strong>Sony Corp. </strong>(<a href="http://www.zacks.com/stock/quote/sne">SNE</a>), Nintendo and <strong>Microsoft Corp. </strong>(<a href="http://www.zacks.com/stock/quote/msft">MSFT</a>) who recently cut prices of the PS3, Wii and Xbox, respectively. Moreover, retailers remain cautious and consumer spending remains weak.<br />
<br />
Although the upcoming holiday season could be weaker than normal, long-term we expect the video game market to get a boost from the recovery in spending. The traditional U.S. video game market is expected to continue growing, with software sales increasing to $19.5 billion in 2013 from $14.7 billion in 2008.<br />
<br />
<em><strong>Cost Reduction</strong></em><br />
<br />
The company took decisive action to right-size the cost structure and lower operating expenses. Under the cost-cutting initiatives, the company will close down several facilities and reduce headcount by approximately 1,500 positions or about 17% of its workforce.<br />
<br />
Management stated that 1,300 of these positions are included in a restructuring plan. The restructuring is expected to be completed by March 2010. The layoffs will result in an annual cost savings of at least $100 million and restructuring charges of $130 - $150 million.<br />
<br />
In fiscal 2010, management plans to increase focus on titles with higher margins. The product portfolio will be narrowed, with fewer than 40 titles scheduled for release, down from around 60 published last year.<br />
<br />
<em><strong>Guidance</strong></em><br />
<br />
Electronic Arts forecasted full-year 2010 earnings per share of 70 cents to $1, excluding one-time items. The company also expects to remain profitable in the next two quarters. Revenue, adjusted for deferrals is estimated to be $4.2 - $4.4 billion for fiscal 2010.<br />
<br />
<em><strong>Acquisition of Playfish</strong></em><br />
<br />
Electronic Arts announced the acquisition of Playfish Ltd., a leading social games company, for $275 million in cash plus $25 million in equity and other considerations, seeking to expand into the growing social gaming sector and strengthen its focus on new gaming platforms by transitioning to digital and social gaming. Playfish has more than 150 million games installed on platforms such as Facebook, MySpace, <strong>News Corp</strong> (<a href="http://www.zacks.com/stock/quote/nws">NWS</a>), <strong>Google </strong>(<a href="http://www.zacks.com/stock/quote/goog">GOOG</a>) and<strong> Apple</strong> (<a href="http://www.zacks.com/stock/quote/aapl">AAPL</a>).<br />
<br />
Electronic Arts will subsequently pay $100 million more if the company meets undisclosed profit targets through 2011. Playfish will operate within EA Interactive, a division of EA focused on the web and wireless space.<br />
<br />
The Playfish deal is expected to be neutral to adjusted non-GAAP earnings but increase net loss per share on a GAAP basis by 15 cents to 25 cents a share, due primarily to acquisition-related tax expenses, deferred revenue adjustments, additional stock-based compensation and amortization of intangible assets. The company believes Playfish will be accretive to its earnings in fiscal 2011.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ERTS">Read the full analyst report on "ERTS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=SNE">Read the full analyst report on "SNE"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MSFT">Read the full analyst report on "MSFT"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=NWS">Read the full analyst report on "NWS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=GOOG">Read the full analyst report on "GOOG"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=AAPL">Read the full analyst report on "AAPL"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/ea-beats-acquires-playfish-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Dollar Decline in Perspective &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/dollar-decline-in-perspective-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/dollar-decline-in-perspective-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 21:44:42 +0000</pubDate>
		<dc:creator>Dirk Van Dijk</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Coca Cola]]></category>
		<category><![CDATA[energy]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[jimmy carter]]></category>
		<category><![CDATA[often going head]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Sp 500]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Wal Mart]]></category>
		<category><![CDATA[White House]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27134/Dollar+Decline+in+Perspective+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
The dollar has clearly been under pressure this year. Most of the graphs of it that you have seen probably look like the first graph below, which shows what the dollar has done against two indexes since the start of the year. The blue line is how the greenback has fared against the major currencies like the Euro and the Yen, and the red line includes those, but also looks at how it has fared against a much broader collection of currencies.<br />
<br />
Since March 9th, the day the market hit bottom -- and the dollar hit its high for the year -- it is down 14.4% against the major currencies and down 11.5% against the broad basket of currencies.<br />
<br />
This has a number of implications. For starters, anyone from outside the country has seen nice gains if they invested in the U.S. market, but not nearly as eye-popping as the returns that domestic investors have seen. It also means that commodity prices have gone up much less for people based in Europe or Japan than they have for people in the U.S. Yes, the price of oil is up in Yen and Euros this year, but not by nearly as much as in the U.S.<br />
<br />
There are those (many with very large soapboxes) who would have you believe that the decline in the dollar is a crisis. I, however, beg to differ.<br />
<br />
While in the big picture over time it is not desirable to have the currency constantly devalued, at this point the decline is not likely to cause major problems. The major downside to a falling dollar is that it makes our imports more expensive, and thus can contribute to inflation. This is particularly true in the case of oil, which tends to rise as the dollar falls. After all, why should the price of oil for someone in France or Japan go down just because the dollar is weak?<br />
<br />
However, right now such inflation is just offsetting deflation in other parts of the economy. The biggest weighting in the CPI is owner&#8217;s equivalent rent, or what it would cost you to rent a home identical to the one you own next door to your house. It makes up almost 24% of the overall CPI. Add in the rent that people pay to landlords if they don&#8217;t own a house and the figure gets close to 30%. It is part of core inflation, so if you strip out food and energy prices it is almost 40% of the core basket of goods.<br />
<br />
Due to the weak housing market, and rapidly rising rental vacancy rates, rents are likely to be under substantial pressure for some time to come.<br />
<br />
There is one currency, though, that the dollar has not declined against, and that is the Chinese Yuan, since the Chinese peg it to the dollar. Since we import a lot of goods from China, the decline in the dollar is not going to cause inflation in those prices.<br />
<br />
The upside is that it means that our exports are much more competitive. This applies even in China, since we are often going head to head, not against local Chinese companies, but against European or Japanese firms. More exports mean more jobs, and a lower trade deficit.<br />
<br />
Remember that net exports are a direct input into the GDP calculations. With an unemployment rate of 10.2% and rising, getting the economy moving again is a FAR higher priority than fighting inflation during a time of major deflationary pressures.<br />
<br />
Since many U.S. companies have substantial operations abroad, or export goods, the decline in the dollar means a major tailwind to their earnings, since the euro they earned is worth more in dollars today than the euro they earned a few months ago was worth then. For the S&#38;P 500 as a whole, more than 40% of the earnings come from abroad. For many companies like <strong>Coca Cola </strong>(<a href="http://www.zacks.com/stock/quote/ko">KO</a>) and <strong>Colgate Palmolive</strong> (<a href="http://www.zacks.com/stock/quote/cl">CL</a>), it is much higher than that.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1257888642.jpg" alt="" /><br />
<br />
One also has to take a longer-term look. The dollar has been slipping against both indexes since 2001, but there was a huge and sharp counter-trend rally a year ago as the world economy saw the wheels come off. The U.S. has always been a safe haven in times of distress, and around the world people flocked to pull their money out of Pounds and Rupees as they tried to find a safe place to hide in the turmoil.<br />
<br />
The dollar still has not returned to the lows it saw early last year. Seeing the dollar decline as a crisis is sort of like seeing the decline in the TED spread as a crisis. It is not -- it is a sign that things are getting back to normal.<br />
<br />
Also, the dollar has suffered far greater declines in the past with no major ill effects on the economy. To believe that a 14.4% decline in the dollar today is going to cause major havoc in the economy, then one must remember the last half of the 1980&#8217;s -- when the dollar fell by almost 40% against other major currencies -- as a period of economic disaster. Somehow that is not my recollection of the time.<br />
<br />
<img src="http://www.zacks.com/images/upload_dir/1257888656.jpg" alt="" /><br />
<br />
Given the chronic trade deficits this country is running, and has been running for a long time, a weak dollar might not be good, but it is necessary. The last quarter we ran a trade surplus in was the 3Q of 1980. That&#8217;s right, when Jimmy Carter was in the White House.<br />
<br />
While recently the trade deficit has come down, it was still 2.71% of GDP in the third quarter. That is still an awful number for our long-term economic health. However, it looks great when you consider that the trade deficit has averaged 4.575 of GDP so far this century and was over 5% of GDP for three straight years, from the second quarter of 2004 through the second quarter of 2007.<br />
<br />
It is the trade deficit that determines how indebted we are to the rest of the world, not the fiscal deficit. We have run up big debts to the rest of the world, resulting in China for example owning over $1.5 Trillion in T-notes. In return, we got all the stuff that line the shelves of <strong>Wal-Mart </strong>(<a href="http://www.zacks.com/stock/quote/wmt">WMT</a>). Now the credit card statement has come and we have to start paying. As the dollar falls it means we get to pay that debt back cheaper. We have to make and sell less stuff overseas compared to the stuff that was made abroad and sent here.<br />
<br />
Now, other countries might not be all that happy about it, but what are they going to do? Sell their dollars so we can repay even cheaper? As long as the decline in the dollar is gradual and orderly, it will help boost the economy. The stock market realizes this. The fact that the market bottomed on the same day the dollar peaked out was no coincidence.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=KO">Read the full analyst report on "KO"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=CL">Read the full analyst report on "CL"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/dollar-decline-in-perspective-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>PWRM, TEVA, DrStockPick.com Stock Report! Power 3 Medical Products Inc. and  Teva Pharmaceutical Industries Ltd.</title>
		<link>http://www.straightstocks.com/stock-watch/pwrm-teva-drstockpick-com-stock-report-power-3-medical-products-inc-and-teva-pharmaceutical-industries-ltd/</link>
		<comments>http://www.straightstocks.com/stock-watch/pwrm-teva-drstockpick-com-stock-report-power-3-medical-products-inc-and-teva-pharmaceutical-industries-ltd/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 21:02:31 +0000</pubDate>
		<dc:creator>Dr. Stock Pick</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[active pharmaceutical ingredients;]]></category>
		<category><![CDATA[advertisement services]]></category>
		<category><![CDATA[ALS]]></category>
		<category><![CDATA[animal health pharmaceutical products]]></category>
		<category><![CDATA[Beijing]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[broker]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Chair and Keynote Speaker]]></category>
		<category><![CDATA[chief scientific officer]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Crown Equity Holdings Inc.;]]></category>
		<category><![CDATA[Delaware]]></category>
		<category><![CDATA[diagnostic tests]]></category>
		<category><![CDATA[Dr Stock Pick]]></category>
		<category><![CDATA[equity trader]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Fda]]></category>
		<category><![CDATA[generic and innovative human pharmaceuticals]]></category>
		<category><![CDATA[generic pharmaceutical]]></category>
		<category><![CDATA[Houston]]></category>
		<category><![CDATA[International Congress]]></category>
		<category><![CDATA[Ira Goldknopf]]></category>
		<category><![CDATA[neurodegenerative disease;]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Pharmaceutical]]></category>
		<category><![CDATA[Power 3 Medical Products Inc.]]></category>
		<category><![CDATA[Power3 Medical Products Inc.;]]></category>
		<category><![CDATA[Power3;]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Prevacid® (Lansoprazole)]]></category>
		<category><![CDATA[professional investment analyst and consultant]]></category>
		<category><![CDATA[stock featured on our site;]]></category>
		<category><![CDATA[Stock Pick]]></category>
		<category><![CDATA[Takeda Pharmaceuticals North America Inc.;]]></category>
		<category><![CDATA[Teva Pharmaceutical Industries Ltd]]></category>
		<category><![CDATA[Texas]]></category>
		<category><![CDATA[U.S. District Court for the District of Delaware]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[www.crowntradingsystems.com]]></category>
		<category><![CDATA[www.crwenews.com]]></category>
		<category><![CDATA[www.drstockpick.com]]></category>
		<category><![CDATA[www.power3medical.com]]></category>
		<category><![CDATA[www.stock-ir.com]]></category>
		<category><![CDATA[www.tevapharm.com]]></category>

		<guid isPermaLink="false">http://drstockpick.com/?p=4678</guid>
		<description><![CDATA[Dr Stock Pick HOT News &#38; Alerts!
_________________________________________

FREE Daily Stock Alerts From DrStockPick.com

_________________________________________

Tuesday November 10, 2009
DrStockPick.com Stock Report!
PWRM, TEVA
**************************************************************
PWRM, Power 3 Medical Products Inc, PWRM.OB
Power3 Medical Products, Inc. is a leading bio-medical company engaged in the commercialization of neurodegenerative disease and cancer biomarkers, pathways, and mechanisms of diseases through the development of diagnostic tests and drug [...]]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/pwrm-teva-drstockpick-com-stock-report-power-3-medical-products-inc-and-teva-pharmaceutical-industries-ltd/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>TRW Posts Robust Profit &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/trw-posts-robust-profit-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/trw-posts-robust-profit-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 20:37:48 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Michigan]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Technology Products]]></category>
		<category><![CDATA[TRW]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27124/TRW+Posts+Robust+Profit+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>TRW Automotive</strong> (<a href="http://www.zacks.com/stock/quote/trw">TRW</a>) has revealed a staggering rise in profits to $76 million or 68 cents per share in the third quarter ended Oct. 2, 2009, from a net loss of $22 million or 22 cents per share in the prior-year quarter. <br />
<br />
The profit was also significantly higher than the Zacks Consensus Estimate of 14 cents per share. The Michigan-based manufacturer of advanced technology products and services for the automotive markets commended its restructuring and cost containment actions for its impressive rise in profit.<br />
<br />
Operating income for the quarter went up to $165 million from $44 million in the prior-year period. Apart from restructuring and cost containment actions, this was driven by lower raw material prices and favorable non-recurring supplier and customer settlements.<br />
<br />
During the quarter, TRW continued to reduce its salaried workforce by an additional 200 employees, which brings the total salaried reductions to about 3,000 since the commencement of programs last year.<br />
<br />
However, sales of $3.1 billion, a decline of 13.5%, were adversely affected by lower sales in most geographic regions resulting from reduced vehicle production volumes. This apart, currency movements also had a negative impact on sales.<br />
<br />
<em><strong>Financial Position</strong></em><br />
<br />
TRW had cash and cash equivalents of $474 million as of Oct. 2, 2009, a decline from $756 million a year ago. Long-term debt amounted to $2.5 billion as on that date. This reflected a long-term debt to capitalization ratio of 60%.<br />
<br />
In the nine months ended Oct. 2, 2009, TRW had a net cash outflow of $57 million from operating activities compared to an inflow of $4 million in the year-ago period. The decline in cash position was attributed to lower operating income, partially offset by lower working capital requirements. Capital expenditures reduced to $121 million from $338 million in 2008. The company had free cash outflow of $178 million in the above period compared to $334 million in the prior-year period.<br />
<br />
<em><strong>Road Ahead</strong></em><br />
<br />
TRW anticipates full-year production to gross 8.6 million units in North America and 16.3 million units in Europe. Based on these revisions and the expectations for foreign currency exchange rates, full-year sales are expected to be $11.4 billion, a bit higher than the Zacks Consensus Estimate of $11.1 billion.<br />
<br />
We believe TRW&#8217;s innovative product portfolio is capable of generating top- and bottom-line growth. It has been successful in its restructuring and cost-containment actions to mitigate the impact of the industry-wide downturn as reflected in the better-than-expected third-quarter results. However, the company still needs to go through the long and gradual process of recovery in the industry. Due to these factors, we recommend the shares of the company as Neutral.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=TRW">Read the full analyst report on "TRW"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/trw-posts-robust-profit-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Flowserve Beats Zacks Consensus &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/flowserve-beats-zacks-consensus-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/flowserve-beats-zacks-consensus-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 19:22:07 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[aftermarket equipment services]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[chemical]]></category>
		<category><![CDATA[chemical and general industries markets]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[flow control]]></category>
		<category><![CDATA[Flowserve Corporation]]></category>
		<category><![CDATA[ITT Corporation;]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oil And Gas]]></category>
		<category><![CDATA[precision-engineered flow control equipment]]></category>
		<category><![CDATA[through distributors]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27115/Flowserve+Beats+Zacks+Consensus+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Flowserve Corporation </strong>(<a href="http://www.zacks.com/stock/quote/FLS">FLS</a>) announced third quarter 2009 fully diluted EPS of $2.07, up 3 cents or 1%, including realignment charges of 5 cents per share. This was higher than the Zacks Consensus Estimate of $2.00 per share. <br />
<br />
Bookings for the quarter were $975 million, down 29%, or 26% excluding negative currency effects of $37 million. Sales for the quarter were $1.05 billion, down 9%, or 5% excluding negative currency effects of $47 million. <br />
<br />
Gross margin increased 150 basis points to 36.6%, including realignment charges of 20 basis points. Flowserve also posted a quarterly operating margin of 15.3%, including charges totaling 110 basis points. Backlog, which represents unexecuted orders, was $2.66 billion, including positive currency effects of $90 million, when compared to $2.83 billion of backlog at Dec 31, 2008. <br />
<br />
In the pump division, bookings of original equipment decreased approximately 60%, which represents most of the total decrease. This original equipment decrease was driven by a decline across all industries, primarily the chemical, oil and gas and general industries markets. <br />
<br />
In the flow control division, bookings decrease was generally attributable to a weakness in the chemical and general industries markets in Europe, Middle East and Africa and Asia-Pacific, partially offset by nuclear orders in North America. Large project awards were delayed as customers reviewed demand, pricing and other savings opportunities. <br />
<br />
In flow solutions division, bookings decrease was primarily attributable to decreased original equipment. The decrease in sales was driven by sales declines in all regions. Reductions in project sales shifted the sales mix toward aftermarket business with a related beneficial impact on gross margin. <br />
<br />
Cash and equivalents were $291 million, long-term debt was $541 million and shareowner&#8217;s equity was $1.7 billion. <br />
<br />
Flowserve Corporation develops, manufactures and sells precision-engineered flow control equipment, besides providing a range of aftermarket equipment services. The company operates in three divisions: Flowserve Pump, Flow Control and Flow Solutions. The company sells its products through direct sales force as well as through distributors and sales representatives. Major competitor is <strong>ITT Corporation</strong> (<a href="http://www.zacks.com/stock/quote/ITT">ITT</a>).<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=FLS">Read the full analyst report on "FLS"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=ITT">Read the full analyst report on "ITT"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/flowserve-beats-zacks-consensus-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Pasko: Dvorishchi ain&#8217;t no Cape Town</title>
		<link>http://www.straightstocks.com/investing-lessons/pasko-dvorishchi-aint-no-cape-town/</link>
		<comments>http://www.straightstocks.com/investing-lessons/pasko-dvorishchi-aint-no-cape-town/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 19:03:05 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[atomic energy;]]></category>
		<category><![CDATA[Auchan]]></category>
		<category><![CDATA[Cape Town]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[cologne]]></category>
		<category><![CDATA[Copenhagen]]></category>
		<category><![CDATA[Dvorishchi]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[first president]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[gas pipeline]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[H. Pohamba]]></category>
		<category><![CDATA[Kazakhstan]]></category>
		<category><![CDATA[Krasnoturyinsk]]></category>
		<category><![CDATA[Lake Baikal;]]></category>
		<category><![CDATA[mass information media]]></category>
		<category><![CDATA[mass media reports]]></category>
		<category><![CDATA[minister]]></category>
		<category><![CDATA[Moscow]]></category>
		<category><![CDATA[N. Angula]]></category>
		<category><![CDATA[Namibia]]></category>
		<category><![CDATA[Nord Stream]]></category>
		<category><![CDATA[Nord Stream gas pipeline;]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Oil Refinery]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Prime Minister]]></category>
		<category><![CDATA[Republic of South Africa;]]></category>
		<category><![CDATA[RUB]]></category>
		<category><![CDATA[Russia's Ministry for the Protection of the Environment and Natural Resources]]></category>
		<category><![CDATA[Russian Federation]]></category>
		<category><![CDATA[S. Nujoma]]></category>
		<category><![CDATA[South Africa]]></category>
		<category><![CDATA[thermal energy;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Vladimir Oblast]]></category>
		<category><![CDATA[Waste Processing]]></category>
		<category><![CDATA[Yuri Petrovich]]></category>
		<category><![CDATA[Yuri Petrovich Trutnev]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22103</guid>
		<description><![CDATA[The last week of October was a tense time for the bureaucrats at Minprirody, Russia's Ministry for the Protection of the Environment and Natural Resources, and naturally for Minister Yuri Petrovich Trutnev. He went all the way to Cape Town,...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/pasko-dvorishchi-aint-no-cape-town/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>McDonald&#8217;s Outdoing Rivals &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/mcdonalds-outdoing-rivals-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/mcdonalds-outdoing-rivals-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 15:30:10 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Africa]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia]]></category>
		<category><![CDATA[Australia]]></category>
		<category><![CDATA[Burger King Holdings Inc.;]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Cosi Inc.]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[food]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[Germany]]></category>
		<category><![CDATA[Japan]]></category>
		<category><![CDATA[Mcdonalds]]></category>
		<category><![CDATA[menu products]]></category>
		<category><![CDATA[Middle East]]></category>
		<category><![CDATA[Red Robin Gourmet Burgers Inc.;]]></category>
		<category><![CDATA[United Kingdom]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Yum Brands Inc]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27096/McDonald%27s+Outdoing+Rivals+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>McDonald&#8217;s Corporation&#8217;s</strong> (<a href="http://www.zacks.com/stock/MCD">MCD</a>) comparable sales for the month of October 2009 showed a sluggish growth of 3.3% as against the rise of 8.2% in the same month last year, exposing its sensitivity to rising unemployment, economic downturn, and the discount war amongst fast-food chains to lure consumers.<br />
 <br />
The company faces stiff competition from <strong>Burger King Holdings Inc</strong>. (<a href="http://www.zacks.com/stock/BKC">BKC</a>), <strong>Wendy&#8217;s/Arby&#8217;s Group, Inc</strong>. (<a href="http://www.zacks.com/stock/WEN">WEN)</a> and <strong>Yum! Brands Inc.</strong> (<a href="http://www.zacks.com/stock/YUM">YUM</a>). However, these quick-service operators are faring better than casual dining restaurant chains, such as <strong>Cosi Inc.</strong> (<a href="http://www.zacks.com/stock/COSI">COSI)</a> and <strong>Red Robin Gourmet Burgers Inc</strong>. (<a href="http://www.zacks.com/stock/RRGB">RRGB</a>), as cash-strapped consumers are trading towards fast-food centers due to relative cheap dining options. <br />
<br />
System-wide sales at McDonald&#8217;s worldwide restaurants climbed 10.3% for the month of October. However, in constant currencies, the rate of increase in system-wide sales dipped to 5.2%.&#8232; In the United States , comparable sales remained flat falling 0.1% in October (versus 5.3% increase last year for the comparable month). New menu products, including Angus Third Pounders and McCafe premium coffee line-up continued to support the month's results. <br />
<br />
The fast-food giant had earlier indicated that U.S. sales for the month of October would be weak. Still the month&#8217;s result fared better than the overall quick-service restaurant industry. <br />
<br />
In Europe, comparable sales increased 6.4% in October (versus 9.8% increase last year for the comparable month) fueled by strong performance in the U.K. , Germany and France . A variety of mid-tier items and premium menu options contributed to sales. &#8232;Comparable sales in Asia/Pacific, Middle East and Africa (APMEA) rose 4.7% in October (versus 11.5% increase last year for the comparable month) driven by Australia and Japan, partly offset by China.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=MCD">Read the full analyst report on "MCD"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=BKC">Read the full analyst report on "BKC"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=WEN">Read the full analyst report on "WEN"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=YUM">Read the full analyst report on "YUM"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=COSI">Read the full analyst report on "COSI"</a><br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=RRGB">Read the full analyst report on "RRGB"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/mcdonalds-outdoing-rivals-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Hain&#8217;s Earnings in Line &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/hains-earnings-in-line-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/hains-earnings-in-line-analyst-blog/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 14:15:41 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Canada]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Hain Pure Protein Corporation]]></category>
		<category><![CDATA[Personal Care Products]]></category>
		<category><![CDATA[Turkey]]></category>
		<category><![CDATA[turkey products]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27091/Hain%27s+Earnings+in+Line+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
The <strong>Hain Celestial Group, Inc</strong>. (<a href="http://www.zacks.com/stock/hain">HAIN</a>), recently reported first-quarter 2010 results. The quarterly earnings of 23 cents a share were in line with the Zacks Consensus Estimate, but fell 17.9% from 28 cents delivered in the prior-year quarter.<br />
 <br />
However, on a reported basis, including one-time items, quarterly earnings came in at 20 cents, and jumped 17.6% from 17 cents posted in the year-ago quarter. Management reiterated that it expects its fiscal year 2010 earnings in the range of $1.19 to $1.28 per share. The Zacks Consensus Estimate of $1.22 per share lies at the low end of the range.<br />
 <br />
Revenue for the quarter tumbled 19.6% to $230.5 million from $286.8 million reported in the prior-year quarter. The quarterly revenue was hurt by higher promotional cost, fall in personal care product sales to drug stores and foreign currency fluctuations. <br />
<br />
Included in the prior-year quarter revenue is $38.4 million sales related to Hain Pure Protein (HPP). Excluding this, revenue for the quarter fell 7.2% year-over-year. Effective Jun 30, 2009, Hain is not incorporating HPP&#8217;s results due to the reduction in the company&#8217;s ownership interest to 48.7% from 50.1%.<br />
 <br />
Hain Pure Protein Corporation processes, markets and distributes antibiotic-free chicken and turkey products. The company expects fiscal year 2010 sales to increase in the range of 4% to 6%. Net sales are anticipated between $1 billion to $1.02 billion.<br />
 <br />
The company in order to protect its shrunken revenue base is attempting to pare its cost structure by trimming headcount, consolidating production locations and achieving optimum productivity. Gross margin expanded 280 basis points to 26.8% during the quarter.The quarterly result also benefited from 20.2% decline in the selling, general and administrative expenses.<br />
 <br />
Hain Celestial produces, distributes, markets, and sells various natural and organic foods as well as personal care products in the United States (U.S.), Canada and Europe . Despite the economic headwinds, management indicated that its U.S. operations remain strong. <br />
<br />
The company generated free cash flow of $30.4 million in the trailing 12-month period. Hain&#8217;s balance sheet remains healthy with debt being 33.8% of shareholders&#8217; equity of $716.1 million. During the quarter, the company lowered its debt by $16.3 million.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=HAIN">Read the full analyst report on "HAIN"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/hains-earnings-in-line-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Zacks Analyst Blog Highlights: Sun Microsystems, Inc., Oracle Corp., International Business Machines, Hewlett-Packard and Microsoft &#8211; Press Releases</title>
		<link>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-sun-microsystems-inc-oracle-corp-international-business-machines-hewlett-packard-and-microsoft-press-releases/</link>
		<comments>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-sun-microsystems-inc-oracle-corp-international-business-machines-hewlett-packard-and-microsoft-press-releases/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 12:00:45 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[Asia Pacific]]></category>
		<category><![CDATA[Blog]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Chicago]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[european commission]]></category>
		<category><![CDATA[Hewlett-Packard]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[Leonard Zacks;]]></category>
		<category><![CDATA[microsoft]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[Oracle Corp.]]></category>
		<category><![CDATA[Securities And Exchange Commission]]></category>
		<category><![CDATA[storage products;]]></category>
		<category><![CDATA[Sun Microsystems Inc.;]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Investment Research Inc.;]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27086/Zacks+Analyst+Blog+Highlights%3A+Sun+Microsystems%2C+Inc.%2C+Oracle+Corp.%2C+International+Business+Machines%2C+Hewlett-Packard+and+Microsoft+-+Press+Releases</guid>
		<description><![CDATA[<p align="left"><strong>For Immediate Release</strong></p>
<p align="left">Chicago, IL &#8211; November 10, 2009 &#8211; Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: <strong>Sun Microsystems, Inc. </strong>(<a href="void(0)">JAVA</a>), <strong>Oracle Corp. </strong>(<a href="void(0)">ORCL</a>), <strong>International Business Machines </strong>(<a href="void(0)">IBM</a>), <strong>Hewlett-Packard </strong>(<a href="void(0)">HPQ</a>) and <strong>Microsoft </strong>(<a href="void(0)">MSFT</a>).</p>
<p align="left">Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5513">http://at.zacks.com/?id=5513</a></p>
<p align="left"><strong>Here are highlights from Monday&#8217;s Analyst Blog: </strong></p>
<p align="left"><strong>JAVA Earnings Beat, Sales Lag</strong></p>
<p align="left"><strong>Sun Microsystems, Inc. </strong>(<a href="void(0)">JAVA</a>) reported results for the first quarter of fiscal 2010 in an SEC filing. Lower operating expenses and higher gross margin helped the company lower its first quarter GAAP loss to $120 million, or 16 cents per share from a loss of $1.68 billion or $2.24 per share reported in the year-ago period and beating the Zacks Consensus estimate of a loss of 23 cents per share.</p>
<p align="left">Earnings on a non-GAAP basis (excluding one-time items) rose to 2 cents per share in the quarter from a net loss of 8 cents per share in the year-ago period. Gross margin improved to 43.4% from 40.2% a year ago. Operating expenses were down 62.3% year over year, as a result of which operating margin improved to -4.5% from -55.2% in the year-ago quarter.</p>
<p align="left">However, total revenue fell 25% to $2.24 billion, with both Products and Service revenues declining 32.7% and 13.9%, respectively from the year-ago period. Revenue was lower than the Zacks Consensus estimate of $2.34 billion. Sales on a year-over-year basis were down 19.1% in North America, down 29.2% in Europe , down 32.8% in emerging markets and down 23.3% in the Asia-Pacific.</p>
<p align="left">Revenue from servers fell 31.4% and from storage products almost 35.9% compared to the year-ago period. Revenue from new products dropped 33%, while unit sales of servers were down 41%.</p>
<p align="left">Revenue from Support Services decreased primarily due to customers seeking higher discounts, delays in service contract renewals and strong competitive pressures. Professional Services revenue decreased primarily due to decreased sales in the Systems business.</p>
<p align="left">The company said that revenue fell across all of its product lines negatively impacted by the pending approval from the European Commission and other foreign regulators on its acquisition by <strong>Oracle Corp. </strong>(<a href="void(0)">ORCL</a>). The delay in approval from the regulatory body is causing Sun Micro to lose about $100 million each month.</p>
<p align="left">Sun had earlier announced a headcount reduction of 3,000 or 10% over the next 12 months. It has already eliminated 7,600 positions in the past three years. The company, which is under severe financial pressure, is struggling to survive the recession.</p>
<p align="left">Despite cost-cutting efforts and increased layoffs, we remain concerned about the delay in closing the merger, which could reduce its value for Oracle's business. Moreover, rivals such as <strong>International Business Machines </strong>(<a href="void(0)">IBM</a>), <strong>Hewlett-Packard </strong>(<a href="void(0)">HPQ</a>) and <strong>Microsoft </strong>(<a href="void(0)">MSFT</a>) are taking advantage of the delay by giving discounts to customers.</p>
<p align="left">Want more from Zacks Equity Research? Subscribe to the free Profit from the Pros newsletter: <a href="http://at.zacks.com/?id=5515">http://at.zacks.com/?id=5515</a>.</p>
<p align="left"><strong>About Zacks Equity Research</strong></p>
<p align="left">Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.</p>
<p align="left">Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.</p>
<p align="left">Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today: <a href="http://at.zacks.com/?id=5517">http://at.zacks.com/?id=5517</a></p>
<p align="left"><strong>About Zacks </strong></p>
<p align="left">Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at <a href="http://at.zacks.com/?id=5518">http://at.zacks.com/?id=5518</a>.</p>
<p align="left">Visit <a href="http://www.zacks.com/performance">http://www.zacks.com/performance</a> for information about the performance numbers displayed in this press release.</p>
<p align="left">Follow us on Twitter: <a href="http://twitter.com/zacksresearch">http://twitter.com/zacksresearch</a></p>
<p align="left">Join us on Facebook: <a href="http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts">http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts</a></p>
<p align="left">Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.</p>
<p align="left">Contact:<br />
Mark Vickery<br />
Web Content Editor<br />
312-265-9380<br />
Visit: <a href="www.zacks.com">www.zacks.com </a></p>
<p align="left"> </p>
<p align="left"> </p><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/zacks-analyst-blog-highlights-sun-microsystems-inc-oracle-corp-international-business-machines-hewlett-packard-and-microsoft-press-releases/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RA&#8217;s Daily Russian News Blast &#8211; Nov 10, 2009</title>
		<link>http://www.straightstocks.com/investing-lessons/ras-daily-russian-news-blast-nov-10-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/ras-daily-russian-news-blast-nov-10-2009/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 09:25:36 +0000</pubDate>
		<dc:creator>Robert Amsterdam</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Russia]]></category>
		<category><![CDATA[adviser]]></category>
		<category><![CDATA[Alexei Dymovsky]]></category>
		<category><![CDATA[Angela Merkel]]></category>
		<category><![CDATA[BBC]]></category>
		<category><![CDATA[Berlin]]></category>
		<category><![CDATA[Constitutional Court;]]></category>
		<category><![CDATA[Corruption-highlighting policeman]]></category>
		<category><![CDATA[Ekaterinburg]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Gazprom]]></category>
		<category><![CDATA[Herbert Knosowski]]></category>
		<category><![CDATA[Igor Yurgens]]></category>
		<category><![CDATA[Interior Minister]]></category>
		<category><![CDATA[Investigative committee]]></category>
		<category><![CDATA[Kalashnikov]]></category>
		<category><![CDATA[Kati Marton]]></category>
		<category><![CDATA[law enforcers;]]></category>
		<category><![CDATA[leader]]></category>
		<category><![CDATA[Leonid Gozman]]></category>
		<category><![CDATA[Medvedev]]></category>
		<category><![CDATA[Mikhael Gorbachev]]></category>
		<category><![CDATA[Moscow]]></category>
		<category><![CDATA[Moscow Times]]></category>
		<category><![CDATA[Nina Ognianova]]></category>
		<category><![CDATA[Nobel prize winning physicist]]></category>
		<category><![CDATA[Okhta Center;]]></category>
		<category><![CDATA[Omsk;]]></category>
		<category><![CDATA[physicist]]></category>
		<category><![CDATA[policeman]]></category>
		<category><![CDATA[president]]></category>
		<category><![CDATA[Protect Journalists]]></category>
		<category><![CDATA[Putin]]></category>
		<category><![CDATA[Rashid Nurgaliyev]]></category>
		<category><![CDATA[Russia's military]]></category>
		<category><![CDATA[Russian Government]]></category>
		<category><![CDATA[St. Petersburg]]></category>
		<category><![CDATA[State University]]></category>
		<category><![CDATA[tank head]]></category>
		<category><![CDATA[The Moscow Times]]></category>
		<category><![CDATA[the Times]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[Vitaly Ginzbur]]></category>
		<category><![CDATA[Yabloko]]></category>
		<category><![CDATA[Yabloko party]]></category>
		<category><![CDATA[youtube]]></category>

		<guid isPermaLink="false">tag:www.robertamsterdam.com,2009://1.22089</guid>
		<description><![CDATA[TODAY: Youtube policeman faces slander investigation; Omsk students threatened with expulsion; Committee to Protect Journalists urge global attention to threats against media in Russia. Merkel thanks Gorbachev; Medvedev approves new military bill; advocates abolition of death penalty. Delay for Gazprom...]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/ras-daily-russian-news-blast-nov-10-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Prieur’s readings (November 10, 2009)</title>
		<link>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-10-2009/</link>
		<comments>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-10-2009/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 07:35:48 +0000</pubDate>
		<dc:creator>Prieur du Plessis</dc:creator>
				<category><![CDATA[Asia]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Market Commentary]]></category>
		<category><![CDATA[Anoop Singh]]></category>
		<category><![CDATA[Bank]]></category>
		<category><![CDATA[bank of england]]></category>
		<category><![CDATA[Barclays Capital]]></category>
		<category><![CDATA[Bernie Sanders;]]></category>
		<category><![CDATA[central bank]]></category>
		<category><![CDATA[Cesar Bacani]]></category>
		<category><![CDATA[Congress]]></category>
		<category><![CDATA[Economist]]></category>
		<category><![CDATA[Edmund Conway;]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[Federal Reserve System]]></category>
		<category><![CDATA[Financial Times]]></category>
		<category><![CDATA[Frederic Mishkin]]></category>
		<category><![CDATA[head]]></category>
		<category><![CDATA[independent U.S. senator]]></category>
		<category><![CDATA[investment postcards]]></category>
		<category><![CDATA[Jim Rogers]]></category>
		<category><![CDATA[Kevin Drawbaugh]]></category>
		<category><![CDATA[Louis Uchitelle]]></category>
		<category><![CDATA[Mark Thoma]]></category>
		<category><![CDATA[Michael Pettis]]></category>
		<category><![CDATA[Nelson Schwartz]]></category>
		<category><![CDATA[nouriel roubini]]></category>
		<category><![CDATA[Oil]]></category>
		<category><![CDATA[Paul Krugman]]></category>
		<category><![CDATA[Paul McCulley]]></category>
		<category><![CDATA[precious-metals strategist]]></category>
		<category><![CDATA[Printing Presses]]></category>
		<category><![CDATA[Suki Cooper;]]></category>
		<category><![CDATA[the New York Times]]></category>
		<category><![CDATA[United States]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[William Pesek]]></category>
		<category><![CDATA[William Rees-Mogg;]]></category>

		<guid isPermaLink="false">http://www.investmentpostcards.com/?p=13434</guid>
		<description><![CDATA[This post provides links to a number of interesting articles I have read over the past few days that you may also enjoy. Please also add the links to any other worthwhile articles you would like to share to the comments section. ]]></description>
		<wfw:commentRss>http://www.straightstocks.com/investing-lessons/prieur%e2%80%99s-readings-november-10-2009/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Amdocs Outperforms Expectations &#8211; Analyst Blog</title>
		<link>http://www.straightstocks.com/stock-watch/amdocs-outperforms-expectations-analyst-blog/</link>
		<comments>http://www.straightstocks.com/stock-watch/amdocs-outperforms-expectations-analyst-blog/#comments</comments>
		<pubDate>Mon, 09 Nov 2009 22:05:08 +0000</pubDate>
		<dc:creator>Zacks Market Commentaries</dc:creator>
				<category><![CDATA[Investing Lessons]]></category>
		<category><![CDATA[Stocks to Watch]]></category>
		<category><![CDATA[Amdocs Limited]]></category>
		<category><![CDATA[Analyst]]></category>
		<category><![CDATA[cent;]]></category>
		<category><![CDATA[Equity]]></category>
		<category><![CDATA[Europe]]></category>
		<category><![CDATA[North America]]></category>
		<category><![CDATA[satellite businesses]]></category>
		<category><![CDATA[USD]]></category>
		<category><![CDATA[Zacks Market Commentaries]]></category>

		<guid isPermaLink="false">http://www.zacks.com/stock/news/27077/Amdocs+Outperforms+Expectations+-+Analyst+Blog</guid>
		<description><![CDATA[<br />
<strong>Amdocs Limited</strong> (<a href="http://www.zacks.com/stock/quote/dox">DOX</a>) declared better-than-expected financial results for the fourth quarter of fiscal 2009. Total revenue of $707.4 million was down 14.3% year-over-year but well above the Zacks Consensus Estimate of $681 million. The company said its revenue from managed services business together with cable and satellite businesses have started to stabilize.<br />
 <br />
Quarterly net income on a GAAP basis was $85.8 million or 42 cents per share, compared to net income of $82.7 million or 38 cents per share in the prior-year quarter. However, fourth quarter adjusted (excluding special items) EPS was 49 cents, significantly above the Zacks Consensus Estimate of 45 cents. This was primarily due to a continuous effort taken by management to streamline the cost structure.<br />
<br />
Cost of sales in the reported quarter was $450.7 million, an improvement of 15.1% year-over-year. As a result, gross margin in the reported quarter was 37% compared to 36.4% in the year-ago quarter. Quarterly operating expenses were $159.9, down 11.6% year-over-year. At the end of the reported quarter, total order backlog was $2,385 million compared to $2,370 million at the end of the pervious quarter.<br />
 <br />
During the fourth quarter, Amdocs generated $183.7 million of cash from operations compared to $178 million in the prior-year quarter. Quarterly free cash flow (cash flow from operations less capital expenditures) was $165.8 million, compared to $145 million in the prior-year quarter. At the end of fiscal 2009, the company had more than $1,173 million of cash and marketable securities and just $1 million of outstanding debt on its balance sheet, compared to $1,244.4 million of cash and marketable securities and just $450 million of outstanding debt at the end of fiscal 2008.<br />
 <br />
<em><strong>Segment Results</strong></em><br />
 <br />
Service revenue was $680.2 million, down 13.2% year-over-year. License revenue was $27.3 million, down 35% year-over-year. Technologically, Customer Experience revenue was $668.6 million, down 11.6% year-over-year. Systems Directory revenue was down year-over-year. Geographically, North America generated $528 million (down 5.5% year-over-year) of fourth quarter revenue, Europe generated $93 million (down 38.4% year-over-year), and the Rest of World generated the remaining $86.4 million (down 25.3% year-over-year).<br />
 <br />
<em><strong>Future Financial Outlook</strong></em><br />
 <br />
Management is expecting first quarter 2010 revenue to be within the range of $705 million - $725 million. Diluted non-GAAP EPS, excluding acquisition-related cost and equity based compensation, is forecasted in the range of $0.51-$0.55. Equity-based compensation is expected at approximately $0.04-$0.05 per diluted share. Diluted EPS, on a GAAP basis, is expected to be within the range of $0.38 - $0.44.<br /><a href="http://register.zacks.com/ucd/step1.php?ALERT=YAHOO_ZR&#38;d_alert=rd_final_rank&#38;ADID=GENSYND_ZER&#38;t=DOX">Read the full analyst report on "DOX"</a><br /><a href="http://www.zacks.com">Zacks Investment Research</a><br />]]></description>
		<wfw:commentRss>http://www.straightstocks.com/stock-watch/amdocs-outperforms-expectations-analyst-blog/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
